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Abstract 
Quaternary amines such as choline and carnitine are essential nutrients for humans 
supplied from daily food; however, quaternary amines metabolism by gut 
microbiota can lead to the development of various diseases, including non-alcoholic 
fatty liver disease and cardiovascular disease. It is hypothesized that both diseases 
are promoted by microbial catabolism of choline and carnitine to trimethylamine 
(TMA).  
Proteus mirabilis is a Gram-negative gut proteobacterium, which can metabolize 
choline anaerobically to form TMA. I demonstrated that the identified cutC gene is 
essential for choline degradation and subsequent TMA production in this bacterium. 
Using P. mirabilis as the model, I investigated the physiological role of quaternary 
amine metabolism from the bacterial perspective and demonstrated that P. mirabilis 
can rapidly uptake and degrade choline to enhance growth rate, cell yield and 
swarming speed under anaerobic and microaerophilic conditions. I also provide the 
first evidence of a novel choline-metabolizing microcompartment, which is present 
in both vegetative and swarming cells supplemented with choline.  
Another important dietary source of TMA in human gut is carnitine. I used two 
model proteobacteria Acinetobacter baumannii and Escherichia coli in this project 
to investigate the role of carnitine metabolism to TMA in health and disease. A. 
baumannii and E. coli can use carnitine as a growth substrate to produce TMA. To 
better understand the role of quaternary amine metabolism in host health and disease, 
I used Caenorhabditis elegans model to investigate carnitine metabolism on the life 
span of the worm. My data suggest that malate, the degradation product of carnitine, 
extends the life span of C. elegans fed on A. baumannii or E. coli. Together, my 
study reveals that choline and carnitine metabolism as an adaptation strategy for gut 
proteobacteria and contributes to better understand the ecology of these TMA-
forming gut bacteria in health and disease.   
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1.1 The ecology and function of the microbial 
community in the human gut 
1.1.1 The ecology of the microbial community in the human gut 
The human gut microbiome is a diverse community, which more than 1000 bacterial 
species inhabit; these encode about 5 million genes (D’Argenio and Salvatore, 2015). 
Thanks to the rapid development of next-generation sequencing technologies and its 
capacity for metagenome analysis, our understanding of the composition and 
ecosystem function of the human gut microbiota has been significantly advanced 
over the past decade (Shreiner et al., 2015). 
It is well known that the gut microbiota plays a fundamental role in health and 
disease. However, certain microbes have started to colonize the human gut as early 
as birth, and the gut microbial community continues developing during the first few 
years, in early childhood (Bull and Plummer, 2014). In the healthy human gut, the 
microbial community is composed of Bacteria, Archaea, viruses and some 
unicellular Eukaryotes (Fig 1.1, D’Argenio and Salvatore, 2015). Among the 
bacterial species, the most dominant are Bacteroidetes, Firmicutes, Actinobacteria 
and Proteobacteria. Bacteroidetes and Firmicutes make up more than 90 % of the 
total microbial biomass in the healthy gut (Arumugam et al., 2011; Yatsunenko et 
al., 2012). It has been reported that the composition of the gut microbial community 
varies among individuals and is associated with numerous factors such as diet. 
Bacteroidetes and Firmicutes have been found to be responsible for the utilisation 
of fiber and peptide from our daily food (Ravcheev et al., 2013; Schoberth and 
Gottschalk, 1969). Interestingly, the excess fat and energy intakes from diet might 
lead to the increased population of Firmicutes and decreased population of 
Bacteroidetes in the gut, which could result in obesity (Conlon and Bird, 2015).  
Proteobacteria, particularly those Gammaproteobacteria of the Enterobacteriaceae 
family, are mainly composed of facultative anaerobes, which are thought to persist 
in close proximity to the mucosa of the gut lumen (Eckburg et al., 2005; El Kaoutari 
et al., 2013; Winter et al., 2013b). Recent studies have found a key role of 
Proteobacteria in quaternary amine metabolism in the human gut. For example, the 
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conversion of dietary choline to trimethylamine (TMA) by certain Proteobacteria 
may increase the risk of various diseases (Wang et al., 2011; Dumas et al., 2006). 
Interestingly, some methanogenic archaeal species, which are also present in human 
gut, may play an important role for the conversion of TMA to methane (Gaci et al., 
2014). 
Moreover, it has been reported that in the healthy human gut, although 
Gammaproteobacteria are a key component of the gut microbiome, they only persist 
at low levels. Indeed, a sudden increase in the abundance of Gammaproteobacteria, 
particularly Enterobacteriaceae, has been reported to be associated with an 
imbalance in gut microbiota, named dysbiosis, which is a key indicator for gut 
malfunction and intestinal inflammation (Winter et al., 2013b). Investigating the 
mechanisms underpinning the microbial community changes in 
Gammaproteobacteria during dysbiosis will advance our understanding of the 
variations between health and unbalanced gut microbial communities, and the 
relationship of gut dysbiosis and microbial metabolism. This would ultimately 
contribute to novel clinical treatment procedures to improve human health. 
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Figure 1.1 The proposed ecology and function of key human gut microbiome (D’Argenio and 
Salvatore, 2015, background picture modified from wed source: 
http://www.nutraingredients.com/Research/Microbiota-may-communicate-with-human-gut-cells-
through-enzyme-signalling, copyright license: William Reed Business Media Ltd registered in 
England no. 2883992). 
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1.1.2 The function of the microbial community in the human gut 
Due to the impact of rapid advances in next generation sequencing on the gut 
microbiome, there is a renewed interest in better understanding the function of key 
gut microbiome species. Large amount of scientific data has been accumulated over 
the past decade, highlighting a significant role of the microbial community in the 
human gut, not only in maintaining a healthy human gut, but also playing a pivotal 
role in disease development and progression. The activity of the gut microbiota can 
be directly associated with a number of health benefits in the human body, including 
biological metabolite synthesis, host-derived immune function, colonization 
resistance, cell differentiation, as well as regulating neural systems. Table 1.1 
summarises some of the most well studied impacts that are associated with the gut 
microbiome. 
One of the best-known examples of gut microbiota in human health is arguably the 
synthesis of essential vitamins, which is largely dependent on the activity of gut 
microbiota. Experiments using mice model have confirmed that the host metabolism 
requires the supplementation with vitamin K and some B vitamins, which are 
primarily synthesized by certain gut microbiota including Bacteroides, Eubacterium, 
Fusobacterium and Propionibacteriumn (Wostmann, 1981; Bentley, 1982).  
Gut microbiota are also responsible for carbohydrates fermentation. The non-
digestible carbohydrates in the diet are largely polysaccharides, undigested 
oligosaccharides and unabsorbed sugars. Furthermore, the product of carbohydrates 
fermentation is primarily short-chain fatty acids. Among them, propionate, acetate 
and butyrate are the three predominant short-chain fatty acid products, which are 
essential in epithelial cell proliferation and differentiation (Frankel, 1994). It is 
therefore not surprising that gut microbiota are essential for colonic physiology 
through their influence on epithelial cell regulation (Canny, 2008). 
Important metabolic processes, which are associated with the gut microbiota, 
include the activation of bioactive food components, the conversion of pro-drugs to 
bioactive forms, xenobiotics and bile acids transformation (Marchesi, 2007; Blaut, 
2007). These associations are important clues that reveal the relationship between 
the microbiome and drug metabolism, but also to uncover the impact of microbiome 
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on host processes of great importance for developing clinical therapeutics (Blaser, 
2013). 
One groundbreaking line of investigation into gut microbiota in recent years is the 
association between gut microbial metabolites and cardiovascular disease. Wang et 
al. has revealed that a diet rich in choline and carnitine can significantly increase the 
risk of atherosclerosis (Wang et al. 2011). Understanding the underlying 
mechanisms for the catabolism of choline by gut microbiota and the subsequent 
impacts on the host is the key aim of this thesis (See Section 1.7).  
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Table 1.1 Health impacts of the microbiota (modified from MSc Module assignment, BS942 Project) 
Function in host Microbial contribution Reference 
Metabolism   
Vitamin synthesis Synthesis of vitamin K and some B vitamins by Bacteroides, Eubacterium, Fusobacterium and 
Propionibacterium 
Wostmann, 1981; Bentley, 1982 
Carbohydrate fermentation Fermentation of large polysaccharides, undigested oligosaccharides, unabsorbed sugars and alcohols Canny, 2008 
Cardiovascular diseases Increasing risk of atherosclerosis from diet rich in choline and carnitine Wang et al., 2011 
Activation of bioactive food components 
and xenobiotic transformation 
Metabolism of xenobiotic compounds by microbiota Marchesi, 2007; Blaut, 2007 
Immunity   
Development of mucosal immune system Interact with host cells at mucosal interface; influence structure of gut-associated lymphoid tissue Linares, 2016 
Enhancement of immunomodulatory 
responses 
Aid activation of macrophages, cytotoxic T-lymphocytes, cytokines; contribute to memory mechanisms 
e.g. oral tolerance 
Canny, 2008 
Other functions   
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Colonization resistance Attachment by commensals to epithelial cells targeted by pathogens; out-compete pathogenic bacteria for 
nutrients 
Canny, 2008 
Epithelial cell proliferation and 
differentiation 
Directed by short-chain fatty acid produced from microbial fermentation Frankel, 1994 
Regulation of neuronal gene expression Production of the short chain fatty acid regulator such as butyrate by gut microbiota Linares, 2016 
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1.2 Quaternary amines and their degradation to 
methylated amines in the human gut  
1.2.1 Choline and its role in human health and disease 
Choline plays several key roles in human health via host metabolism. Apart from 
the common role as central nutrient, choline also contributes to the synthesis of 
phospholipids (phosphatidylcholine, PC and sphingomyelin), which are the essential 
components of cell membrane lipids. Phosphatidylcholine can be generated from 
dietary choline through the so-called cytidine 5’-diphosphocholine (CDP-choline) 
pathway or via the sequential methylation of phosphatidylethanolamine (Ueland, 
2011; Gibellini and Smith, 2010). Choline is also involved in cell signaling, nerve 
transmission, lipid transport and osmoregulation (Gibellini and Smith, 2010; Li and 
Vance, 2008; Noga and Vance, 2003; Noga et al., 2002; Ueland, 2011). Choline-
derived glycine betaine is the major methyl donor in human and other mammals, 
which is used for the conversion of homocysteine to methionine through betaine: 
homocysteine methyltransferase (BHMT) (Pellanda, 2013). Current known 
functions of choline in human metabolism are summarized in Table 1.2. 
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Table 1.2 The major roles of choline in host metabolism 
Role Description Reference 
Maintaining structural integrity of cell 
membrane 
Construction of the cell membrane via synthesis of phosphatidylcholine and sphingomyelin Ueland, 2011; Gibellini and 
Smith, 2010 
Cell signaling Generating intracellular messages and cell-signaling molecules such as diacylglycerol and ceramide Gibellini and Smith, 2010 
Nerve impulse transmission Synthesis of acetylcholine as a neurotransmitter involved in muscle control, circadian rhythm and 
memory 
Li and Vance, 2008 
Lipid (fat) transport and metabolism Assisting very-low-density lipoproteins (VLDL, mainly fat and cholesterol) assembly and secretion from 
liver 
Noga and Vance, 2003; Noga et 
al., 2002 
Major source of methyl donor Methyl donor from choline-converted glycine betaine for methylation of homocysteine  Pellanda, 2013 
Osmoregulation Regulation of cell volume and protecting cell integrity against osmotic stress by choline-converted 
glycine betaine 
Ueland, 2011 
Integration with other nutrients Metabolism of nucleic acids and amino acids and generation of methyl group donor together with other 
B-vitamins 
Zeisel and Corbin, 2012 
	 11		
1.2.1.1 Sources of choline 
Although humans can synthesise choline via a dedicated de novo synthesis pathway, 
our daily requirement of choline is in fact mainly met from dietary intake, such as 
fish, eggs, meat and milk. De novo choline synthesis is produced via the methylation 
of phosphatidylethanolamine to PC by phosphatidylethanolamine N-
methyltransferase (PEMT) using S-adenosylmethionine (SAM) as the methyl group 
donor (Vance, 2014). In addition to the de novo choline pathway, choline can also 
be released as a byproduct during the synthesis of phosphatidylserine (Li and Vance, 
2008), therefore it was not classified as an essential vitamin (Secades, 2011). 
However, de novo synthesis of choline is far from sufficient to meet the metabolic 
needs of a healthy human, and choline supplements in the form of choline salts or 
lecithin from soybean and egg yolk are required (Koc et al., 2002; Hendler and 
Rorvik, 2008) (Table 1.3). 
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Table 1.3 The major sources of choline 
Sources Description Reference 
De novo synthesis (biosynthesis) Conversion of phosphatidylethanolamine to PC; substitution of choline by serine from PC to 
phosphatidylserine;  
Li and Vance, 2008 
Food sources Eggs, liver, peanuts, fish, pasta, rice, meat, poultry and dairy food; homocysteine remethylation; 
PC in dietary food; Lecithin extracts 
Food and Nutrition Board, 1998; Chester et al., 
2007-2008; Craig, 2004; Zeisel and Corbin, 2012; 
Koc et al., 2002 
Supplements CDP-choline and choline salts, such as choline chloride and choline bitartrate; PC supplements; 
commercial lecithins prepared from soybean, sunflower and rapeseed; egg yolk lecithin 
Koc et al., 2002; Hendler and Rorvik, 2008 
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1.2.1.2 Choline metabolism and cardiovascular disease 
As discussed previously, choline plays various fundamental roles through 
metabolism in healthy humans. One of the most important roles is that choline can 
generate glycine betaine, which is essential for the conversion of homocysteine to 
methionine by betaine:homocysteine methyltransferase (BHMT) (Pellanda, 2013). 
Disordered choline metabolism to glycine betaine, however, will cause increased 
concentrations of homocysteine in the blood. It has been reported that elevated 
homocysteine levels increase the risk of cardiovascular disease (CVD). 
Homocysteine-induced injury to the arterial walls initiate the process of 
atherosclerosis and eventually to strokes and heart attacks (Gerhard and Duell, 
1999). Moreover, elevated homocysteine concentrations may trigger the 
development of atherosclerosis and thrombogenesis by the mechanisms of 
inflammation, abnormal blood coagulation, oxidative stress and disordered lipid 
metabolism endothelial (Zhou and Austin, 2009).  
It is well-known that plasma choline levels are related to cardiovascular risk factors, 
such as the percentage of body fat, serum triglycerides and high-density lipoprotein 
(HDL) (Konstantinova et al., 2008). However, an intriguing recent observation was 
that trimethylamine N-oxide (TMAO) in the blood, rather than choline, is the key 
biomarker in the development of cardiovascular events (Wang et al., 2011). 
Understanding how TMAO is formed from dietary choline through microbial 
metabolism in representative gut microbiota is one of the key aims of this PhD thesis 
(See Chapters 4&5). 
1.2.1.3 Choline metabolism and liver diseases 
Choline metabolism in the gut is also associated to the development of liver diseases. 
Dumas et al. (2006) have demonstrated a remarkable finding that disruption of 
choline metabolism by gut microbiota is associated with nonalcoholic fatty liver 
disease (NAFLD). It is hypothesized that NAFLD is directly linked to gut microbial 
transformation of choline to TMA. This microbial bypass resulted in a reduction of 
choline bioavailability to the host, leading to a low level of plasma PC and a high 
level of urinary methylamines, triggering choline-deficiency and subsequent 
NAFLD.  
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In addition, animal experiments suggest that dietary choline deficiency caused an 
increased risk of spontaneous liver cancer (hepatocellular carcinoma) and increased 
sensitivity to carcinogenic chemicals (Pellanda, 2013). Several mechanisms have 
been reported to reveal the effect of choline deficiency on the increased risk of 
cancer, such as enhanced liver cell regeneration and tissue sensitivity to chemical 
insults, altered gene expressions and regulation (cell proliferation, differentiation, 
DNA repair, and improper DNA methylation caused apoptosis), damaged DNA by 
mitochondrial dysfunction-induced oxidative stress, and increased liver cell 
apoptosis caused by activated protein kinase C-mediated cell-signaling cascade 
(Ueland, 2011).  
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1.2.2 Gut microbial degradation of quaternary amines 
Quaternary amines (QAs) play vital roles in both eukaryotic and prokaryotic 
organisms. They are characterized as various structures, involved in signaling, 
osmoregulatory and metabolic roles in human body. The most common QAs include 
choline, glycine betaine (GBT) and carnitine (Ikawa and Taylor, 1973; Landfald and 
Strøm, 1986; Graham and Wilkinson, 1992) (modified from the PhD thesis of 
Lidbury, 2015).  
Choline and GBT are both important quaternary amine compounds, which can 
generate methylamines (MAs) anaerobically. They share a special feature that they 
both contain a tertiary amine group with a two-carbon (C2) side chain (acetyl group), 
which can be cleaved off during the degradation to trimethylamine (TMA) (King, 
1984). Carnitine, another important QA, can be converted to TMA aerobically via 
the cleavage of the C4 side group by gut microbiota (Zhu et al., 2014) (modified 
from the PhD thesis of Lidbury, 2015). The chemical structures of choline, glycine 
betaine, carnitine and methylamines are shown in Fig 1.2. 
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(A) 
 
(B) 
Figure 1.2 The chemical structures of (A) quaternary amines involved in this study: choline, glycine 
betaine and carnitine (B) methylated amines involved in this study: trimethylamine (TMA), 
dimethylamine (DMA), monomethylamine (MMA) and trimethylamine N-oxide (TMAO) (chemical 
structures modified from web source: http://www.wikiwand.com, free online open access). 
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Fig 1.3 summarizes the super metabolic pathways involved in the transformation of 
QAs to MAs by the gut microbiota or the host via the key functional enzymes, 
including choline-TMA lyase, which is the focus of this project (modified from 
Griffin et al., 2015 and Fennema et al., 2016). The key enzymes responsible for each 
step are shown in Table 1.4 with corresponding EC numbers (http://www.brenda-
enzymes.org). Table 1.5 lists the representative microorganisms involved in QA 
metabolism to MA (Fennema et al., 2016). 
Choline conversion by gut microbiota to TMA has been reported as early as in the 
1950s (Zeisel et al., 1989; Chalmers et al., 2006; Hayward and Stadtman, 1959). 
Craciun and Balskus (2012) have recently identified the choline-TMA lyase (CutC), 
which is a glycyl radical containing protein. CutC and associated proteins involved 
in choline metabolism by microorganisms is located on the so-called choline 
utilization gene cluster (cut) (Fig. 1.3, Table 1.4 & Table 1.5). The essential role of 
cutC was unequivocally confirmed by the inactivation of cutC in Desulfovibrio 
desulfuricans, which completely abolished the ability of the bacterium to produce 
TMA from choline. A detailed bioinformatics analysis was carried out in Chapter 
4 to reveal cutC homologs in genome-sequenced gut bacteria.  
It has also been reported that carnitine can be converted to TMA by gut bacteria, 
with the cleavage of the 3-hydroperoxybutyryl moiety (Meadows and Wargo, 2015). 
There are several candidate gut bacterial species, which may encode this pathway, 
for example, Serratia marascescens and Acinetobacter calcoaceticus (Meadows and 
Wargo, 2015). Zhu et al. (2014) has recently identified a two-component 
oxygenase/reductase Rieske-type enzyme encoded by cntAB using bioinformatics. 
This enzyme is responsible for catalyzing carnitine degradation to TMA (Fig 1.3, 
Table 1.4 & Table 1.5).  
TMAO can be produced from the oxygenation of TMA either via a bacterial TMA 
monooxygenase (Tmm) or by a class of flavin-containing monooxygenases (FMOs) 
in the human liver. The reaction uses NADPH as an electron donor and oxygen as 
the oxidizing agent (Chen et al., 2011). TMAO can be reduced to TMA by bacterial 
TMAO reductase anaerobically (Kwan and Barrett, 1983) (Fig 1.3 & Table 1.4). It 
is thought that high amount of TMAO present in circulation may cause heart attack, 
stroke, arteriosclerosis or other cardiovascular disease although the underlying 
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biochemical mechanisms are not well-understood (Wang et al., 2011).  
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Figure 1.3 The super metabolic pathways involved in the degradation of quaternary amines (QA) to methylated amines (MA) by the gut microbiota or the host via the 
key functional enzymes including choline-TMA lyase (No.1), which is the focus of this project (modified from Griffin et al., 2015 and Fennema et al., 2016).  
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Table 1.4 The key enzymes involved in the degradation of quaternary amines to methylated amines associated with each pathway 
No. Enzyme EC number (http://www.brenda-enzymes.org) 
1 Choline-TMA lyase EC 4.3.99.4 
2 Flavin-containing TMA monooxygenase (FMO3) EC 1.14.13.148 
3 TMAO reductase EC 1.7.2.3 
4 Trimethylamine-oxide aldolase (TMAO demethylase) EC 4.1.2.32 
5 Trimethylamine dehydrogenase  EC 1.5.8.2 
6 Dimethylamine dehydrogenase EC 1.5.8.1 
7 Methylamine dehydrogenase (amicyanin) EC 1.4.9.1 
8 Carnitine reductase/oxidase / 
9 γ -butyrobetainyl-CoA: carnitine-CoA transferase EC 2.8.3.21  
10 γ-butyrobetaine hydroxylase EC 1.14.11.1  
11 Carnitine-TMA lyase / 
12 L-carnitine dehydrogenase EC 1.1.1.108 
13 Choline dehydrogenase, betaine aldehyde dehydrogenase EC 1.1.99.1, 1.2.1.8 
14 betaine reductase EC 1.21.4.4 
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15 Glycine betaine transmethylase EC 2.1.1.5 
16 Dimethylglycine dehydrogenase EC 1.5.8.4 
17 Sarcosine dehydrogenase EC 1.5.8.3 
18 Creatinase EC 3.5.3.3  
19 Creatininase EC 3.5.2.10 
20 Creatine kinase EC 2.7.3.2  
21 Betaine-homocysteine methyl transferase EC 2.1.1.5  
22 Phosphatidylethanolamine methyltransferase EC 2.1.1.17, 2.1.1.71  
23 Phospholipase D EC 3.1.4.4  
24 Choline kinase EC 2.7.1.32 
25 Choline O-acetyltransferase EC 2.3.1.6  
26 Methylene-tetrahydrofolate reductase EC 1.5.1.20  
27 Methylene-tetrahydrofolate dehydrogenase EC 1.5.1.5  
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Table 1.5 Representative microorganism involved in QA metabolism to TMA (modified from Fennema et al., 2016) 
Phylum Genus or Species Reference 
Choline   
Actinobacteria Mobiluncus Cruden and Galask, 1988 
 Olsenella Craciun and Balskus, 2012; Martinez-del Campo et al., 2015 
Bacteroidetes Bacteroides  Cruden and Galask, 1988 
Firmicutes Anaerococcus Craciun and Balskus, 2012; Romano et al., 2015 
 Clostridium Robinson et al., 1952; Bradbeer, 1965; Fiebig and Gottschalk, 1983; Moller et al., 1986; Craciun and Balskus, 2012; Martinez-del Campo et al., 2015; Romano et al., 2015 
 Desulfitobacterium Craciun and Balskus, 2012 
 Enterococcus Simenhoff et al., 1976 
 Streptococcus Robinson et al., 1952; Simenhoff et al., 1976; Chao and Zeisel, 1990; Craciun and Balskus, 2012; Martinez-del Campo et al., 2015 
Proteobacteria Desulfovibrio Hayward and Stadtman, 1959, 1960; Baker et al., 1962; Bradbeer, 1965; Fiebig and Gottschalk, 1983; Craciun and Balskus, 2012 
 Edwardsiella Romano et al., 2015 
 Enterobacter Eddy, 1953; Craciun and Balskus, 2012 
 Escherichia Craciun and Balskus, 2012; Martinez-del Campo et al., 2015; Romano et al., 2015 
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 Klebsiella Eddy, 1953; Craciun and Balskus, 2012; Kuka et al., 2014; Kalnins et al., 2015; Martinez-del Campo et al., 2015 
 Proteus Seim et al., 1982a; Craciun and Balskus, 2012; Kuka et al., 2014; Martinez-del Campo et al., 2015; Romano et al., 2015 
 Providencia Craciun and Balskus, 2012; Romano et al., 2015 
 Pseudomonas Robinson et al., 1952; Kleber et al., 1978 
 Yokenella Craciun and Balskus, 2012 
Carnitine   
Proteobacteria Acinetobacter Kleber et al., 1977; Seim et al., 1982b; Miura-Fraboni et al., 1982; Ditullio et al., 1994; Zhu et al., 2014 
 Citrobacter Zhu et al., 2014 
 Escherichia Zhu et al., 2014 
 Klebsiella Kuka et al., 2014; Zhu et al., 2014 
 Proteus Seim et al., 1982a 
 Pseudomonas Kleber et al., 1978; Miura-Fraboni et al., 1982 
Glycine Betaine   
Firmicutes Clostridium Naumann et al., 1983; Moller et al., 1986 
 Eubacterium Zindel et al., 1988; Hormann and Andreesen, 1989 
 Sporomusa Moller et al., 1986; Hormann and Andreesen, 1989 
TMAO   
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Actinobacteria Micrococcus Robinson et al., 1952 
 Mobiluncus Cruden and Galask, 1988 
Firmicutes Bacillus Robinson et al., 1952 
 Clostridium Robinson et al., 1952 
 Staphylococcus Robinson et al., 1952 
 Sarcina Robinson et al., 1952 
 Streptococcus Robinson et al., 1952 
Proteobacteria Alcaligenes Robinson et al., 1952 
 Campylobacter Sellars et al., 2002 
 Citrobacter Lin and Hurng, 1989 
 Escherichia Robinson et al., 1952; Ishimoto and Shimokawa, 1978; Cox and Knight, 1981; Takagi et al., 1981; Easter et al., 1982; Lin and Hurng, 1989; Denby et al., 2015 
 Proteus Robinson et al., 1952; Strom et al., 1979; Stenberg et al., 1982 
 Pseudomonas Robinson et al., 1952; Lee et al., 1977; Easter et al., 1982; Chen et al., 2011 
Ergothioneine   
Proteobacteria Alcaligenes Yanasugondha and Appleman, 1957; Kelly and Appleman, 1961 
 Escherichia Wolff, 1962 
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Although it has been known for over a century that anaerobic degradation of choline 
can produce TMA, the underpinning molecular and biochemical mechanisms 
remained largely un-established when the PhD project started. While my 
investigation was on-going, research carried out at Harvard University has revealed 
a gene cluster responsible for anaerobic choline utilization by a sulfate-reducing 
bacterium Desulfovibrio desulfuricans (Craciun and Balskus, 2012), which has been 
previously reported to metabolize choline to TMA (Chao and Zeisel, 1990). This 
gene cluster was analysed by bioinformatics and found to contain a set of genes to 
encode a glycyl radical enzyme encoded by cutC and a glycyl activating protein 
encoded by cutD. The function of the gene cluster in D. desulfuricans was confirmed 
by genetic knockout strategy. The cutC gene was disrupted by transposon 
mutagenesis and the generated mutant strain was found unable to degrade choline 
any more. In addition, the cutC and cutD genes were heterologously expressed in 
Escherichia coli, which enabled E. coli to utilize choline and produce TMA. The 
mechanism of choline degradation by this novel enzyme was studied by electron 
paramagnetic resonance (EPR) spectroscopy and it was found that cutC belongs to 
the member of C-N bond cleaving glycyl radical enzyme (GRE) family (Craciun 
and Balskus, 2012). 
In contrast, in this PhD project, I started the investigation of choline metabolism in 
a model gut microbiota organism, namely Proteus mirabilis, which is known to be 
capable of producing TMA from choline (Sandhu and Chase, 1986). In order to 
identify the key genes involved in choline-to-TMA transformation, a comparative 
transcriptomics method was employed (See Chapter 4).  
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1.3 Proteus mirabilis 
In this study, the Gram-negative enteric Proteus mirabilis, a bacterium capable of 
colonizing the gut and the urogenital tract, was used as a model to investigate the 
role of choline metabolism. P. mirabilis is a facultative anaerobic, rod shaped 
bacterium which is found in the gut microbiota in healthy individuals. It is also 
widely distributed in soil and water (Burall et al., 2004). The name of P. mirabilis 
is suggested from its typical swarming motility, which refers to the flagellum-
dependent movement across a surface (Fig 1.4), in contrast to swimming through 
liquid or soft agar. This form of motility is thought to allow P. mirabilis to migrate 
across catheters, gaining entry to the urinary tract and causes infection (Armbruster 
and Mobley, 2012).  
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                                              (A)                                                                                     (B)                                                                                            (C) 
Figure 1.4 (A&B) Swimming and swarming cells of P. mirabilis under transmission electron microscope, rod shaped cells are swimming cells and elongated cells with 
flagella are swarming cells. (C) Swarming pattern of P. mirabilis on solid agar plate (images taken during the course of this study, TEM pictures obtained in collaboration 
with Dr Stefanie Frank from University of Kent). 
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P. mirabilis can causes severe infections in humans. The most commonly infected 
body site is the urinary tract, which is characterised by an alkaline urine with a very 
distinct fishy odor (the smell of TMA). P. mirabilis can be diagnosed in the lab 
according to its characteristic swarming motility, and the incapability to metabolize 
lactose using a MacConkey agar plate assay. If left untreated, the increased alkalinity 
can lead to the formation of calcium carbonate crystals of struvite, which can 
subsequently lead to kidney stones. Once the stones develop and if they are allowed 
to grow large enough, it will cause obstruction and renal failure. Although rare, some 
Proteus species can also cause septicaemia, wound infections and pneumonia 
(Armbruster and Mobley, 2012).  
P. mirabilis is also known to have probably the ability for quaternary amine 
metabolism. It has been reported, in the 1980s, that Proteus mirabilis can also 
produce TMA from choline (Sandhu and Chase, 1986). It has been suggested that 
the increasing concentration of TMAO in the plasma, which results from dietary 
intake of choline or carnitine followed by gut microbial degradation to TMA and 
subsequent oxygenation to TMAO by FMO3 in the liver, increases the risk of 
cardiovascular disease (Wang et al., 2011; Bennett et al., 2013; Koeth et al., 2013; 
Tang et al., 2013; Obeid et al., 2016). Therefore, I aim to use this strain as the model 
organism in this study to explore molecular genetics and biochemistry underpinning 
choline degradation to TMA. 
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1.4 Comparative transcriptomics RNA-Seq analysis 
Transcriptome sequencing technologies have been developed and widely adopted 
over the last decades to facilitate the genome-wide analyses of gene expression in 
various conditions. Microbial transcriptome and meta-transcriptome information 
can be used for predicting resistance to specific antibiotics, understanding host-
pathogen immune interactions, tracking disease progression and quantifying gene 
expression changes during microbial metabolism (Han et al., 2015). Of particular 
interest is the RNA-Seq technique, which was significantly advanced thanks to the 
improvement and reduced cost of next-generation sequencing platforms. There are 
many advantages of RNA-Seq enabled transcriptomic analyses compared to 
hybridization-based methods such as microarrays, which require gene-specific 
probes and large quantity of mRNA (Nookaew et al., 2012). For example, RNA-Seq 
identifies common and novel transcripts in an unbiased strand-specific way. It 
allows for confident identification for both high and low expression of gene 
transcripts at a dynamic range, and makes it possible for streamlined workflow with 
multiple samples. It offers low-cost, large and complex datasets at single nucleotide 
resolution (Han et al., 2015). However, the methods for data-mining, interpretation, 
and analysis of RNA-Seq for the metabolic mechanism is the most important part of 
transcriptomics. Fig 1.5 illustrates the general workflow of RNA-Seq in 
bacteriology, including the key steps such as RNA extraction, mRNA sequence 
enrichment, qualification and quantification, cDNA library preparation, RNA-Seq 
alignment, read counts comparison, and finally gene expression and statistical 
analysis. Table 1.6 lists several commonly used methods for transcriptomic data 
analyses. 
In this project, RNA-Seq and the aforementioned bioinformatics tools are employed 
to identify the genes involved in choline-to-TMA transformation in the model 
bacterium, Proteus mirabilis (Chapter 4). 
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Figure 1.5 The schematic workflow of bacterial RNA-Seq work. (a) RNA-Seq library construction. 
Firstly, 300,000 to 3 million cells are used to extract the total RNA. Secondly, mRNA enrichment is 
carried out to remove any rRNA thus only mRNA is retained. mRNA is fragmented into a uniform 
size distribution and RNA gel electrophoresis or Agilent Bioanalyzer is used to monitor the size and 
the quality of the fragment. Finally, cDNA library is built and Agilent Bioanalyzer is used to check 
the size distribution pattern of the library. (b) RNA-Seq alignment. Sequence read counts are aligned 
to the reference genome and splice junctions are mapped via mapping programs. The gene expression 
level is quantified as absolute read counts or normalized values such as RPKM (reads per kilo base 
per million mapped reads). (c) RNA-Seq de novo sequence assembly. RNA transcripts can be 
generated by assembling mapped reads. (d) RNA-Seq analysis. Transcriptome reads are compared 
with the reference genome, and the sequence variants are mined and identified as genomic variants 
(for example, SNPs) or candidates for RNA editing (picture adapted from Zeng and Mortazavi, 2012, 
copyright license number: 4123720380187).  
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Table 1.6 Transcriptomic analysis methods for RNA-Seq in microbial metabolism 
Methods Description Reference 
DGE analysis Assess differences in transcript level across samples Han et al., 2015 
RPKM method Account for expression and normalized read counts with respect to overall mapped read number and 
gene length, but not sequencing depth, gene length, and isoforms abundance.
  
Han et al., 2015 
Expectation Maximization (RSEM) Accurate estimates for gene and isoform expression levels and can be used even for species without 
a reference genome assembly 
Han et al., 2015 
EdgeR function in the Degust 
Interactive Web-based RNA-Seq 
visualization software 
Comparison of read counts between different conditions, to calculate log-fold values for count data 
so that comparison of two conditions can be visualized and significance can be tested statistically.  
Zhao et al., 2016 
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1.5 Bacterial microcompartments  
During the metabolic activities of some bacteria, an unusual metabolic compartment 
called bacterial microcompartments (BMCs) are formed. These organelle-like 
structures are characterized by being enclosed with a protein shell rather than a lipid 
bilayer seen in eukaryotic organelles (Armbruster and Mobley, 2012; Davanloo et 
al., 1984; Hampel et al., 2014). The role of BMCs has been well documented and it 
is suggested that they are formed to optimize pathways with toxic or volatile 
intermediates. It has been revealed that the protein shell of the BMC usually acts as 
a diffusion barrier that helps channel an intermediate to the next pathway enzyme 
(Chowdhury et al., 2014).  
The most well-known BMC is the carboxysome, which is mostly found in 
cyanobacteria and some chemoautotrophic bacteria. It is reported that this 100 nm 
in diameter shell protein plays a role in the fixation of carbon dioxide (Iancu et al., 
2007; Schmid et al., 2006; Tanaka et al., 2008). Another important BMC is 
propanediol BMC, which has polyhedral shapes with proteinaceous structures 
within the cell. The metabolism associated with 1,2-propanediol is shown 
schematically below (Fig 1.6). The faces of the structure are formed with the 
association of hexagonal shell proteins, which are the most abundant proteins in the 
metabolosome, such as PduA, PduB, and PduJ. The vertex of the assembly is formed 
from a pentameric shell protein, representing PduN (highlighted in red in Fig 1.6). 
Table 1.7 summaries the most commonly reported BMC and their functional 
pathways.   
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Figure 1.6 The polyhedral-shaped proteinaceous structures of propanediol BMC, with faces of the 
structure formed with the association of hexagonal shell proteins PduA, PduB, PduJ, PduK and PduU, 
and the vertex formed with pentameric shell protein PduN (highlighted in red). The propanediol BMC 
is associated with 1,2-propanediol utilization pathway (pictures adapted from Parsons et al., 2010, 
copyright license number 4123720753402). 
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Table 1.7 Metabolic pathways involving microcompartments and their functions (Yeates et al., 2010) 
Names Pathways Descriptions 
Carboxysome Carbon dioxide fixation House both the Calvin cycle enzyme ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) and carbonic anhydrase; 
capsules the inter-conversion of carbon dioxide and bicarbonate; concentrates carbon dioxide and overcome the well-
documented inefficiency of RuBisCO. 
Propanediol (Pdu) 
BMCs 
1,2-propanediol utilization pathway Organize enzymes for forming and consuming propionaldehyde within the protein shell; channel the aldehyde to the next 
enzyme to limit its cellular toxicity. 
Ethanolamine (Eut) 
BMCs 
Ethanolamine utilization pathway Glutathione-based detoxification pathways and DNA polymerase repair functions; channel toxic or volatile intermediates 
Pyruvate to ethanol  N/A Metabolize Pyruvate to ethanol in Vibrio furnissii M1 
Ethanol to acetate  
N/A 
Butyrate synthesis in Clostridium kluyveri 
Glycerol N/A Metabolic pathway through a 3- hydroxylpropionaldehyde intermediate 
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One of the key findings from this PhD project was the identification and observation 
of BMC formation during choline-to-TMA transformation in the model bacterium, 
Proteus mirabilis (Chapters 4 and 5). The proposed microcompartments in choline 
utilization in P. mirabilis comprise five different proteins in the cut gene cluster: 
PMI2714, PMI2718, PMI2720, PMI2721 and PMI2722 (See Chapter 4). In the 
RNA-Seq experiment shown in Chapter 4, it was found that these 
microcompartment shell proteins were heavily induced by choline. The role of 
microcompartments is hypothesized either to help retain the volatile intermediates 
such as aldehyde and carbon dioxide or to protect the cell from the potential toxic 
effects of the intermediates (e.g. acetaldehyde) (Hampel et al., 2014). Since one of 
the products of choline metabolism is acetaldehyde, I hypothesized that the 
microcompartments are essential in preventing the release of this toxic compound 
into the cell.  
In an attempt to investigate the role of each of the five microcompartment genes and 
to identify which are essential for the assembly of the shell, these genes were 
amplified and introduced into E. coli for overexpression (See Chapter 5).  
	 37		
1.6 Caenorhabditis elegans 
Caenorhabditis elegans, also referred here as nematode or worm, was first described 
as a free-living organism in the 1900s and classified in the Nematoda phylum 
(Riddle et al., 1997). It feeds on bacteria and is usually found in soil or on vegetation 
of temperate zones (Altun and Hall, 2017).  
1.6.1 C. elegans anatomy and life cycle  
As can be seen from Fig 1.7, the length of an adult C. elegans is ~1 mm (Altun and 
Hall, 2017) and its body can be divided in three parts: the head, the mid-body and 
the tail. The head of C. elegans also contains three parts: the grinder (to crush food), 
the pharynx (to push food into the grinder), and the pharyngeal-intestinal valve (to 
allow the passage of crushed food into the intestine) (McGhee, 2007). The mid-body 
section is the longest part of C. elegans body. It is surrounded by the hypodermis 
that secretes cuticles functioning as exoskeleton (Altun and Hall, 2017). The 
intestine is the most important place, where degradation of bacteria, absorption and 
storage of nutrients occurs (McGhee 2007). The gonads, the pseudocoelom (or body 
cavity) and the muscles present beneath the hypodermis (Altun and Hall, 2017). The 
last part is the tail, which contains the anus where defecation occurs (Altun and Hall, 
2017).  
The most significant character of C. elegans is its predominant population of 
hermaphrodites, which produce both sperm and oocytes and lay fertilized eggs in 
which early embryogenesis takes place (Fig 1.7). The life cycle of nematodes is 
usually divided into 4 stages, starting after embryo-hatching, it undergoes four 
moulting states (larval stages named L1 to L4) before becoming an adult able to lay 
eggs (Riddle et al., 1997; Altun and Hall, 2017). Besides, the nematodes are very 
sensitive to the environment such as temperature, food and growth conditions. The 
change of temperature could significantly affect the life cycle of C. elegans - it takes 
~2.5 days at 25 °C, ~3 days at 20 °C or ~6 days at 15 °C to complete the entire life 
cycle (Byerly et al., 1976) (Fig 1.8). Interestingly, under food deficiency, a special 
form of nematodes, named dauer, will develop directly after L1 larval and go 
through a completely different life cycle to L4 larval, skipping the L2 and L3 stages 
(Fig 1.8). 
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Figure 1.7 Anatomy of an adult C. elegans. Upper: Image of C. elegans obtained by differential 
interference contrast microscopy, left lateral side, scale bar 0.1mm. Lower: Schematic drawing of C. 
elegans anatomical structures, left lateral side (picture modified from Altun and Hall, 2017, free 
online open access).  
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Figure 1.8 Schematic representation of C. elegans life cycle at 22°C. Numbers in blue indicates the 
time required for each stage and L1, L2, L3 and L4 represent the nematode larval stages (picture 
modified from Altum and Hall, 2017 and images taken during the course of this study). 
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1.6.2 Importance of C. elegans as a model organism for studying 
host-bacteria interactions 
C. elegans was first employed as a model organism by Sydney Brenner who used 
the N2 (Bristol) strain to study its development and nervous system (Brenner, 1973; 
Brenner, 1974; Brenner, 1988). There are many important characteristics of C. 
elegans that set it apart from other animal models and make it a unique model 
organism for research: 1) easy maintenance. Nematodes can be stored stably for 
years and maintained in large numbers in the lab by feeding on an E. coli strain OP50, 
which is also cheap and straightforward to grow (Stiernagle, 2006); 2) high 
reproducibility. ~1000 offspring can be generated by nematodes every day, which 
are identical to the progenitor (Altun and Hall, 2017); 3) easy to study. It has a short 
life cycle and a transparent body (Altun and Hall, 2017), allowing study of its 
development under a microscope and the adoption of any florescent compounds 
(Irazoqui and Ausubel, 2010); 4) suitable for genetic manipulation as C. elegans 
genome was completely sequenced in 1998 and mutants can be readily made (Fay, 
2013). 
There are some similarities between C. elegans model and murine models of 
infection, for example, they both have innate immunity, however, C. elegans doesn’t 
have an adaptive immune system, circulatory system and professional phagocytes 
(Sifri et al., 2005) and cannot be reared at 37°C, at which temperature some 
virulence factors are expressed (Wurtzel et al., 2012). Despite dissimilarities, a lot 
of evidence have shown the advantage of C. elegans model over mouse model for 
host-bacteria metabolism. Table 1.8 summarizes key studies using C. elegans to 
investigate bacteria-host interactions. 
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Table 1.8 The applications of C. elegans as a model organism to investigate host-bacteria interactions 
Application Description Reference 
Cell biology Study programmed-cell death; signal transduction  Metzstein et al., 1998; Kornfeld, 1997 
Neuroscience Nervous and muscle systems development Hekimi et al., 1998 
Molecular microbiology Control of gene expression without genetic manipulation by RNA interference Ahringer, 2006; Billi et al., 2014; Fire et al., 
1998 
Physiology Sex determination; embryogenesis; ageing; Marin and Baker, 1998; Hekimi et al., 1998 
Immunology Employing innate immunity as defense against infection with conserved innate immune pathways 
compared to mammalian cells such as the p38 MAPK and the insulin-like pathways. 
Ewbank 2006 
Microorganism infections Nematodes can be fed on different bacterial strains by growing worms on media prepared in the lab Kurz and Ewbank, 2007; Sifri et al., 2005 
Host-pathogen interactions Monitoring pathology by following nematode survival; changes in behavior; changes in appearance; 
accumulation of bacteria in the intestine; monitoring gene expression via qRT-PCR or reporter 
transgenic systems 
Darby, 2005; Tan et al., 1999; Zhang et al., 
2005; Hodgkin et al., 2000; Aballay et al., 
2000; Troemel et al., 2006; Irazoqui et al., 2008 
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1.6.3 Use of C. elegans to study Acinetobacter baumanni infection  
As I have discussed earlier, dietary intake of carnitine can promote cardiovascular 
diseases in humans through microbial production of TMA and its subsequent 
oxidation to TMAO by hepatic flavin-containing monooxygenases (Koeth et al., 
2013; Benett et al., 2013; Wang et al., 2011; Tang et al., 2013). Previously studies 
in the lab have shown that both A. baumanni and Escherichi coli SE11 are excellent 
bacterial models for the investigation of biochemical pathways and mechanisms of 
carnitine degradation to TMA (Fig 1.9A&B). Using bioinformatics approaches, Zhu 
et al. first identified a two-component Rieske-type oxygenase/reductase (CntAB) 
and associated gene cluster proposed to be involved in carnitine metabolism in these 
bacteria. CntA belongs to a group of previously uncharacterized Rieske-type 
proteins and has an unusual “bridging” glutamate but not the aspartate residue, 
which is believed to facilitate inter-subunit electron transfer between the Rieske 
centre and the catalytic mononuclear iron centre. Using Acinetobacter baumannii as 
the model, cntAB is confirmed to have an essential role in carnitine degradation to 
TMA. Heterologous overexpression of cntAB enables Escherichia coli to produce 
TMA, confirming that these genes are sufficient in TMA formation. Site-directed 
mutagenesis experiments have confirmed that this unusual “bridging glutamate” 
residue in CntA is essential in catalysis and neither mutant (E205D, E205A) is able 
to produce TMA (Fig 1.10).  
In an attempt to reveal the role of TMA formation in A. baumannii and E. coli 
infection, C. elegans was chosen as the model to compare carnitine degradation of 
the wild type and mutants in TMA formation and the subsequent impact on the life 
span of the worm. This offers the opportunity to better understand the human gut 
microbiota and their dynamics in human health and disease in large-scale 
epidemiological and dietary intervention studies.  
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(A) 
 
 
 
(B) 
Figure 1.9 (A) The quantification of carnitine degradation and TMA formation in A. baumanni (left) 
and E. coli SE11 (right) (B) The predicted pathway of carnitine degradation to TMA via CntA/B 
(modified from Zhu et al., 2014, freely available online through the PNAS open access option). 
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Figure 1.10 Carnitine degradation gene cluster of cntAB for A. baumanni and the knock-out genes 
are shown with red cross which create the mutants (ΔcntA::aacC1 and ΔcntB::aacC1, respectively) 
(upper); the quantification of carnitine and TMA for wild-type and the mutants in the culture medium 
supplemented with carnitine and succinate. The experiments run in triplicates and standard deviation 
was shown as error bars (lower) (modified from Zhu et al., 2014, freely available online through the 
PNAS open access option). 
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1.7 Aims and hypotheses 
The overall aim of this project is to establish the function of choline metabolism and 
TMA formation in representative gut microbiota.  Specifically, I aim to 
1) use RNA-Seq to identify the key genes responsible for choline degradation 
to TMA in P. mirabilis and confirm the essential role of choline-TMA lyase 
(cutC) in TMA formation (Chapter 4). 
2) investigate the physiological role of choline degradation in P. mirabilis from 
the bacterial perspective (Chapter 5). 
3) investigate the microcompartment protein (BMC) formation in choline 
degradation in P. mirabilis (Chapter 5). 
4) investigate the impact of gut microbiota formation of TMA from dietary 
carnitine on the life span of the host using C. elegans as the model (Chapter 
6). 
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Materials and Methods 
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2.1 Proteus mirabilis 
All reagents used in this thesis were prepared using Milli-Q H2O and sterilized by 
autoclaving at 121 °C for 15 min or filter-sterilized through a 0.2 µm membrane 
(Millipore, Darmstadt, Germany). pH of the reagents was adjusted with the addition 
of NaOH (10 M) or HCl (10 M). The vitamins solution, containing biotin (0.4 mg l-
1), folic acid (0.4 mg l-1), thiamine hydrochloride (1 mg l-1), riboflavin (1 mg l-1), 
nicotinic acid (1 mg l-1), pantothenic acid (1 mg l-1), 4-aminobenzoic acid (1 mg l-1), 
lipoic acid (1 mg l-1), pyridoxine hydrochloride (2 mg l-1) and vitamin B12 (20 mg 
l-1), was filter-sterilized using a 50 ml syringe.  
2.1.1 Maintenance of Proteus mirabilis strains 
All the maintenance and growth experiments of Proteus mirabilis strains were 
carried out by myself. All P. mirabilis strains listed in Table 2.3 were stored as 
glycerol stocks (Luria-Bertani containing 10 % (v/v) glycerol) at -80 °C. For all 
experiments, cells were first revived from the glycerol stocks on non-swarming (see 
receipt below) agar plates (1.5 %, w/v). The plates were incubated at room 
temperature around 20 °C, and for short-term storage at 4 °C (See details described 
below in this section).  
Growth experiments using P. mirabilis in this thesis were carried out anaerobically 
using a defined NH4+ medium containing (per litre) 7 g K2HPO4, 3 g KH2PO4, 0.1 g 
MgSO4·7H2O, 1 g (NH4)2SO4, 5 ml micronutrients (per litre: 3 g each L-histidine, 
L-tryptophan, L-nicotinamide and L-isoleucine), 50 µM ferric citrate, 50 mM 
sodium fumarate. The growth medium was supplemented with choline and other 
carbon sources (10 mM glucose, glycerol or choline).  
For anaerobic growth in liquid, 90 ml liquid cultures were grown anaerobically in 
crimp-sealed 125 ml serum vials until OD600 >0.6 at 37 °C with no shaking. Starter 
cultures were inoculated by taking 1 ml of overnight P. mirabilis liquid culture 
grown in LB broth, and then injecting into the sealed serum vials. Each serum vial 
was de-gassed for 30 min with O2-free N2 gas to establish anaerobic conditions.  
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For growth on solid agar plates, aerobic non-swarming agar plates were prepared 
with 10 g tryptone, 5 g yeast extract, 0.5 g NaCl, and 5 ml glycerol and 1.5 % (w/v) 
agar. Anaerobic swarming agar plates were prepared using the same defined NH4+ 
medium described above solidified with 1.5 % (w/v) agar and supplemented with 
yeast extract (0.025 %, w/v). 
2.1.2 Antibiotics used for Proteus mirabilis strains 
All antibiotics used in this study were prepared by the in-house media preparation 
team at the University of Warwick. The following concentrations were required to 
isolate and maintain P. mirabilis mutant strains unless otherwise stated: ampicillin 
(150 µg ml-1), kanamycin (150 µg ml-1), and chloramphenicol (200 µg ml-1). 
2.1.3 Preparation and transformation of electrocompetent P. 
mirabilis cells  
The method to prepare electrocompetent P. mirabilis cells was adapted from Visalli 
et al. (2003) and detailed in Jameson et al (2015). Briefly, LB broth without NaCl 
was used to grow P. mirabilis cells aerobically at 37 °C, until mid-log phase (OD600 
of 0.3-0.6) before the cultures were harvested. Cells were washed four times with 
ice-cold, sterile 10 % (v/v) glycerol to remove any LB medium and then re-
suspended in a final volume of 2 mL 10 % (v/v) glycerol. 50 µl aliquots were rapidly 
frozen in dry ice/ethanol and stored at −80 °C for a maximum for 4 months.  
2.1.4 Construction and complementation of cutC mutant in P. 
mirabilis 
The cutC mutant was constructed using the TargeTron targeted transposon 
mutagenesis system (Sigma-Aldrich Company Ltd., Dorset), which inserted a 
kanamycin-resistance gene into the cutC gene following the manufacturer’s 
instructions. Non-swarming agar plates containing kanamycin (150 µg ml-1) were 
used for the selection of cutC::kan mutant. The cutC complemented mutant was 
constructed by cloning the native cutCD (PMI2716/15) of P. mirabilis into pGEM-
T. The resulting vector pGEM-T-cutCD was electroporated into the P. mirabilis 
cutC::kan mutant. The complimented mutant was then selected on non-swarming 
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agar plates containing ampicillin (150 µg ml-1). All primers used for the construction 
and complementation of the cutC::kan mutant are shown in Table 2.4. 
2.1.5 Growth of P. mirabilis on choline and quantification of choline 
and TMA 
The aforementioned NH4+ defined medium was used to investigate the growth of P. 
mirabilis on choline. The degradation of choline and production of TMA were 
quantified using ion chromatography on an 881 Compact IC Pro (Metrohm, Herisau, 
Switzerland). 
2.1.6 P. mirabilis swarming assays 
For the swarming assays, the same NH4+ defined medium was used. The protocol 
was detailed in Jameson et al 2015. Briefly, 2 µl P. mirabilis culture was incubated 
on agar plates which were then left at 30 °C in an anaerobic growth cabinet (Don 
Whitley Scientific). Swarm radius was measured for triplicate plates supplemented 
with glycerol, choline or glycerol plus choline as the carbon sources.  
2.1.7 Heterologous expression of P. mirabilis choline-TMA lyase 
CutC and CutD 
Codon-optimised cutC (PMI2716) and cutD (PMI2715) of P. mirabilis were ordered 
from GenScript (Piscatsaway, USA) to make sure that the putative cutCD genes are 
compatible for expression in E. coli before heterologous expression was carried out. 
The detailed cloning protocol was adapted from Jameson et al. (2015) using the 
expression vector pCOLADuet-1 (Novagen, Merck, Darmstadt, Germany). A 
modified M9 medium was used to grow the E. coli expressing P. mirabilis proteins 
anaerobically. The medium was supplemented with 40 mM NaNO3, 50 µM FeCl3, 
30 mM glucose, yeast extract (0.05 %, w/v) and 400 mM NaCl. A high concentration 
of salt (400 mM) was used here in order to enhance the choline-uptake by E. coli via 
increased choline transporter betT expression (Lamark et al., 1991). Expression of 
the recombinant protein was confirmed by sodium dodecyl sulphate-polyacrylamide 
gel electrophoresis (SDS-PAGE) of whole extract. Individual bands corresponding 
to the expected size of CutC and CutD were removed from the gel and analysed by 
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matrix-assisted laser desorption/ionization-time of flight mass spectrometry 
(MALDI-TOF). 
2.1.8 Transmission electron microscopy (TEM) imaging of P. 
mirabilis microcompartments 
To observe microcompartments by TEM, anaerobic cultures of P. mirabilis were 
grown in 80 ml NH4+ defined medium supplemented with glucose, choline or 
glucose plus choline. Liquid cultures were fixed for 14 hours by injection with 
fixative to a final concentration of 2.5 % (w/v) glutaraldehyde in 100 mM sodium 
cacodylate (pH 7.2). The cells were harvested by centrifugation at 4,000 rpm for 15 
min and the cell pellet was re-suspended in 4 ml of the sodium cacodylate buffer. 2 
ml of cells was centrifuged at 10,000 rpm for 2 mins, and then dehydrated twice in 
100 mM sodium cacodylate (pH 7.2) for 5 mins, 1 % osmium tetroxide for 2 hours, 
three times in 100 mM sodium cacodylate (pH 7.2) for 5 mins, 50 % (v/v) ethanol 
for 15 mins and 70 % (v/v) ethanol overnight. The cells were further dehydrated in 
90 % (v/v) ethanol for 15 mins, three times with 100 % ethanol for 15 mins, twice 
with propylene oxide for 15 mins, propylene oxide: agar low viscosity (LV) resin 
(1:1) for 30 mins, 2x LV resin for 90 mins. The samples were placed in 0.5 ml 
BEEM® capsules, centrifuged for 5 min at 900 × g to concentrate the cells to the tip 
and incubated at 60 °C for 24 hr to polymerize.  
To observe the microcompartments of P. mirabilis grown on agar plates, agar plus 
bacteria were cut into a wedge shape (wider at the edge of the colony and narrower 
towards the middle of the colony) approximately 10 mm long, 5-6 mm (at wide end 
of wedge) and 2-3 mm (at narrow end of wedge). Three samples per plate were 
prepared. The wedge was cut with sloping sides-narrower at the surface of the agar 
and wider at the base of the agar so that the location of the bacteria relative to where 
they were on the plate was easy to identify (Fig 2.1A). After the agar wedges were 
stained with 0.1 % alcian blue (w/v) in 0.1 % acetic acid (v/v) to make it easy for 
sample handling and processing as described above. Aluminium dish moulds were 
used to place the processed wedges with the P. mirabilis swarming culture facing 
down in LV resin. All the samples were incubated at 60 °C for 24 hr to polymerize 
(Fig 2.1B).  
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                                                 (A)                                                            (B) 
Figure 2.1 Swarming plates used for TEM sample preparation: (A) Agar plus bacteria of swarming 
cells were cut in a wedge shape, three samples per plate for each conditions, choline, glycerol and 
glycerol plus choline. (B) Agar wedges were stained with 0.1 % (w/v) alcian blue in 0.1 % (v/v) 
acetic acid processed for TEM, as described above. 
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2.1.9 Purification of P. mirabilis microcompartments  
An attempt was made to purify microcompartments (BMCs) from choline-induced 
P. mirabilis culture. 2 L of liquid culture of P. mirabilis was grown on choline and 
glucose plus choline respectively until a certain cell density was achieved (OD600 
0.4-0.6). The BPER II purification method was carried out to purify the 
microcompartments (Sinha et al., 2012). Briefly, cells were harvested by 
centrifugation and washed twice with 40 ml of buffer A (12.5 mM MgCl2, 50 mM 
Tris-HCl [pH 8.0], 500 mM KCl, and 1.5 % 1,2-PD). After that, 2 g wet weight of 
cells were re-suspended in a mixture of 20 ml of buffer A and 30 ml of BPER-II 
containing 3 EDTA-free protease inhibitor tablets, 5 mM β-mercaptoethanol, 20 µl 
Benzonase and 50 mg of lysozyme. The re-suspended sample was incubated with 
60 rpm of rotator shaking for 30 mins at room temperature, followed by 5 mins 
incubation on ice. Cell debris was removed by centrifugation twice at 12,000 × g for 
5 mins at 4 °C. The remained microcompartment proteins were then centrifuged at 
20,000 × g for 20 min at 4 °C. The pellet was washed once with a mixture of 8 ml 
of buffer A and 12 ml of BPER-II supplemented with 1 ml of buffer B (5 mM MgCl2, 
50 mM Tris-HCl [pH 8.0], 50 mM KCl, 1 % 1,2-PD) containing protease inhibitor. 
Finally, the remaining cell debris was removed by centrifugation three times at 
12,000 × g for 1 min at 4 °C. The purified BMCs were stored at 4 °C until used. 
2.2 Escherichia coli  
2.2.1 Maintenance of Escherichia coli 
For growth in liquid medium, Luria-Bertani (LB) medium: 10 g l-1 tryptone, 5 g l-1 
yeast extract, 5 g l-1 NaCl, 40 µl 5 M NaOH (Sambrook et al., 2001) was used to 
cultivate E. coli strains, listed in Table 2.3. For growth on agar plates, Bacto agar 
(Difco) was added (1.5 % w/v). Liquid cultures were incubated at 37 °C in an orbital 
shaker (150 rpm). Stock cultures were prepared by adding 10 % (v/v) glycerol into 
LB culture and then stored at -80 °C.  
There were four E. coli strains used throughout this thesis (Table 2.3). E. coli JM109 
(Sigma-Aldrich Company Ltd., Dorset) was used for cloning. E. coli BLR (DE3) 
pLysS (Novagen, Merck, Darmstadt, Germany) was used for protein overexpression. 
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E. coli SE11 was used to investigate carnitine degradation to TMA, which was 
cultivated either in LB medium or in the same defined medium for A. baumannii 
(See Chapter 6). E. coli OP50 was used to maintain C. elegans (see below). 
2.2.2 Antibiotics used for Escherichia coli 
The antibiotics used for E. coli in this study and their appropriate concentrations 
were prepared as follows: kanamycin (25-50 µg ml-1), gentamicin (10 µg ml-1), 
spectinomycin (25 µg ml-1), tetracycline (10 µg ml-1), ampicillin (100 µg ml-1), and 
streptomycin (50 µg ml-1). 
2.2.3 Transformation of chemically competent E. coli cells 
E. coli JM109 high competency cells (Promega, Fitchburg, WI, USA) were used for 
all the routine cloning steps performed in this thesis. Transformation was carried out 
following the protocol from Sambrook et al. (Sambrook et al., 2001). Transformed 
cells were plated onto LB agar plates containing the appropriate antibiotic(s).  
2.3 Acinetobacter baumannii 
A. baumannii ATCC19606 wild-type and the mutants (∆cntA::aacC1, ∆cntB::aacC1) 
were cultivated in either Luria-Bertani (LB) medium or M9 defined medium. M9 
defined medium was prepared following the protocol from Zhu et al. (2012): NH4Cl 
(1 g l-1), NaCl (0.5 g l-1), KH2PO4 (3 g l
-1), Na2HPO4·7H2O (12.8 g l
-1), MgSO4·7H2O 
(0.5 g l-1), CaCl2·2H2O (0.15 g l
-1), Na2MoO4·2H2O (0.5 mg l
-1), FeCl3 (50 µM), 
supplemented with a mix of the vitamins: biotin (0.4 mg l-1), folic acid (0.4 mg l-1), 
thiamine hydrochloride (1 mg l-1), riboflavin (1 mg l-1), nicotinic acid (1 mg l-1), 
pantothenic acid (1 mg l-1), 4-aminobenzoic acid (1 mg l-1), lipoic acid (1 mg l-1), 
pyridoxine hydrochloride (2 mg l-1) and vitamin B12 (20 mg l-1). 
2.4 Extraction of nucleic acids  
DNA extractions from bacteria in this study were carried out using the FastDNA® 
SPIN Kit for Soil (MP Biomedicals, LLC, CA, USA) according to the 
manufacturer’s instructions. Normally, 1-10 ml of bacteria liquid culture was 
	 54		
centrifuged (8, 000 x g for 5 min) to generate a cell pellet before extraction was 
carried out.  
RNA extraction and purification were performed following the protocol from 
Jameson et al. (2015). Anaerobic P. mirabilis cultures were grown in the NH4+ 
defined medium supplemented with glucose only or glucose plus choline, five 
replicates for each condition. Cells were grown until the OD600 reached 0.4 and were 
harvested by centrifugation. Total RNA was extracted using the TRI reagent (Sigma-
Aldrich Company Ltd., Dorset). DNA was removed by treating with on-column 
DNAse (QIAgen, Crawley, UK).  Total RNA was purified using the RNeasy Mini 
Kit (QIAgen, Crawley, UK) according to the manufacturer’s protocols. 
For plasmid mini-prep, 1.5-5 ml overnight E. coli culture containing the appropriate 
plasmid was used. Plasmid extraction was carried out using the QIAprep Miniprep 
Kit (QIAgen) or GeneJET kit (Fermentas) according to the manufacturer’s protocols.  
For E. coli carrying a low-copy number plasmid (e.g. pCOLADuet), the QIApep 
Midiprep Kit (QIAgen) was applied according to the manufacturer’s instructions. 
2.5 RNA-Seq 
60 µl RNase-free water was used to re-suspend the purified RNA. Messenger RNA 
was enriched using the Ribo-Zero rRNA Removal Kit (Gram-negative Bacteria, 
Epicentre, Cambio, UK). An Agilent bioanalyser (Agilent, Edinburgh, UK) was 
used to assess the quality and quantity of RNA. ScriptSeq v2 RNA-Seq Library 
Preparation Kit (Epicentre, Cambio, UK) was used to prepare complementary DNA 
libraries. Illumina HiSeq 2500 platform (Illumina, Little Chesterfield, UK) was then 
applied to run each sample of one hundred bp paired-end sequencing. FASTX 
Toolkit was used to trim and filter the raw Illumina RNA-Seq reads to 55 bp based 
on read quality. Only high-quality sequences, with Illumina base quality score of 20 
for either 96 % or 100 % of bases, were retained. Finally, the RNA-Seq reads were 
aligned to the P. mirabilis HI4320 genome sequence via the TOPHAT program. A 
more detailed method for subsequent bioinformatics analysis of RNA-Seq data is 
presented in Chapter 4. 
2.6 Nucleic acid manipulation techniques  
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An ND-1000 spectrophotometer (NanoDrop Technologies Inc., Wilmington, DE, 
USA) was used to quantify nucleic acids. A 1 % (w/v) agarose gel made with TBE 
buffer was used to check the integrity and purity of DNA.  
PCR in this study was carried out in a total reaction volume of 50 µl. A T-100 
thermocycler (Bio-rad Laboratories Inc., Hercules, CA, USA) was used to perform 
the reaction, with either KAPATaq (KAPA biosystems, Willimgton, MA, USA), 
Dreamtaq (Fermentas) or Pfu polymerase (Promega). Each component for a general 
PCR is shown in Table 2.1 and a typical reaction procedure is shown in Table 2.2. 
For colony PCR, DMSO (4 %, v/v) and BSA (0.04 %, w/v) were added to the 
reaction to help permeabilise cell membranes and stabilise enzymes respectively. 
Negative controls (with no template DNA) were always run in parallel to check for 
any DNA contamination. For overnight running, the reaction is usually set to be held 
at 4 °C.  
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Table 2.1 The amount of each component in a standard PCR mix 
Component 50 µl reaction Final concentration 
Nuclease-free sterile dH2O Up to 50 µl N/A 
5 x Buffer 10 µl 1 x 
MgCl2 (usually present in the 5 x buffer) N/A N/A 
dNTPs (10 mM each nucleotide) 1 µl 0.2 mM each nucleotide 
10 µM forward primer 2 µl 0.4 µM 
10 µM reverse primer 2 µl 0.4 µM 
Template DNA Dependent on the manufacturer’s protocol <0.5 µg/50 µl 
DNA polymerase Dependent on the manufacturer’s supply 2.5 unites 
 
Table 2.2 The general procedure of a standard PCR cycle 
Step Temperature Duration Cycles 
Initial denaturation 95 °C 3 min (5 min for colony PCR) 1 
Denaturation 95 °C 1 min 
30 Annealing 45-60 °C (dependent on primers) 30 sec 
Elongation 72 °C 1 min/kb 
Final elongation 72 °C 5 min 1 
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DNA restriction digests were carried out using enzymes from Promega or Fermentas 
according to the manufacturer’s recommendations. 
DNA fragments from agarose gels were purified using QIAquick (QIAgen) or 
Nucleospin (Macherey-Nagel, Düren, Germany) gel extraction kits according to the 
manufacturers’ instructions. 
DNA ligations were routinely carried out using T4 DNA ligase (Promega, or 
Fermentas) with varying amounts of DNA and varying ratios of vector: insert, 
according to the general guidance of Molecular Cloning (Green & Sambrook). 
PCR products were routinely cloned into a pGEM-T Easy vector (Promega) 
according to the manufacturer’s instructions. 
Sanger sequencing of PCR products or purified plasmids was carried out by GATC, 
Germany. DNA sequence analysis was carried out using SeqMan Pro, part of the 
Lasergene software suite (DNASTAR, Madison, WA, USA).  
For electrophoresis of DNA, 0.5-2 % (w/v) agarose gels were made with 1 × TBE 
buffer, with the addition of ethidium bromide (0.5 µg ml-1) prior to casting to 
visualize the DNA. DNA fragments were run and separated on the gel alongside 1kb 
plus DNA ladder (Fermentas) as marker to estimate the sizes of DNA fragments. 
Gels were visualised on a Gene Genius transilluminator (Syngene, Cambridge, UK). 
2.7 Analytical methods 
Cation-exchange ion chromatograph coupled with a conductivity detector was used 
in this study to quantify choline and TMA, retention times 18.34 min and 14.46 min 
respectively (Fig 2.2). A Metrosep C4/250-mm separation column was used to 
separate methylated amines and quaternary amines from other cations. 
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Figure 2.2 An example chromatograph showing the respective peaks and retention times for choline and TMA. 
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2.8 Protein manipulation methods  
Bacterial cells were broken for protein work by passing through a French Press unit 
(American Instrument) three times at 110 megapascals at 4 °C. 
A Bio-Rad Protein Assay Kit (Bio-Rad) was used to determine the total protein 
concentration, according to the manufacturer’s instructions. A standard curve was 
plotted using bovine serum albumin (BSA, 0.25, 0.5, 0.75, 1 mg ml-1). 
Sodium dodecyl sulphate (SDS)-PAGE was applied in this study for routine 
analyses of purified proteins or over-expressed, IPTG-induced recombinant proteins, 
with PageRuler Plus pre-stained protein ladder (Fermentas) as a molecular mass 
reference. 
2.9 Quantification of β-galactosidase activity (Miller 
assay) 
Z-buffer stock solution (4.27 g Na2HPO4, 2.75 g NaH2PO4·H2O, 0.375 g KCl, 0.125 
g MgSO4·7H2O) was prepared according to the protocol of Lidbury, 2015. 500 ml 
of stock solution was stored at 4 °C with pH adjusted to 7.0. Before use, 50 ml of Z-
buffer was mixed with 0.14 ml ß-mercaptoethanol. Fresh O-nitrophenyl-ß-D-
galactoside (ONPG) (4 mg ml-1) was also prepared prior to use. 1 M Na2CO3 was 
prepared and stored at 4 °C. 
Transconjugants, carrying the appropriate lac fusion plasmid, were stored on P. 
mirabilis non-swarming agar plates with spectinomycin (150 µg ml-1). Fresh cells 
were prepared by re-streaking onto new agar a week prior to the enzyme assays. 
Colonies were picked and placed into M9 defined medium containing glucose and 
spectinomycin (150 µg ml-1). This culture was then grown overnight and used as an 
inoculum (2.5 %, v/v). Cells were grown overnight in M9 with either choline or 
glucose (10 mM) as the sole carbon source. For these two groups, equal amounts of 
cells (10-30 ml, according to OD600) were harvested (centrifugation for 10 min at 
8,000 x g) and washed with Z Buffer (5 ml) prior to re-suspension in 1 ml Z buffer.  
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The enzyme assay was initiated by mixing cells with the artificial substrate OPNG, 
resulting in the formation of the yellow product O-nitrophenol, as can be seen from 
Fig 2.3. The following equation was used to calculate the promotor activity by 
converting into Miller Units:   
 
Time = time of reaction (min)  
Vol = volume of cells used (ml)  
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Figure 2.3 An example of the β-galactosidase activity assay, showing the choline-TMA lyase 
promoter activity of P. mirabilis in choline medium (right), in contrast to in glucose medium (left) 
(See Chapter 5). 
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2.10 Caenorhabditis elegans life span assays  
2.10.1 Maintenance of C. elegans  
C. elegans N2 strain was obtained from Dr Andre Pires da Silva (University of 
Warwick, UK). C. elegans strain CF512 fer-15(b26) II; fem-1(hc17) IV was 
purchased from Caenorhabditis Genetic Center (CGC, University of Minnesota, 
USA). Modified nematode growth medium (NGM) plates were used to maintain 
nematodes: 3 g l-1 NaCl, 2.5 g l-1 bacteriological peptone, 25 mM potassium 
phosphate buffer (1 M KH2PO4, 1 M K2HPO4, pH= 6), 1 mM CaCl2, 1 mM MgSO4, 
5 mg ml-1 cholesterol, 25 ug ml-1 nystatin, 17 g l-1 Bacto agar (Difco), and 50 ug ml-
1 Streptomycin (Tan et al., 1999). The plates were seeded with Escherichia coli 
OP50 strain as previously described by Stiernagle (2006). Briefly, 50 µl of E. coli 
OP50 overnight LB culture was seeded onto NGM agar. The plates were then 
incubated for 8 h at 37 °C or at room temperature for 24 h. OP50 plates were kept at 
4 °C in the fridge until needed. C. elegans were then transferred to a new plate 
seeded with OP50 by transferring a chunk of agar from an old plate. Plates with 
nematodes were incubated at 16 °C for 4-7 days until the E. coli (nematode food) 
was almost finished. A new agar chunk was then transferred to seed a new plate.  
2.10.2 Bleach synchronization of C. elegans 
This method is applied to obtain age-synchronized C. elegans N2 or CF512 for the 
life span assay. The nematodes were washed off from 3-4 day old OP50 plates with 
M9 buffer (3 g l-1 of KH2PO4, 6 g l
-1 of Na2HPO4, 5 g l
-1 NaCl and 100 mM MgSO4), 
and collected into a 50 ml falcon tube. The worms were then treated with 0.5 M 
NaOH and 1 % NaClO for 5 min. The aim of this step is to kill the nematodes at 
both adult and larval stages with only eggs intact, as reported by Stiernagle (2006). 
After that, the falcon tube was filled with PBS 10X (80 g l-1 of NaCl. 2 g l-1 of KCl. 
14.4 g l-1 of Na2HPO4 2.4 g l-1 of KH2PO4, pH=7.4) with gentle shaking for a few 
seconds. This step dilutes and neutralizes the NaOH and bleach. Eggs were collected 
by centrifugation at 1,500 x g for 5 min and washed twice with the aforementioned 
M9 buffer. Eggs were then re-suspended with M9 buffer and transferred to a new 50 
ml falcon tube and incubated for 16-24 h at 20 °C while spinning on a rotating 
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carousel at 10 rpm. During this time, the eggs hatched but remained at the first larval 
stage (L1), due to a lack of food, as reported by Stiernagle (2006). After incubation, 
L1 larvae were gained by spinning at 1,000 g for 5 min and removing the top layer 
of medium. L1 larvae were then plated on NGM plates seeded with OP50 for 3 days 
at 20 °C to reach the young adult stage.  
2.10.3 The role of carnitine degradation on C. elegans life span 
2.10.3.1 Carnitine degradation in Acinetobactor baumannii on C. elegans life 
span 
All work on A. baumannii described in this thesis was carried out by myself in the 
laboratory of Dr Kumar Rajakumar at The University of Leicester. As shown in Fig 
2.4, A. baumannii wild type, cntA and cntB mutant strains were recovered from 
frozen stocks by streaking onto LB plates and incubating overnight at 37 °C. One 
colony of each strain was cultivated in 5 mL LB for 16 h at 37 °C with shaking (200 
rpm). 1 % (v/v) LB inoculum of wild type, the cntA and the cntB mutants were added 
to a defined M9 medium supplemented with 20 mM of carnitine or 20 mM of 
succinate with gentamycin (80 µg ml-1), incubated at 37 °C while shaking at 200 
rpm until OD600 reached 0.6. The same amount of cells of wild type or mutants were 
collected and washed with NH4+ free M9 medium, containing carnitine or succinate. 
100 µl of M9-washed culture was spotted on NH4+ free M9 medium agar plates 
supplemented with carnitine or succinate without gentamycin. The plates were 
incubated overnight at room temperature before use.  
Ten age-synchronized adult nematodes were manually transferred onto a plate 
containing A. baumannii wild type, cntA, or cntB mutant. Ten plates were used for 
each bacterial strain, resulting in 100 worms in total for each experiment. The 
nematode plates were observed at 20 °C every day and the numbers of nematodes 
found alive, dead or censored were recorded. ‘Censored’ worms indicate those that 
had dried on a plate wall, bagged with progenies or missing during the life span 
experiment (Fig 2.5). Nematodes were observed as dead if they did not react or move 
when touched. The percentage of surviving worms was plotted over time and log-
rank tests were performed using the Kaplan-Meier survival analysis in Sigmaplot 
(version 11.0). 
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Figure 2.4 Schematic representation of the impact of carnitine degradation in A. baumannii on C. 
elegans life span (modified from the protocol of Crosatti, 2014). 
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                                                 (A)                                                                      (B) 
Figure 2.5 (A) Different stages of C. elegans on un-synchronized NGM plates, from L1 to L4 lava 
and to adult during their life cycle, as indicated by red arrows. (B) Observation of C. elegans during 
its life span was recorded as, upper: alive; middle: dead; lower: censored (bagged). 
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2.10.3.2 Carnitine degradation in Escherichia coli SE11 on C. elegans life span 
The same protocol (See section 2.10.3.1) was used to investigate the impact of 
carnitine degradation in E. coli SE11 on C. elegans life span (Fig 2.6). 
A temperature sensitive nematode strain was used. C. elegans CF512 strain was 
maintained on OP50 plates at 15 °C until needed. Age-synchronized worms were 
grown at 25 °C to adults and transferred onto five different groups of E. coli SE11 
plates supplemented with: 20 mM of carnitine, malate, succinate, malate plus TMA, 
or succinate with TMA respectively (100 worms per group). The plates were kept at 
25 °C throughout the life span experiment since CF512 is a strain unable to produce 
offspring at this temperature and thus remain sterile (Hsin, 2007). 
Survival assays were carried out for the C. elegans N2 strain at both 20 °C and 25 °C 
to compare the difference of the impact of carnitine degradation in E. coli SE11 on 
C. elegans life span. 
2.10.4 Survival analysis  
At the end of each assay, the life span data collected were used to carry out the 
survival analysis, taking into account the missing nematodes during the experiments 
as censored. The life span data were analysed to investigate whether each worm 
survived, died or was censored, as well as the time at which any of these events 
occurred. Sigma-plot software was used to carry out this analysis using the Kaplan-
Meier method. The comparisons of the survival of nematodes between different 
bacterial strains and between mutants and wild type were carried out using Log-rank 
statistical test. 
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Figure 2.6 Schematic representation of the impact of carnitine degradation in E. coli SE11 on C. 
elegans life span (modified from the protocol of Crosatti, 2014).  
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Table 2.3 A complete list of strains and plasmids used throughout the course of this study 
Plasmids/strains Description/use Reference 
Bacterial strains 
Acinetobacter baumannii ATCC 19606 
A. baumanii ΔcntA::aacC1 
A. baumanii ΔcntB::aacC1 
Escherichia coli BLR(DE3) pLysS 
E. coli JM109 
E. coli SE11 
E. coli OP50 
Proteus mirabilis DSMZ4479 
P. mirabilis HI4320 
P. mirabilis P14 
P. mirabilis P19 
P. mirabilis ΔcutC::Km 
P. mirabilis ΔcutC::Km+cutCD 
Plasmids 
pACD4K-C 
pACD4K-cutC 
pAR1219 
pBIO1878 
pBIO1878 (PtetR-lacZ) 
pCOLADuet 
 
Wild type 
Wild type derivative with cntA deletion 
Wild type derivative with cntB deletion 
Host for heterologously protein expression 
Routine host for cloning 
Wild type 
Wild type 
Wild type 
Fully sequenced as genome reference 
Clinical isolate 
Clinical isolate 
Wild type with disrupted cutC 
cutC mutant complemented with pGEM-T-cutC/D 
 
TargeTron vector, KanR 
Disrupted cutC cloned into pACD4K-C 
Helping plasmid for TargeTron transposon mutagenesis, AmpR 
SpcR derivative of pMP220 with LacZ reporter gene 
The promoter of cutC gene cluster cloned into pBIO1878 
Dual expression vector, KanR 
 
University of Leicester laboratory collection 
Zhu et al., 2014 
Zhu et al., 2014 
(Sambrook et al., 2001) 
(Sambrook et al., 2001) 
(Oshima et al., 2008) 
(Stiernagle, 2006) 
DSMZ culture collection, Braunschweig, Germany 
Pathology Department of Cambridge University 
Pathology Department of University of Cambridge 
Pathology Department of University of Cambridge 
This thesis 
This thesis 
 
TargeTron gene knock out system, TA0100, Sigma 
This thesis 
TargeTron gene knock out system, TA0100, Sigma 
(Todd et al., 2012) 
This thesis 
Novagen 
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pCOLADuet-cutC/D 
pCOLADuet-cutC’/cutD 
pGEM-T-cutC/D 
pk18mobsacB 
Animal strains 
Caenorhabditis elegans N2 
C. elegans CF512 fer-15(b26) II; fem-1(hc17) IV 
cutC and cutD cloned into pCOLADuet 
N-terminus truncated cutC cloned into pCOLADuet-cutD 
cutC and cutD cloned into pGEM-T easy vector, AmpR 
Positive control vector for electroporation of P. mirabilis, KanR 
 
Wild type, store at 15 °C, grow at 20 °C or 25 °C 
Temperature sensitive strain, grow at 15 °C, sterile at 25 °C 
This thesis 
This thesis 
This thesis 
(Schäfer et al., 1994) 
 
University of Warwick laboratory collection 
Caenorhabditis Genetic Centre, University of Minnesota, 
USA 
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Table 2.4 A list of primers used throughout the course of this study 
Primers Sequence Used for 
CutC-IBS 
 
CutC -EBS2 
 
CutC -EBS1d 
 
cdt mutant F 
cdt mutant R 
T7 F 
5’R kpnI 
5898-6656 R 
6656-7415 F 
3’ F kpnI 
M13 R 
N-terminus truncated cutC F 
N-terminus truncated cutC R 
F1 pGEMT 
F2 pGEMT 
F3 pGEMT 
PtetR F 
PtetR R 
AAAAAAGCTTATAATTATCCTTAAAATTCCATCTGGTGCG
CCCAGATAGGGTG 
TGAACGCAAGTTTCTAATTTCGGTTAATTTCCGATAGAGG
AAAGTGTCT 
CAGATTGTACAAATGTGGTGATAACAGATAAGTCCATCTG
ACTAACTTACCTTTCTTTGT 
GCGGTTAATCCGCGTGTTTC 
AGGCATTTGCCGGTGTATCA  
TAATACGACTCACTATAGGG  
AAAAAGGTACCACGCCATGCGATATCAGGAG  
AAATATTTTGCCGGTTATCAA  
CCACCGTTAAGTTGATAAAGG  
AAAAAGGTACCAGGGCACGAAGAGTTACTGC 
GGATAACAATTTCACACAGG  
CCATGGACATCAACGATCCGCGCGTGA 
GATTATGCGGCCGTGTACAA 
TCAGATCTGTCGTATCACCA 
TTCGTTAAAGTCTACCAGCC 
CTATCCGCAAACTGGTGTAT 
GAATTCAAATCCACATTACTTTCTCGCTCA  
GGTACCTTTTATTTCCTCCAGGAAGCCGTT 
ΔcutC by TargeTron transposon mutagenesis system 
 
ΔcutC by TargeTron transposon mutagenesis system 
 
ΔcutC by TargeTron transposon mutagenesis system 
 
Confirmation of ΔcutC complement mutant 
Confirmation of ΔcutC complement mutant 
Confirmation of ΔcutC complement mutant 
Confirmation of ΔcutC complement mutant 
Confirmation of ΔcutC complement mutant 
Confirmation of ΔcutC complement mutant 
Confirmation of ΔcutC complement mutant 
Confirmation of ΔcutC complement mutant 
Cloning region of N-terminus truncated cutC 
Cloning region of N-terminus truncated cutC 
Confirmation of N-terminus truncated cutC 
Confirmation of N-terminus truncated cutC 
Confirmation of N-terminus truncated cutC 
Cloning region of the choline-TMA lyase promoter  
Cloning region of the choline-TMA lyase promoter 
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PMI2722-20 F 
PMI2722-20 R 
PMI2718 F 
PMI2718 R 
PMI2814 F 
PMI2714 R 
PMI2722-10 F 
PMI2722-10 R 
PMI2725-09 F 
 
PMI2725-09 R 
GGAATTCCATATGGGTGATGCATTAGGTCTG 
CTAGCTAGCTCAGGCTTTATGTTGCTCTG  
CATGCCATGGATGATCCTCGCAAAGGTAATC 
CTAGCTAGCTTACTCCTTACTGTCCCGATAAAC 
CATGCCATGGATGAACAGTTTAGGTGTGATTG 
CTAGCTAGCTTATTTTTTACCTTTACGGC 
CGCGGATCCATGGGTGATGCATTAGGTCTG 
AAAAAGCGGCCGCTTACATCGTTGAAAAGGTATTC 
CGCGGATCCATGAATACAACCGCACATCAC 
 
AAAAAGCGGCCGCTTATTTTATTTCAATATTATC 
Cloning region of microcompartment proteins 
Cloning region of microcompartment proteins 
Cloning region of microcompartment proteins 
Cloning region of microcompartment proteins 
Cloning region of microcompartment proteins 
Cloning region of microcompartment proteins 
Cloning region of the cutC operon 
Cloning region of the cutC operon 
Cloning region of cutC operon+tetR regulator+ protein-tyrosine 
phosphatase 
Cloning region of cutC operon+tetR regulator+ protein-tyrosine 
phosphatase 
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Chapter 3 
 
Developing a method for 
genetic manipulation of 
Proteus mirabilis 
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3.1 Introduction 
Proteus mirabilis is a Gram-negative, facultative anaerobic, rod shaped bacterium, 
which is part of the gut microbiota in healthy individuals, but also a frequent cause 
of urinary tract infections (UTI) after Escherichia coli (Pearson et al., 2008). P. 
mirabilis is unique in that this bacterium can differentiate from short vegetative 
swimmer cells to elongated highly-flagellated swarmer cells (Pearson et al., 2008). 
This distinct feature was first observed by Hauser in 1885 (Rather, 2005). It has been 
well-documented since the 1980s that P. mirabilis can produce TMA from choline 
(Sandhu and Chase, 1986), therefore it was chosen in this project as a model to 
uncover the key genes and metabolic pathways for choline degradation to TMA. 
However, the method for plasmid transfer and gene knock-out mutagenesis for P. 
mirabilis has not been well reported.  
Between January, 2004 and December, 2007, a total of 198 non-duplicate isolates 
of P. mirabilis were isolated from clinical specimens in hospitalized patients (Yu et 
al., 2010). P. mirabilis strain HI4320 is one of the representatives of the species, 
which was isolated from the urine of an elderly female patient suffering from a long-
term indwelling catheter (Pearson et al., 2008). The whole genome of strain HI4320 
was subsequently sequenced by the Mobley group. It is 4.063 Mb long with a 
relatively low GC content (39 %). 3,685 gene-coding ORFs were identified in the 
genome and it has seven rRNA loci. One plasmid of 36,289 nucleotides was also 
identified from the genome sequences. HI4320 has since become the most widely-
used strain in recent studies because it is well-characterized and the whole genome 
is fully closed. Complete genome sequencing of HI4320 has significantly facilitated 
the study of P. mirabilis physiology and metabolism (Pearson et al., 2008).  
During the course of this PhD study, two clinical isolates were also used. Strain P14 
and strain P19 (U6250) were isolated from hospital patients with chronic urinary 
tract infections (Liaw et al., 2001).  
Strain DSMZ4479 has also been widely investigated for urinary tract infection, 
genome sequencing analysis and clinic detection studies (Schaffer and Pearson, 
2015; Gosiewski et al., 2014; Bonkat et al., 2012). It was identified by ion mobility 
spectrometry, which is used to determine microbial volatile organic compounds, and 
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also brings a new identification tool for human pathogenic bacteria via 
determination of their characteristic volatile metabolomes (Jünger et al., 2012). 
Gene mutagenesis and homologous recombination studies in E. coli showed that this 
strain was the easiest and most preferred strain for genetic manipulation (Schaffer 
and Pearson, 2015), although its genome has not been fully sequenced. The aim of 
this chapter is therefore 1) to test several P. mirabilis isolates for their ability to 
degrade choline to TMA and 2) to establish a method for genetic manipulation in 
representative P. mirabilis strains.  
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3.2 Proteus mirabilis strains and their growth on 
choline 
During my PhD study, I obtained the four strains of P. mirabilis and tested their 
ability to produce TMA from choline anaerobically. P. mirabilis strain DSMZ4479 
was obtained from the DSMZ culture collection, Braunschweig, Germany. Strains 
HI4320, P14 and P19 were obtained from the Pathology Department of Cambridge 
University. These four strains were grown anaerobically at 37 °C in NH4+ medium 
on choline (10 mM) as the sole carbon source and choline was degraded completely 
within 5 days. Quantification of TMA using a cation exchange Ion chromatography 
(881 Compact IC Pro Metrohm, Herisau, Switzerland) demonstrated the production 
of TMA from choline degradation in all four isolates (See Chapter 2 materials and 
Methods). 
3.3 Minimum inhibitory concentration test on P. 
mirabilis strains 
In order to establish a protocol for generating mutants in P. mirabilis, I firstly carried 
out minimum inhibitory concentration (MIC) tests. I tested the four strains on the 
non-swarming agar plates (See Chapter 2 Materials and Methods for medium 
compositions) using kanamycin, ampicillin and gentamycin. The MIC data for 
kanamycin, ampicillin and gentamycin showed no significant difference among the 
four strains (Table 3.1). I chose the strain DSMZ4479 for further exploration 
because it has been reported previously that it was amenable for genetic 
manipulation (Schaffer and Pearson, 2015) although its genome sequence has not 
been reported (Table 3.2). 
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Table 3.1 MIC (µg ml-1) for four different strains of P. mirabilis on non-swarming agar plates 
                              MIC 
Strains 
Kanamycin 
 
Ampicillin 
 
Gentamicin 
DSMZ4479  150 150 50 
HI4320  150 150 20 
P14 150 100 50 
P19 150 150 20 
 
Table 3.2 MIC (µg ml-1) for P. mirabilis DSMZ4479 on non-swarming agar plates 
Antibiotics MIC 
Kanamycin 150 
Ampicillin 150 
Gentamicin 50 
Spectinomycin  150 
Streptomycin 250 
Chloramphenicol 150 
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3.4 Establishment of the protocol for plasmid 
transfer in P. mirabilis strain DMSZ4479 
I initially planned to generate marker-exchange knockout mutants using the vector 
pKNG101 through conjugation. pKNG101 is a suicide plasmid, suitable for positive 
selection of double recombination mutants in a range of Gram-negative bacteria 
(Kaniga et al., 1991). It contains an oriR6k type of origin of replication, a mobRK2 
type of origin of transfer and an antibiotics selection marker (streptomycin resistance, 
SmR) (Kaniga et al., 1991). However, after several attempts, I did not manage to 
obtain any mutants in P. mirabilis DSMZ4479 using this approach. A previous deep 
investigation on the whole genome of P. mirabilis HI4320, however, has revealed 
the presence of an R6K-type of plasmid in this bacterium. It has been reported that 
this R6K-type plasmid in strain HI4320, named pHI4320, is highly related to the 
R6K plasmid in E. coli, which encodes the R6K replication proteins (encoded by 
PMIP37 to PMIP39) and the p protein (encoded by PMIP01) (Kaniga et al., 1991; 
Pearson et al., 2008). One of the necessary facts for successful bacterial conjugation 
is plasmid compatibility, which means the donor cell provides a conjugative genetic 
element, usually a plasmid, while the recipient cell does not already contain a similar 
plasmid. The genome of P. mirabilis strain DSMZ4479 has not been genome-
sequenced but it is possible that a similar R6K type plasmid is present in DSMZ4479, 
therefore making it impossible for conjugating pKNG101 (which contains an oriR6k 
type of replication origin) into this bacterium due to plasmid incompatibility. This 
approach was therefore abandoned.  
I then tried to use electroporation for plasmid transfer to DSMZ4479 using a vector 
that does not contain an oriR6k type of replication origin. I adapted the protocol 
from Visalli et al. (2003) to make electrocompetent cells. The protocol was further 
optimised to improve competency. The cells were grown in a LB broth medium 
(without NaCl) and harvested when the optical density (OD600) reached between 0.3 
and 0.6, which took 2.5-4 hours after inoculation. Immediately before 
electroporation, the competent cells were mixed with plasmid DNA and incubated 
on ice for 1 hour before electroporation to improve electroporation efficiency. 
During the experiment, I used a pGEMT-based construct containing a KanR cassette 
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as a positive control to optimize the gene transfer protocol. The transformation 
efficiency of plasmid transfer using this established protocol was estimated to be ~ 
4×105 CFU/µg. 
Briefly, mid-log phase P. mirabilis cultures were harvested when they reached 
OD600 0.3-0.6, approximately 2.5-4 hours in LB (minus NaCl) at 37 °C with shaking. 
Cells were chilled on ice and washed 4 times by centrifugation at 3,200 g with ice-
cold, sterile, 10 % (v/v) glycerol solution. The culture was concentrated 500-fold 
and aliquots of 60 µl snap-frozen in a dry-ice ethanol bath and stored at -80 °C. 
Before electroporation thawed competent cells were combined with 500 ng of 
plasmid DNA and incubated on ice for 1 hour. The cells were then transferred to a 
1 mm gap cuvette and electroporated at 1.8 kV and the time constant was 4.5-4.6 
ms. 
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3.5 Generating a cutC knockout mutant in P. 
mirabilis using a TargeTron targeted transposon 
mutagenesis system 
3.5.1 Construction of the pACD4K-cutC 
In Chapter 4, a comparative transcriptomic approach is used to identify key genes 
involved in choline degradation to TMA. One of the key genes that is highly induced 
by choline is designated as cutC (See later in Chapter 4). I therefore chose this 
gene for testing the gene knockout method. The cutC mutant (ΔcutC) was generated 
using the TargeTron gene knockout system (Sigma-Aldrich, TA0100-3EA) (Fig 3.1 
and Fig 3.2). The cutC gene sequence was loaded onto the TargeTron Design 
Website (sigma-aldrich.com/targetronacess) and three cutC-retarget specific 
primers IBS, EBS2, and EBS1d were designed by the software. The system provided 
a few sets of these three specific primers for the target site and the set with lowest E 
value (0.010) was used in this study (Table 2.2, Materials and Methods).  
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                                          (A)                                                       (B) 
Figure 3.1 (A) One-step assembly PCR using the EBS universal primer and the three primers specific 
for cutC was carried out to mutate (re-target) the intron RNA. The PCR product ~ 350 bp (B) of the 
retargeted intron was cloned into pGEM-T which was then confirmed by DNA sequencing using the 
M13 primers. The retargeted intron was then sub-cloned into the plasmid pACD4K-C to create 
pACD4K-cutC (Fig 3.2).  
 
Figure 3.2 The plasmid map of pACD4K-C and the retargeted intron RNA site. 
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3.5.2 Electroporation of P. mirabilis DSMZ4479 [pAR1219] 
competent cells with pACD4K-cutC 
P. mirabilis DSMZ4479 competent cells were first electroporated with the T7 helper 
plasmid pAR1219 (Davanloo et al., 1984). The helper plasmid is a pBR322-based 
vector that expresses T7 RNA polymerase under control of the IPTG inducible lac 
UV51 promoter and is intended for use with the TargeTron Gene Knockout System 
(TA0100). Therefore, this step is essential because the helper plasmid would assist 
the late intron RNA transcription once the transformation of P. mirabilis DSMZ4479 
and pACD4K-cutC was done. Transformants were selected on non-swarming agar 
plates containing 150 µl/ml ampicillin. Electrocompetent P. mirabilis DSMZ4479 
containing pAR1219 were then prepared which were stored at -80 °C before use. 
The pAR1219 containing cells were electroporated with the construct pACD4K-
cutC, and putative cutC mutants were selected for by overnight growth in LB 
containing 150 µl/ml ampicillin cultures, 200 µl/ml chloramphenicol and 1 % 
glucose. The addition of 0.5 mM IPTG to the chloramphenicol- and ampicillin-
resistant isolate induced the intron to insert into the cutC gene in the P. mirabilis 
chromosome. Successful transformants were selected on non-swarming agar plates 
containing 150 µl/ml kanamycin. This mutant, ΔcutC, was confirmed by PCR using 
sequencing primers F and R (Fig 3.3A). The resulting PCR product for the wild type 
is around 1 kb whereas the size of mutant is around 3 kb since the KanR cassette 
from the intron is about 2kb (Fig 3.3B).  
 
 
 
	 82		
    
                                        (A)                                                                            (B) 
Figure 3.3 (A) The primer binding positions for the sequencing primers F and R, and the intron 
retargeting sites (position 3359 bp in total 3429 bp of cutC). (B) Agarose gel electrophoresis of the 
PCR products of the wild type and the mutant. lane 1, 1kb plus DNA ladder (Invitrogen); lane 2, PCR 
product of the ΔcutC ; Lane 3, PCR product of the wild type; and Lane 4, negative control of PCR.  
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3.5.3 Complementation of the cutC mutant  
To complement the cutC mutant, the intact cutC and cutD genes were amplified 
from the genomic DNA of P. mirabilis wild type DMSZ4479 using a proof-reading 
DNA polymerase (KAPA HiFi Tag). The PCR product was analysed by agarose gel 
electrophoresis in Fig 3.5 (A), which was further purified before dA-tailing. In the 
same way, the dA-tailing product was purified and ligated with the pGEM-T vector 
(Promega) to obtain pGEM-T-cutC/D (Fig 3.4 & Fig 3.5B). This construct was 
confirmed by digestion with the restriction enzyme, NotI (Fig 3.5C) and subsequent 
DNA sequencing analysis using the primers listed in (See Table 2.2, Materials and 
Methods). The competent cells of P. mirabilis cutC mutant were electroporated with 
pGEM-T-cutC/D, and the complemented mutant was selected on an LB agar plate 
with ampicillin (150 µg/ml). 
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Figure 3.4 cutC-cutD genes (4.7 kb) were amplified from P. mirabilis that was cloned into the 
pGEM-T vector. Its expression was driven by the lac promoter in the upstream of cutC (picture 
modified from pGEMT Easy Vector System technical manual, Promega, free online open access). 
 
                                 (A)                                                     (B)                                        (C) 
Figure 3.5 (A) Agarose gel electrophoresis of the PCR product of the cutC-cutD gene cluster. From 
left to right, 1 kb DNA ladder (Invitrogen), PCR product of cutC-cutD (replicate 1), PCR product 
(replicate 2), 1 kb DNA ladder. The uppermost 4.7 kb band is the product of expected size. (B) The 
dA-tailing product of cutC-cutD was purified from the agarose gel, which was then ligated into the 
pGEM-T Easy vector (Promega). (C) Digested pGEM-T-cutC/D with the restriction enzyme, NotI 
to confirm the presence of the cutC-cutD gene cluster in this plasmid. From left to right, 1 kb DNA 
ladder (Invitrogen), linearized pGEM-T Easy vector control (3 kb), pGEM-T-cutC/D (the upper 4.7 
kb band represents the cutC-cutD gene cluster and the lower 3 kb band was the linearized pGEM-T 
Easy vector). 
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3.6 Conclusions 
This chapter describes the initial test of four P. mirabilis strains (strains HI4320, 
P14, P19 and DSMZ4479) and their ability to convert choline to TMA. In good 
agreement with previous studies (Sandhu and Chase, 1986) all four strains tested are 
capable of producing TMA from choline anaerobically. MIC tests were then carried 
out for the four stains of P. mirabilis, which demonstrated no difference in antibiotic 
resistant profile (Table 3.1). DSMZ4479 was therefore used as the model strain in 
this study to establish the method of plasmid transfer and targeted gene knock-out 
mutagenesis, because it proved amenable for genetic manipulation although its 
genome sequence has not been reported. To validate the method, one of the highly 
expressed genes during growth on choline was chosen for further mutagenesis (See 
results presented in next chapter). This cutC gene was successfully deleted from P. 
mirabilis DSMZ4479. The cutC::kan mutant was further complemented by cloning 
and expression of the native cutC/D gene from DSMZ4479. Further growth tests of 
the wild-type, mutant and the complemented mutant are presented in Chapter 5. 
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Chapter 4 
 
Comparative 
transcriptomic analysis of 
Proteus mirabilis by 
RNA-Seq 
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4.1. Introduction  
The advent of next generation sequencing methods, and in particular comparative 
transcriptomics (RNA-Seq), has revolutionized the study of prokaryotic 
transcriptomes (Güell et al., 2009; Sharma et al., 2010b; Mitschke et al., 2011). 
Despite this, few studies have employed this technology to study the transcriptomes 
of quaternary amine metabolism in bacteria.  
One of the most important advantages of RNA-Seq is to identify the differential 
expression of genes under two or more conditions. The differentially expressed 
genes are identified by a combination of expression change threshold and score 
cutoff, which are usually based on p values calculated by statistical modeling. It is 
necessary to normalize the context of different analyses, as the presence of 
systematic variation between samples, as well as, differences in library composition 
will be taken into account via normalization. 
It is known that P. mirabilis can grow on choline as a sole carbon and energy source 
(Sandhu and Chase, 1986), however it is unclear which genes, enzymes and 
metabolic pathways are involved. The aim of this chapter is therefore to provide a 
global view of whole cell response to choline metabolism in this bacterium, by 
comparing transcripts of choline-grown cultures with glucose-grown cultures.  
In this chapter, RNA-Seq was carried out to investigate which genes are switched 
on and highly expressed under growth conditions with or without choline. Several 
modern bioinformatics tools have been used in this study: Bedtool-intersect toolset 
(Quinlan, 2015) for raw data comparison and calculation, to get read counts files, 
Degust interactive web-based RNA-Seq visualization software (Zhao et al., 2016) 
for read counts analysis and R program (DESEQ package) for statistical analysis. 
The phylogenetic and genome analysis were subsequently carried out to identify the 
functional choline-TMA lyase and the cutC gene cluster in P. mirabilis and to 
compare the CutC between P. mirabilis and D. desulfuricans.  
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4.2 Results 
4.2.1 Experimental setup 
P. mirabilis cultures were grown anaerobically in defined medium with glucose only 
or glucose plus choline as a carbon source, with five replicates for each condition. 
Cells were grown and harvested at the late exponential phase, when OD600 reached 
0.4, for glucose plus choline at 15 hours, and for glucose only at 20 hours, as 
indicated in black arrows (Fig 4.1). The whole process of RNA-Seq was carried out 
using the pipeline indicated in Fig 4.2. Briefly, the total ribonucleic acid (RNA) was 
firstly extracted and purified, and then the messenger RNA was enriched using an 
rRNA-depletion kit. The quality and quantity of the enriched mRNA were assessed 
on an Agilent bioanalyser. cDNA library preparation, RNA Hi-Seq program, and 
raw Illumina RNA-Seq alignment were carried out following the procedures detailed 
in Chapter 2 (Materials and Methods, Section 2.5 RNA-Seq). Note that the raw 
reads were mapped to P. mirabilis HI4320 genome sequence, because the genome 
sequence of the strain used in this study is not available. The raw read counts were 
gained from extracting via the HTSEQ PYTHON package.  
Two independent methods were then used to analyze the raw read counts data. In 
the first instance, differential expressions of genes were determined by the R 
software package DESEQ for the cultures grown under conditions with or without 
choline. This was carried out by Dr Jameson and myself at the beginning of my PhD 
(Jameson et al., 2015). Fig 4.2 indicates the contributions for each one of us for the 
work presented in this chapter. 
Additionally, the raw read counts of RNA-Seq were also processed using the 
transcriptomic Bedtool online program (Bedtool-intersect toolset, 
http://bedtools.readthedocs.io/en/latest/content/tools/intersect.html) by myself. The 
alignment of the data (file format: sample_hits.bam.bai) was carried out in Artemis 
(Sanger), using the reference strain P. mirabilis HI4320. The expression analysis 
and plots were carried out using the Degust website program 
(http://www.vicbioinformatics.com/degust/index.html), while the different 
expression levels of each gene were also investigated (Fig 4.2).  
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Figure 4.1 Growth curve of P. mirabilis in the defined medium supplemented with glucose or glucose plus choline anaerobically. Cells were harvested when OD600 
reached 0.4, for glucose plus choline at 15 hours, and for glucose only at 20 hours, as shown in black arrows. 
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Figure 4.2 RNA-Seq pipeline for the whole experiment. The extraction and purification of RNA was carried out in Warwick; RNA enrichment, quality and quantity 
assessment and cDNA library preparation were carried out in Exeter, and the raw read counts and the later RNA-Seq analysis were carried out in Warwick and Exeter.  
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4.2.2 RNA-Seq raw read count data summary  
After extraction and purification, messenger RNA was enriched using an rRNA-
depletion kit. The quality of enriched mRNA and their quantities before and after 
the enrichment were assessed on an Agilent bioanalyser to assess the quality of the 
enrichment. Fig 4.3 is a typical example showing the difference of E. coli mRNA 
before and after enrichment. In enriched mRNA samples, the main big peaks of 16S 
and 23S rRNA were depleted, and only small peaks of mRNA remained and thus 
were enriched (MICROB ExpressTM Kit protocol, Part number AM1905). Exactly 
the same process of analysis was carried out for the RNA enrichment of P. mirabilis 
under choline and non-choline conditions. Among those five biological replicates in 
each condition, three of them had better quality and higher quantity. They are C1rep1, 
C1rep2 and C1rep3 represent choline-grown condition, and C2rep1, C2rep2 and 
C2rep3 are glucose-grown condition, respectively. Thus these six samples (three 
replicates for each condition) were used for later library preparation and sequencing 
analysis. Fig 4.4 shows a typical QC report of one sample (C1rep3) after Hiseq runs. 
Table 4.1 shows the raw data counts of RNA-Seq of the three replicates for each 
condition. 
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Figure 4.3 Bioanalyzer analysis of E. coli RNA before and after mRNA Enrichment. The E. coli mRNA was enriched using the MICROBExpress kit from 10 µg of 
total RNA. 200 ng of RNA was used to generate the above electropherograms before and after mRNA enrichment by Agilent 2100 bioanalyzer using the RNA LabChip 
kit (MICROB ExpressTM Kit protocol, Part number AM1905). 
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(A) 
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(B) 
Figure 4.4 The quality report of C1rep3 replicate (sequence length 15-50bp, GC content 40 %) of the total six replicates under two conditions. (A) quality score across 
all base. Yellow bars show the quality scores of each base. (B) GC distribution over the whole 100bp sequence, the red line is the GC count per read and the blue line is 
the theoretical distribution.  
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Table 4.1 Raw data counts of RNA-Seq of the two conditions, glucose plus choline and glucose only 
 Glucose + choline Glucose 
 C1rep1 C1rep2 C1rep3 C2rep1 C2rep2 C2rep3 
Total reads 15,674,358 13,332,183 13,830,281 9,629,506 8,887,177 14,357,080 
Mean 14,278,941 10,957,921 
Standard Deviation 1,233,863 2,967,065 
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4.2.3 Assessment of biological replicates 
The repeatability of the three samples in each conditions was assessed by MDS plot. 
Fig 4.5 gives an overview of the variation of the three biological replicates under 
each condition. Both conditions had good repeatability between samples. 
 
Figure 4.5 MDS plot of the variation of the RNA-Seq sample replicates for each condition. 
Replicates shown in blue with the prefix “C1” represent choline-grown cultures, and replicates shown 
in orange with the prefix “C2” represent are glucose-grown cultures. The analysis was carried out 
using the Degust program (http://www.vicbioinformatics.com/degust/index.html).  
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4.2.4 Comparative transcriptome analysis by RNA-Seq in Proteus 
mirabilis 
4.2.4.1 Differential expression of genes in response to choline degradation to 
TMA in P. mirabilis 
Although Sandhu and Chase (1986) have previously confirmed that P. mirabilis can 
metabolize choline to TMA anaerobically, the key enzymes responsible for this 
transformation remain unknown. Comparative transcriptomic analysis of P. 
mirabilis cultivated on glucose with/without additional choline provided an 
overview of the key genes that are regulated by choline addition. Initial analyses 
carried out by Jameson et al. showed that a number of genes are highly induced by 
choline. The top 20 highly expressed genes in P. mirabilis are presented in Table 
4.2. Interestingly, several of these highly induced proteins (PMI2722, PIM2721, 
PMI2720, PMI2718 and PMI2714) were annotated as bacterial microcompartment 
shell proteins by the Integrated Microbial Genomes database at the Joint Genome 
Institute (http:// img.jgi.doe.gov/). 
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Table 4.2 Top 20 differentially expressed genes. Positive log2-fold change indicates down regulation with the addition of choline and negative values indicate up 
regulation with choline (Jameson et al., 2015). 
No. Locus tag Gene name Log2-fold change p-value Gene description 
1 PMI2721 eutM/pduA/J homologue -10.853338 8.58E-38 Microcompartment protein (BMC domain, PF00936.14) 
2 PMI2720 eutM/pduA/J homologue -9.9694882 1.25E-36 Microcompartment protein (BMC domain, PF00936.14) 
3 PMI2722 eutM/pduA/J homologue -9.3293139 2.06E-27 Microcompartment protein (BMC domain, PF00936.14) 
4 PMI2716 cutC -7.3519216 3.39E-26 Choline-trimethylamine lyase, CutC 
5 PMI2719 cutF -7.9456261 1.66E-20 Aldehyde dehydrogenase, CutF 
6 PMI2715 cutD -6.0539258 8.64E-20 Choline-trimethylamine lyase, activating enzyme, CutD 
7 PMI2714 eutM/pduA/J homologue -5.2834574 7.49E-17 Microcompartment protein (BMC domain, PF00936.14) 
8 PMI2718 eutN/ccmL homologue -10.804654 1.71E-15 Microcompartment/carboxysome/ethanolamine utilizatin protein 
(EutN_CcmL, PF03319.8) 
9 PMI2711 emrE  homologue -8.6639517 7.24E-13 Quaternary ammonium compound resistance protein 
10 PMI2717 cutO -9.6507023 1.08E-10 Alcohol dehydrogenase 
	 99		
11 PMI2710 emrE homologue -9.2090116 2.81E-06 Multi-drug resistance protein, EmrE homologue 
12 PMI0695 trxB -1.9182025 0.000123 Thioredoxin reductase 
13 PMI2713 cutH -5.5647202 0.000259 Phosphate acetyltransferase 
14 PMI0501  -1.8393886 0.000698 Uncharacterized conserved protein YjdB, phage protein 
15 PMIt054  3.6411425 0.001508 tRNA-Met 
16 PMI1739  -1.6050110 0.001628 Hypothetical protein YfaZ precursor, putative exporter protein 
17 PMI3109 fdoH -1.6200982 0.001691 Formate dehydrogenase-O subunit beta, transmembrane 
18 PMI0297  -1.7078902 0.001728 Fimbrial subunit 
19 PMI1288 ydfG -1.7860287 0.001896 NADP-dependent L-serine/L-allo-threonine dehydrogenase 
20 PMI1955 eco -1.6974899 0.002404 Protease inhibitor ecotin; homodimeric protease inhibitor 
BMC, bacterial microcompartment; NADP, nicotinamide adenine dinucleotide phosphate 
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4.2.4.2 Re-analysis of differential gene expression by RNA-Seq in P. mirabilis 
The initial analysis by Jameson et al. used the FASTX toolkit to trim the data and 
the TOPHAT program to align the RNA-Seq reads to the P. mirabilis HI4320 
genome. Statistical analysis was performed using the R software package DESEQ. 
However, in the DESEQ experiment, p < 0.05 was applied rather than p adjust value, 
thus there is a likelihood of obtaining false positive hits. Therefore, a different 
bioinformatics approach was applied, aiming to re-analyze the RNA-Seq data to 
minimize the chance of false positives in data analyses. For this purpose, the user-
friendly online program Bedtool-intersect (Quinlan, 2015) was used to re-run the 
raw read counts. Degust online program (Zhao et al., 2016) was then used to analyse 
and visualize the new read counts and perform the statistical analysis. False 
discovery rate (FDR) was applied at 0.05 cut off. 
The MA plot (Fig 4.6A&B) visualized the different gene expression levels of the 
choline and non-choline conditions, by transforming the measured data of these two 
conditions onto M-values and A-values. M-values (y axis) are the log intensity ratio 
of the two conditions (log fold-change), whereas A-values (x axis) are the log 
intensity averages of the two conditions (average of log expression value). The red 
dots represent the FDR value < 0.05 while the blue indicates FDR value ≥ 0.05. Fig 
4.6A shows the distribution of genes at FDR cut off of 1, and Fig 4.6B shows at 
log2-fold change with a more stringent cut off of FDR <0.05, there are 18 highly 
expressed genes that are statistically significant, 17 genes are indicated in red with 
FDR value less than 0.05, while only one gene is shown in blue with the FDR value 
0.05.  
The details of these 18 genes are listed in Table 4.3. Positive log-fold change 
indicates down regulation with the addition of choline and negative values indicate 
up regulation with choline. The highest log-fold change is -11.07 for PMI2721, a 
gene annotated as a pduA/J microcompartment protein, followed by-10.30 
(PMI2720), -9.29 (PMI2722), -9.26 (PMI2718), and -5.35 (PMI2714). The high log-
fold changes of the five putative bacterial microcompartment shell proteins suggest 
that the microcompartment formation is highly correlated to the presence of choline.  
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The parallel coordinates plot (Fig 4.7) was used to visualise the top 18 most highly 
differentially expressed genes and how expression varied between the choline 
supplemented culture and glucose only culture, at log2-fold change with FDR cut off 
of 0.05. Each condition has three replicates. Each line in Fig 4.7A shows the 
difference of expression in log-fold change values between the two conditions. 
Positive log-fold change values (above zero on the right axis) indicate up-regulation 
of glucose (down regulation with choline), and negative values (below zero on the 
right axis) indicate down-regulation of glucose (up regulation with choline). The red 
lines show the genes with FDR < 0.05 and only one blue line shows one gene with 
FDR ≥ 0.05. Gene numbers were shown on the right axis. Fig 4.7B is a heatmap 
indicating the different expression levels of the 18 genes between the two conditions. 
Each block represents one gene. The bar legend indicates the positive log-fold 
change with red colour and the negative log-fold change with blue colour. The top 
18 blocks on the heatmap is choline grown condition, showing an inceseaing up-
regulation of choline from left to right (gene no. 18 to 1), while the bottom 18 bolcks 
is glucose grown condition, showing a decreasing down-regulation of glucose from 
left to right (gene no. 18 to 1). Gene numbers were shown on top of the heatmap 
with gene annotations corresponding to Table 4.3. 
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(A) 
 
(B) 
Figure 4.6 shows the MA plot of the RNA-Seq data for the two conditions (A) at FDR cut off of 1 
(B) at FDR cut off of 0.05. The red dots represent the FDR value < 0.05 and the blue indicates FDR 
value ≥ 0.05. The x axis represents average log expression and the y axis represents log fold change. 
The analysis was carried out using the Degust program 
(http://www.vicbioinformatics.com/degust/index.html).  
 
. 
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Table 4.3 Top 18 differentially expressed genes. Positive log2-fold change indicates down regulation with the addition of choline and negative values indicate up 
regulation with choline (this study).  
No. Locus tag Gene name Log2-fold change FDR (p < 0.05) Gene description 
1 PMI2721 eutM/pduA/J homologue -11.07 1.15E-47 Microcompartment protein (BMC domain, PF00936.14) 
2 PMI2720 eutM/pduA/J homologue  -10.30 6.67E-31 Microcompartment protein (BMC domain, PF00936.14) 
3 PMI2722 eutM/pduA/J homologue -9.29 4.24E-41 Microcompartment protein (BMC domain, PF00936.14) 
4 PMI2718 eutN/ccmL homologue -9.26 9.61E-34 Microcompartment/carboxysome/ethanolamine utilizatin protein (EutN_CcmL, PF03319.8) 
5 PMI2711 emrE  homologue -8.74 2.29E-33 Quaternary ammonium compound resistance protein 
6 PMI2710 emrE homologue -8.65 7.16E-26 Multi-drug resistance protein, EmrE homologue 
7 PMI2719 cutF -7.30 7.30E-37 Aldehyde dehydrogenase, CutF  
8 PMI2716 cutC -6.38 1.34E-28 Choline-trimethylamine lyase, CutC 
9 PMI2712  -5.96 3.35E-14 System hypothetical protein  
10 PMI2713 cutH -5.47 2.10E-17 Phosphate acetyltransferase 
11 PMI2714 eutM/pduA/J homologue -5.35 1.91E-19 Microcompartment protein (BMC domain, PF00936.14) 
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12 PMI2715 cutD -5.19 7.26E-27 Choline-trimethylamine lyase, activating enzyme, CutD 
13 PMI2717 cutO -4.69 1.08E-16 Alcohol dehydrogenase 
14 PMI2544 groS -2.43 0.05 10 kDa chaperonin 
15 PMI0908  -2.26 0.01 Phage protein  
16 PMI0178  2.11 0.03 Membrane protein 
17 PMIt053  2.51 5.42E-03 tRNA-Met 
18 PMI2552  3.60 5.42E-03 Plasmid-related protein 
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(B)
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Figure 4.7 (A&B) Parallel coordinates plot of the RNA-Seq for two conditions, glucose with choline and without choline at log2-fold change, indicating the top 18 
highly expressed genes (down regulation with choline with positive log-fold change in purple colour, up regulation with choline with negative log-fold change in red 
colour). (A) Parallel coordinates plot, each line shows the change in expression in one gene, between choline and glucose only. (B) Heatmap, each block represents one 
gene. Each condition has three biological replicates. The analysis was carried out using the Degust program (http://www.vicbioinformatics.com/degust/index.html).  
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4.2.5 Identification a choline-TMA lyase gene cluster in Proteus 
mirabilis 
The top 13 genes identified by Degust (Table 4.3) were exactly the same as ones 
identified by DESEQ (Table 4.2), confirming that these genes are highly expressed 
in the presence of choline. Many of these genes form a putative gene cluster in the 
genome, suggesting they have a key role in the conversion of choline to TMA. 
Therefore, further phylogenetic and genome analysis of this gene cluster were 
carried out. 
One of the most highly induced genes from the RNA-Seq analyses is annotated as a 
glycyl radical containing protein (PMI2716). While this PhD project was on-going, 
the enzyme responsible for the conversion of choline to TMA was identified from 
Desulfovibrio desulfuricans (Cracium and Balskus, 2012). This choline-TMA lyase 
enzyme has high sequence similarity to PMI2716 and also belongs to the glycyl 
radical enzyme family. Using the online IMG program hosted by the Joint Genome 
Institute (http://img.jgi.doe.gov/), the two genes clusters were compared (Fig 4.8A). 
Functional annotation of these two gene clusters are also carried out by IMG, which 
are summarized in Table 4.4 and Table 4.5.  
The 13 top expressed genes in the cutC gene cluster, and their gene number are 
visualised in Fig 4.8B and cross-referenced to Table 4.3. Among them, the 
microcompartment proteins (gene numbers 1, 2, 3 and 4) are the most highly expressed 
genes within the cutC gene cluster, in the presence of choline. There is a significant 
difference in the total read counts and expression level between the choline-grown and 
glucose-grown conditions for these shell proteins, with total reads 59860, 70485, 
12249, 8116 in choline-grown culture, compared to 21, 42, 14, 10 in glucose-grown 
culture (Table 4.6). 
Based on the RNA-Seq data and the work on D. desulfuricans, the metabolic 
pathway of choline degradation to TMA is proposed (Fig 4.9). The function of the 
bacterial microcompartments is proposed to optimize pathways with toxic or volatile 
intermediates, in this case, acetaldehyde, to channel it to the next pathway enzyme, 
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converting it to ethanol by an alcohol dehydrogenase (PMI2717, cutO) or to acetyl-
CoA by an acetaldehyde dehydrogenase (PMI2719, cutF) (Max and Lidstrom, 2002).  
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(B) 
Figure 4.8 (A) The candidate gene clusters involved in choline degradation in the genome of D. desulfuricans (upper) and P. mirabilis (lower) predicted by the online 
IMG program at the Joint Genome Institute (http:// img.jgi.doe.gov/) (B) shows the putative microcompartment proteins (highlighted in light blue, gene No. 1, 2, 3, and 4) 
are most highly expressed on the cutC gene cluster with the presence of choline. Gene No. represents the top 13 genes in Table 4.3 (picture adapted from the Hi-Seq 
Illumina raw RNA-Seq from Dr Jameson during the course of this study).  
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Table 4.4 The predicted functions of the choline-TMA lyase gene cluster in D. desulfuricans. 
Gene Locus Tag Homology-based function prediction Proposed function in choline degradation 
A Ddes_1352 
 
MerR-family transcriptional regulator 
 
 
pfam06445- GyrI-like, pfam13411- MerR_1 
 
B Ddes_1353 system hypothetical protein accession no.YP_002479933 
C Ddes_1354 system hypothetical protein accession no.YP_002479934 
D Ddes_1355 microcompartments protein  microcompartment shell protein 
E Ddes_1356 aldehyde-alcohol dehydrogenase aldehyde dehydrogenase 
F Ddes_1357 Formate C-acetyltransferase Pyruvate-formate lyase 
G Ddes_1358 glycyl-radical enzyme activating protein family Pyruvate-formate lyase-activating enzyme 
H Ddes_1359 microcompartments protein microcompartment shell protein 
I Ddes_1360 acetaldehyde dehydrogenase (acetylating) aldehyde dehydrogenase 
J Ddes_1361 microcompartments protein microcompartment shell protein 
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K Ddes_1362 Propanediol utilization protein accession no.YP_002479942 
L Ddes_1363 ethanolamine utilization protein EutJ family protein accession no.YP_002479943 
M Ddes_1364 system hypothetical protein accession no.YP _002479944 
N Ddes_1365 Ethanolamine utilization protein EutN accession no.YP _002479945 
O Ddes_1366 microcompartments protein microcompartment shell protein 
P Ddes_1367 system hypothetical protein accession no.YP_002479947 
Q Ddes_1368 microcompartments protein microcompartment shell protein 
R Ddes_1369 iron-containing alcohol dehydrogenase alcohol dehydrogenase 
S Ddes_1370 Respiratory-chain NADH dehydrogenase accession no.YP_002479950 
T Ddes_1371 microcompartments protein microcompartment shell protein 
U Ddes_1372 microcompartments protein microcompartment shell protein 
V Ddes_1373 ethanolamine utilization protein EutP accession no.YP_002479953 
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Table 4.5 The predicted functions of the choline-TMA lyase gene cluster in P. mirabilis. 
Gene Locus Tag Homology-based function prediction Proposed function in choline degradation 
a PMI2725 TetR-family transcriptional regulator 
 
pfam00440 - TetR_N 
 
b PMI2724 
 
regulatory protein 
 
pfam00486 - Trans_reg_C 
c PMI2723 system hypothetical protein 
 
accession no.YP_002152424 
 
d PMI2722 
 
microcompartments protein 
 
microcompartment shell protein 
e PMI2721 
 
microcompartments protein 
 
microcompartment shell protein 
f PMI2720 
 
microcompartments protein 
 
microcompartment shell protein 
g PMI2719 aldehyde-alcohol dehydrogenase 
 
acetylaldehyde dehydrogenase (cutF) 
 
h PMI2718 
 
system hypothetical protein 
 
microcompartment shell protein 
i PMI2717 propanediol utilization protein (alcohol dehydrogenase) alcohol dehydrogenase (cutO) 
j PMI2716 propanediol utilization protein (dehydratase) choline-TMA lyase (cutC) 
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k PMI2715 propanediol utilization protein (dehydratase activating enzyme) choline-TMA lyase, activating enzyme (cutD) 
l PMI2714 propanediol utilization protein microcompartment shell protein 
m PMI2713 propanediol utilization protein Phosphate acetyltransferase, acetyl-CoA => acetate 
n PMI2712 system hypothetical protein accession no.YP_002152413 
o PMI2711 quaternary ammonium compound resistance protein pfam00893 - Multi_Drug_Res 
p PMI2710 multidrug resistance protein  
 
pfam00893 - Multi_Drug_Res  
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Table 4.6 The read counts data of the highly expressed genes on the cutC gene cluster (Reads Per Kilobase Million, RPKM) 
No. Locus Tag 
Glucose + choline Glucose 
Rep1 Rep2 Rep3 Total reads Rep1 Rep2 Rep3 Total reads 
1 PMI2721 26264 18171 15425 59860 7 3 11 21 
2 PMI2720 26231 19631 24623 70485 29 3 10 42 
3 PMI2722 6060 2342 3847 12249 9 1 4 14 
4 PMI2718 1540 3256 3320 8116 6 3 1 10 
5 PMI2711 6533 2473 7286 16292 10 11 6 27 
6 PMI2710 2225 619 3367 6211 3 1 8 12 
7 PMI2719 1692 1151 2061 4904 9 3 12 24 
8 PMI2716 11786 5488 9285 26559 82 56 100 238 
9 PMI2712 338 337 1285 1960 13 4 8 25 
10 PMI2713 1574 1083 2729 5386 54 15 24 93 
11 PMI2714 5950 4991 6876 17817 173 68 86 327 
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12 PMI2715 2798 2718 3355 8871 64 46 79 189 
13 PMI2717 1767 2971 4280 9018 87 73 121 281 
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Figure 4.9 The metabolic pathway of choline degradation to TMA and acetaldehyde via the proposed 
enzymes. Choline is converted to TMA and acetaldehyde by the choline-TMA lyase and the 
activating protein (PMI2715, cutC and PMI2716, cutD respectively). Acetaldehyde is further 
metabolized inside the microcompartment to ethanol by an alcohol dehydrogenase (PMI2717, cutO) 
or to acetyl-CoA by an acetaldehyde dehydrogenase (PMI2719, cutF) (Max and Lidstrom, 2002) 
(picture modified from Craciun and Balskus, 2012, Chowdhury et al. 2014, free online open access).  
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The identification of choline TMA lyase (CutC) offers the opportunity to further 
understand the distribution of this novel metabolic pathway in bacteria. Genome 
analysis was therefore carried out to investigate the phylogeny and distribution of 
CutC in genome-sequenced bacteria using the IMG database. A neighbour-joining 
phylogenetic tree was constructed, which is shown in Fig 4.10. As reported by 
Martínez-del Campo et al. (2015) recently, phylogenetic analysis indicates that there 
are two distinct clusters of CutC proteins. The first cluster, designated as type I CutC, 
is mainly found in obligate anaerobes including D. desulfuricans (Craciun and 
Balskus, 2012). The second, type II CutC cluster, which contains facultative 
anaerobes including P. mirabilis and many isolates of the Enterobacteriaceae family, 
is further divided into two subclades, II.a containing Gammaproteobacteria and II.b 
including Firmicutes and Deltaproteobacteria.  
Multiple sequence alignment of type I CutC versus type II CutC have revealed 
differences between these cutC genes in their length: the type I and II.b cutC gene 
are approximately 2.5 kb, while the type II.a is about 3.4 kb. The translated CutC of 
type II.a therefore is almost 300 amino acids longer (Fig 4.11). Despite the notable 
difference in N terminus of CutC variants, the rest of the CutC sequence is highly 
conserved. 
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Figure 4.10 shows the relationship of choline TMA-lyase relative to other glycyl-radical enzymes of the family.  The phylogenetic tree was constructed using the amino 
acid sequences using the neighbour-joining method. Two distinct clusters of CutC were observed, which has also been reported by Martínez-del Campo et al. previously 
(2015). Type I and II.b sub-clusters are approximately 2.5 kb in length whereas Type II.a sub-cluster is approximately 3.4 kb in length. The scale bar presented the 
evolutionary distance in mutations per residue. 1000 replicates were used with bootstrap values > 70 % (figure taken from Jameson et al., 2015).  
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Figure 4.11 The CutC sequence alignment of P. mirabilis (upper) and D. desulfuricans (lower). The 
red box shows the extended N-terminus of 300 amino acids in P. mirabilis. 
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4.3 Discussion 
RNA-Seq was employed in this chapter in order to identify the genes that were 
differentially expressed between culture grown in the presence or absence of choline, 
in the model bacterium, P. mirabilis DSMZ4479. Two independent statistical 
analyses have revealed a novel gene cluster involved in choline metabolism, 
including the newly discovered choline-TMA lyase encoded by cutC/D and several 
genes encoding microcompartment shell proteins.  
I have therefore chosen CutC as the functional maker to investigate choline-to-TMA 
transformation in genome-sequenced bacteria. Phylogenetic analyses have shown 
that many isolates of Gammaproteobacteria (particularly Enterobacteriaceae), 
Firmicutes and Deltaproteobacteria have the genetic potential for choline 
degradation to TMA (Fig 4.10). Interestingly, multiple sequence alignment of CutC 
homologues and subsequent phylogenetic analyses have revealed the presence of 
two clades of CutC. The type II.a CutC found in Enterobacteriaceae, including P. 
mirabilis, is longer than the type I or II.b CutC, such as found in the obligate 
anaerobe D. desulfuricans, with an additional ~300 amino acids at the N-terminus 
(Fig 4.11). The function of the extra N-terminal of type II.a CutC is still unknown. 
From the genome analysis it suggests that type II.a CutC was only identified from 
facultative anaerobes. Thus, it is hypothesised that this additional N-terminus of 
CutC may play a role in stabilising the enzyme during transient oxygen exposure, 
which would allow facultative anaerobes to thrive on the intestinal or urinary tract 
epithelia. Therefore, further work has been carried out to investigate the extra N-
terminal in type II.a CutC (See Chapter 5). 
The proposed microcompartments in choline utilization comprise five different 
proteins in the cut gene cluster: PMI2714, PMI2718, PMI2720, PMI2721 and 
PMI2722 (Fig 4.8 & Table 4.6). Except for PMI2718, the other four 
microcompartment shell proteins (PMI2714, PMI2720, PMI2721, PMI2722) are 
homologues to the shell proteins PduJ/PduA in the 1,2-propanediol utilization (Pdu) 
microcompartments and EutM in the ethanolamine utilization (Eut) compartment 
(Jameson et al., 2015). RNA-Seq data shows that these microcompartment shell 
proteins were heavily induced by choline in P. mirabilis (Fig 4.8, Table 4.3 & 4.6), 
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which suggests a link between choline degradation and microcompartment 
formation. Further investigation was required to confirm the microcompartment 
protein formation in the presence of choline. Growth experiments were carried out 
in liquid culture and in swarming cells on agar plates (See Chapter 5) to investigate 
the formation of microcompartments within the cells and their occurrence in 
response to choline addition in the culture medium. Moreover, I also investigated 
whether the formation of microcompartments is directly related to the enhancement 
of growth rate and swarming motility in P. mirabilis in the presence of choline (See 
Chapter 5). 
The initial statistic analysis carried out by Jameson et al. identified 20 differentially 
expressed genes identified by DESEQ analysis, with significant log2-fold change 
values (Table 4.2). In the DESEQ analysis, p-values rather than FDR values was 
used to estimate the significance level of the differential gene expression. However, 
p-value is only applicable for a set of genome data when most of the genes are 
regulated or expressed. In the actual experiment, only the cut operon was over-
expressed, p-value, in this case, will calculate the average of expression level by 
taking the whole genome expression into account, which lead to false positives. 
Therefore, FDR values should be applied in this case and thus I carried out the new 
analysis using Bedtool and the Degust program. 
The Degust program uses EdgeR as the normalization and statistical calculation 
method. I carried out RNA-Seq in Degust using EdgeR package. Fig 4.5 shows the 
gene expression and distribution under the two growth conditions: glucose and 
glucose plus choline at FDR cut off of 0.05. The down regulation level is shown as 
purple lines/dots while the up-regulation level is shown in red. 18 genes were 
consistently highly expressed in the presence of choline, at log2-fold change. Fig 4.4 
indicates there was good repeatability between the biological replicate samples. 
High consistency in the biological replicates reduces variation and increases the 
statistical power of the analysis, resulting in a more sensitive detection of genes that 
were differentially expressed between conditions. Although I have reproducible 
samples, the method EdgeR relies precisely on measuring biological variability to 
establish the statistical significance of differences in gene expression across 
conditions.  
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Among the 18 highly expressed genes identified by the Degust analysis, only one 
gene is indicated in blue dots with FDR value equal to 0.05, the 10 kDa chaperonin 
(PMI2544) (Fig 4.6 & Table 4.3). My analyses also revealed that there is one gene 
encoding phage protein that is up-regulated by choline (PMI0908). Interesting, 
phage-like particles were observed in P. mirabilis during preparation of 
microcompartments (See chapter 5). 
Apart from those that are up-regulated in the presence of choline, three genes were 
down regulated, which encoded: a membrane protein, tRNA-Met and plasmid-
related protein. The role of these proteins in choline metabolism remains to be 
established. tRNA-Met was found to be highly differentially expressed at FDR cut 
off of 0.05 (Table 4.3). Genome sequencing of strain HI4320 revealed the presence 
of seven complete rRNA operons, one 16S-23S-5S-5S operon and six 16S-23S-5S 
operons (Pearson et al., 2008) and tRNA-Met is usually located nearby these rRNA 
operons. However, it remains unclear why the bacterium downregulated tRNA-Met 
during its growth on choline. 
The occurrence of an elongated N-terminus of CutC in P. mirabilis is intriguing, 
which may either have a role in the folding of CutC in this bacterium or help P. 
mirabilis to cope with transient oxygen exposure in this facultative anaerobe. Protein 
folding in vivo is vectorial, meaning that the N-terminus of a protein becomes 
solvent exposed in the cytoplasm before its more C-terminal regions. As a result, it 
is assumed that spatial and temporal constraints are produced on the nascent 
polypeptide chain in its folding trajectory so that folding dynamics of the N terminus 
of a protein will affect the correct formation of the entire polypeptide (Spencer and 
Barral, 2012). In this case, the extra N-terminus of CutC in facultative anaerobes 
may enhance the protein folding of CutC in order to minimize the exposure of 
nascent polypeptide to transient oxygen exposure during protein folding. In strict 
anaerobes, however, CutC is unlikely to encounter oxygen during CutC expression 
and it is likely that this extra N-terminus is therefore unnecessary in these bacteria. 
Therefore, mutagenesis of this extra N-terminus would be necessary to further 
confirm this hypothesis. 
PMI2725, encoding the tetR-family transcriptional regulator, is located in the 5’ of 
the cutC gene cluster (Fig 4.8 & Table 4.5). I postulated that the tetR gene plays an 
	 126		
important role in choline degradation in P. mirabilis, functioning as a negative 
repressor. When choline is not present, it suppresses the transcription of the whole 
cut gene cluster. However, in the presence of choline, TetR will bind to choline, and 
thus the whole gene cluster will be switched on. Besides, the structure and folding 
of tRNA may change to assist the regulation of the tetR with or without choline. To 
prove the function of this regulator, knock-out mutagenesis and overexpression are 
required to confirm the role of tetR (See Chapter 5). 
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Chapter 5 
 
Anaerobic choline 
degradation in 
Proteus mirabilis  
 
 
 
 
	 128		
5.1 Introduction 
Choline is a B-type vitamin and plays a fundamental role as an essential nutrient for 
human beings (Wang et al., 2011). Our daily demand for choline (~70 %) largely 
comes from an extensive range of dietary intake such as red meat, milk, eggs, liver, 
fish and shell fish (Wang et al., 2011). However, current research has demonstrated 
that choline degradation to TMA by gut microbiota will lead to the accumulation of 
TMAO in the human liver by the hepatic enzyme FMO3 and can lead to further 
cardiovascular and non-alcoholic liver disease (Wang et al., 2011; Dumas et al., 
2006).  
Yet the genes responsible for encoding this choline utilization to TMA were 
unknown at the start of this PhD project. Using comparative transcriptomics analysis, 
I have identified a gene cluster that is highly induced by choline (See Chapter 4). 
The aim of the work presented in this Chapter is therefore to identify the functional 
genes involved in the choline degradation to TMA using P. mirabilis as the model 
system through targeted mutagenesis. Using the marker exchange mutagenesis 
method established in Chapter 3, I investigated whether the cutC gene is indeed 
essential for choline metabolism and subsequent TMA production in P. mirabilis. In 
addition, I investigated the physiological role of choline degradation to TMA in this 
bacterium in both liquid culture and on solid agar plates. The data presented in this 
Chapter demonstrated that choline enhances P. mirabilis growth in broth culture, 
and plays a greater role in swarming where it significantly enhances swarming speed 
and reduces the necessity for consolidation. Furthermore, I observed the formation 
of microcompartments in this bacterium during its growth on choline and the role of 
the shell protein in choline degradation, as well as the role of CutC protein in the 
formation of microcompartment protein.  
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5.2 Results 
5.2.1 Heterologous expression of the putative cutCD from P. 
mirabilis to E. coli 
Prior to the start of my PhD project, the initial growth of P. mirabilis was carried 
out by Dr Jameson in our group and the anaerobic degradation of choline to TMA 
in P. mirabilis has been confirmed (Fig 5.1A). The cutC gene cluster, including the 
cutC and cutD genes, was heavily induced by choline as revealed by comparative 
transcriptomics (RNA-Seq) (See Chapter 4). Therefore, heterologous expression of 
the putative cutCD genes from P. mirabilis to E. coli was carried out to test whether 
P. mirabilis CutC and the accompanying activating enzyme CutD were sufficient 
for TMA formation from choline in a foreign host.  
Several initial attempts had been carried out by Dr Jameson and during my project, 
we collaboratively verified the anaerobic choline-dependent TMA production in 
recombinant E. coli (Fig 5.1B). The codon-optimised putative cutCD (See Chapter 
2, Materials and Methods) was first cloned into E. coli under the regulation of the 
T7-lac promoter, and the inducible TMA production was observed anaerobically 
(Fig 5.1B). Both the cutC and cutD genes were required to form TMA from choline 
since E. coli expressing either cutC or cutD alone was unable to degrade choline to 
TMA (data not shown). To test the function of CutC in choline degradation, the 
crucial glycine residue that provides the glycyl radical was mutated to alanine by 
site-directed mutagenesis (CutC mutant: VRVAAYSA vs wide type: VRVAGYSA). 
TMA was not detectable in the culture of the site-directed mutant. Therefore, the 
conserved glycine residue (G1126 in CutC) for this group of radical enzymes is 
essential (Fig 5.1B).  
Together, the data presented above demonstrated that a functional choline-TMA 
lyase was confirmed to be encoded by the cutC homolog in P. mirabilis, despite the 
fact that the CutC of P. mirabilis is distinct from the characterized CutC of D. 
desulfuricans, according to the phylogenetic analyses presented in Chapter 4. 
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(A) 
   
  (B) 
Figure 5.1 (A) Initial growth of P. mirabilis in the defined NH4+ medium supplemented with glucose 
plus choline. Choline and TMA concentrations were quantified by ion-exchange chromatography. 
(B) Quantification of TMA production in recombinant E. coli over-expressing both the cutC-cutD 
genes, first two bars: wild-type CutC with or without induction, third bar: a glycyl radical site CutC 
mutant (G1126A). Defined M9 medium for E. coli was used supplemented with 1 mM choline 
chloride. 2 mM of isopropyl β-D-1-thiogalactopyranoside (IPTG) was added and induction occurred 
at 5 hours. Three replicate cultures were carried out and error bars represent standard deviations 
(adapted from Jameson et al., 2015, Creative Commons Attribution-3.0 Unported license, CC BY 
3.0). 
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5.2.2 Marker exchange mutagenesis of the essential cutC in TMA 
formation from choline in P. mirabilis 
In order to test if cutC is required for choline metabolism in P. mirabilis, a marker-
exchange cutC mutant was generated using the method established in Chapter 3. 
The mutant was cultivated in a defined NH4+ medium (See Chapter 2 Materials 
and Methods) anaerobically to validate its role in choline metabolism by 
quantifying TMA production and choline consumption (Fig 5.2). The medium was 
supplemented with choline as a sole carbon source. The wild type strain was able to 
metabolize choline to TMA and 10 mM of choline was completely degraded to TMA 
within 14 hours (Fig 5.2A). As predicted, P. mirabilis cutC::kan mutant lost the 
ability to catalyze TMA formation from choline, TMA was no longer produced and 
choline remained unused in the culture supernatant (Fig 5.2B). However, when the 
cutC::kan mutant was complemented with the native copy of the cutCD, conversion 
of choline to TMA was restored (Fig 5.2C). Overall, the experiments confirmed that 
cutCD is required for TMA formation from choline. 
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                             (A)                                                    (B)                                                  (C) 
Figure 5.2 Quantification of choline and TMA concentrations and measurement of optical density 
(at 600 nm) of P. mirabilis wild type (A), the cutC::kan mutant (B) and the cutC::kan complemented 
mutant (C) respectively. The cells were grown anaerobically in a defined NH4+ medium with choline 
as the sole carbon source. 
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5.2.3 Identification of the physiological role of choline degradation 
in P. mirabilis  
5.2.3.1 Choline metabolism promotes anaerobic growth of P. mirabilis in liquid 
broth 
To identify the role of choline metabolism in P. mirabilis, anaerobic liquid growth 
experiments were first carried out in NH4+ defined medium supplemented with five 
different carbon sources: glucose, glycerol, choline, glucose plus choline or glycerol 
plus choline. The optical density at 600 nm (OD600) was recorded as the 
measurement of growth rate over a time course. As can be seen from Fig 5.3A. P. 
mirabilis was able to grow on all of the five conditions utilising choline as a sole 
carbon/energy source. The bacterium grew fastest on glucose alone, followed by 
glycerol alone and then choline alone. The additional choline with either glucose or 
glycerol enhanced the growth rates and increased final cell yields. However, there 
was no significant difference in the final OD for glucose or glycerol with additional 
choline and the growth was the slowest when it was grown on choline alone. 
5.2.3.2 Choline metabolism promotes anaerobic swarming of P. mirabilis 
Anaerobic swarming assay of P. mirabilis was carried out on swarming agar plates 
with different carbon sources; glucose, glycerol, glucose plus choline and glycerol 
plus choline. P. mirabilis can swarm anaerobically on glucose or glycerol as a sole 
carbon source, and differences in swarming-associated colony expansion rates were 
observed (Fig 5.3B). The fastest colony expansion was found on plates 
supplemented with glucose, whereas the slowest rate was found when it was grown 
on glycerol plates. The addition of choline significantly enhanced the colony 
expansion speed (Fig 5.3B). Unlike a uniform ring pattern formed under aerobic 
swarming growth, anaerobic swarming of P. mirabilis formed a dendritic growth 
pattern instead, starting from irregular points around the initial inoculation colony 
(Fig 5.3C, D, E&F). There was no well-defined consolidation zone demarking 
shorter swimmer cells between swarming intervals, compared to aerobic swarming 
patterns on rich medium (Williams and Schwarzhoff 1978). The addition of choline 
also affected the uniformity of the formed colony (Fig 5.3C, D, E&F). 
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                                                                       (A) 
  
                                   (B) 
Figure 5.3 (A&B) Anaerobic liquid growth of P. mirabilis in the defined NH4+medium at 37 °C and 
anaerobic swarm radiuses of P. mirabilis on the swarming agar plates at 30 ºC in anaerobic cabinet 
on different carbon sources: glucose and choline (dashed ▼), glucose only (solid ▼), glycerol and 
choline (dashed ▲), glycerol only (solid ▲) and choline only (solid ●). Three replicates were used 
for each growth experiments and error bars indicate standard deviation (C, D, E, F) Anaerobic 
swarming pattern of P. mirabilis on agar plates supplemented with (C) glycerol and choline (10 days’ 
growth); (D) glycerol (10 days’ growth); (E) glucose and choline (6 days’ growth); (F) glucose (10 
days’ growth) (pictures adapted from supplementary figures from Jameson et al., 2015, Creative 
Commons Attribution-3.0 Unported license, CC BY 3.0). 
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5.2.3.3 Choline degradation to TMA enhances anaerobic swarming motility in 
P. mirabilis 
Anaerobic swarming assays were carried out in order to determine the role of choline 
metabolism in this bacterium. A defined medium containing NH4+ was used (See 
Chapter 2 Materials and Methods). Agar plates were inoculated anaerobically 
with 2 µl liquid culture of P. mirabilis of wild type, the cutC::kan mutant or the 
complemented mutant (Fig 5.4). Because the cutC::kan mutant does not grow on 
choline as the carbon source, I supplemented the medium with glycerol.  
Wild type P. mirabilis strain showed increased colony expansion rates in the 
presence of additional choline (Fig 5.4A). The cutC::kan mutant was still able to 
grow on glycerol agar plates, however, no difference in colony expansion rates was 
observed when compared to the growth on plates with additional choline (Fig 5.4B). 
The complemented mutant, however, showed increased colony expansion rates 
again on plates supplemented with additional choline (Fig 5.4C). These experiments, 
therefore, confirmed the role of choline metabolism in enhancing swarming rates in 
P. mirabilis. In order to verify the defective growth of the cutC::kan mutant and the 
complemented mutant, their growth in liquid culture was also carried out. These 
strains were grown in the defined NH4+ medium supplemented with either glycerol, 
glycerol plus choline or choline alone (Fig 5.5). The results showed no increased 
growth of the cutC::kan mutant on glycerol with additional choline (Fig 5.5C), 
therefore confirming that cutC is essential for choline-dependent growth promotion 
in this bacterium.  
To further explain why additional choline enhanced swarming rates in P. mirabilis, 
growth experiments were carried out to test two hypothesises:  
1) Choline degradation provides cellular energy for swarming cells and/or 
differentiation. To test this hypothesis, the wild type of P. mirabilis was grown on 
NH4+ agar plates using 10 mM of glycerol supplemented with different 
concentrations of choline (1, 10, 50 mM) (Fig 5.6A), and swarming radius were 
determined and compared with increasing concentrations of glycerol (32, 50, 130 
mM) as the energy source (Fig 5.6B). Interestingly, choline alone shows significant 
increased swarming rate than glycerol alone. High amounts of choline further 
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increased the swarming rate while increased amounts of glycerol shows no 
difference on swarming rates (Fig 5.6A&B). This suggests that choline did have the 
effect to enhance swarming motility and it is likely that choline serves as an energy 
source instead of carbon source for this bacterium. 
2) TMA produced from choline degradation counteracts decrease of pH during 
glycerol fermentation in liquid culture (Letoffe et al., 2014). In order to assess the 
impact of pH on swarming cells, phenol red was added to the agar plates as a pH 
indicator (Alteri et al., 2012). The anaerobic swarming assay was thus carried out 
using 10 mM of glycerol supplemented with different concentrations of TMA (1, 10, 
50 mM) (Fig 5.6C), and the swarming radius was compared with 10 mM of glycerol 
supplemented with different concentrations of choline (1, 10, 50 mM) (Fig 5.6A) 
and different concentrations of glycerol (32, 50, 130 mM) (Fig 5.6B). Additional 
TMA did not increase the swarming rates, suggesting that pH variation could not 
explain the enhanced rates of choline-promoted swarming (Fig 5.6A, B&C). 
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                               (A)                                                  (B)                                                     (C) 
Figure 5.4 Anaerobic swarming radiuses of P. mirabilis grown on glycerol or glycerol plus choline 
for (A) wild-type (B) the cutC::kan mutant and (C) the complemented mutant with native cutCD. 
Three replicate plates were used and error bars show standard deviation. The agar plates were 
incubated at 30 ºC in an anaerobic cabinet.  
 
 
 
 
 
 
                       (A)                                                    (B)                                                     (C) 
Figure 5.5 Anaerobic growth of P. mirabilis in defined NH4+ liquid medium supplemented with 
glycerol, glycerol plus choline or choline alone for (A) wild-type (B) the cutC::kan mutant and (C) 
the cutC::kan mutant complemented with native cutCD (adapted from supplementary figure from 
Jameson et al., 2015, Creative Commons Attribution-3.0 Unported license, CC BY 3.0). 
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                              (A)                                                (B)                                                 (C) 
Figure 5.6 Anaerobic swarming for P. mirabilis wild type in 10 mM of glycerol supplemented with 
different concentrations of choline (1, 10, 50 mM) (A), compared with different concentrations of 
glycerol (32, 50, 130 mM, the total amount of carbon source was same as glycerol plus choline one 
respectively) (B), and also compared 10 mM of glycerol supplemented with different concentrations 
of TMA (1, 10, 50 mM) (C). The agar plates were incubated at 30 ºC in an anaerobic cabinet. 
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5.2.4 Choline induces microcompartment protein formation in 
anaerobic liquid cultures or on swarming plates of P. mirabilis 
Comparative transcriptomic analysis in Chapter 4 has shown that the choline 
utilisation (cut) operon of P. mirabilis is heavily induced by choline. In addition to 
cutC and cutD, five genes annotated as microcompartment shell proteins: PMI2722, 
PMI2721, PMI2720, PMI2718 and PMI2714 are among the highly expressed genes 
that respond to choline addition (See RNA-Seq data in Chapter 4).  
Four of the five shell proteins (PMI2722, PMI2721, PMI2720, PMI2714) share high 
sequence similarity to the shell proteins PduJ/PduA involved in the formation of the 
1,2-propanediol utilisation (Pdu) microcompartments and EutM involved in the 
formation of the ethanolamine utilisation (Eut) microcompartment (Crowley et al., 
2010; Kofoid et al., 1999). PMI2718, however, is homologues to the EutN/CcmL 
family of shell proteins (Kofoid et al., 1999). Previous studies have suggested that 
choline could be involved in the induction and formation of shell proteins in cut 
clusters of Desulfovibrio desulfuricans and Desulfovibrio alaskensis (Kuehl et al., 
2014, Martinez-del Campo et al., 2015). Therefore, it is likely that choline could 
also induce the formation of microcompartments in P. mirabilis. 
5.2.4.1 Microcompartment protein formation in anaerobic liquid cultures 
supplemented with/without choline 
A liquid culture growth experiment was first carried out in order to test the 
hypothesis of choline-induced microcompartment formation. P. mirabilis wild-type 
was grown in the defined NH4+ medium anaerobically supplied with glucose, 
choline or glucose plus choline as sole carbon sources (Fig 5.7). Cultures were 
collected at regular time intervals (at 2, 4, 6, 8, 13, 25, 48, 77 hrs) for optical density 
(OD) measurement and TMA quantification. The OD began to increase at 4-6 hrs 
and TMA was first detected at 4 hrs in cultures supplemented with choline. Thus, 
samples from 4 hrs onwards were collected for transmission electron microscopy 
(TEM) analysis. 
TEM images presented in Fig 5.7 showed that microcompartments were observed 
(indicated by red arrows) in the presence of choline from 6 hrs onwards. The 
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appearance of microcompartments coincided with the sharp increase of OD and the 
production of TMA in cultures supplied with choline. However, in glucose only 
cultures, no microcompartments were observed. The data therefore suggests that 
microcompartment formation in anaerobic cultures is induced by choline. For all 
three media, at 13 and 25 hrs, the cells had a large layer of extracellular 
polysaccharides (EPS) around, however, at 48 and 77 hrs the EPS layer was either 
thinner or disappeared. 
5.2.4.2 Microcompartment protein formation on anaerobic swarming plates 
supplemented with/without choline 
Similar to the TEM images in anaerobic liquid cultures, no microcompartment 
proteins were observed in cells cultivated on glycerol swarming plates (Fig 5.8A), 
and larger amounts of regular BMCs were observed in cells cultivated with choline 
and glucose plus choline, indicated by red arrows (Fig 5.8B&C). The data again 
suggests that microcompartment formation in cells cultivated on anaerobic 
swarming plates was induced by choline. 
5.2.4.3 Microcompartment protein formation in the wild type, the cutC::kan 
mutant and the complemented mutant 
P. mirabilis wild type, the cutC::kan mutant and the complemented mutant were 
grown on glucose supplemented with choline anaerobically in the defined NH4+ 
medium for 77 hrs and the cells were harvested and fixed for TEM.  
The wild type BMCs appear electron dense, around 100 nm in diameter and are 
regularly shaped (Fig 5.9A). Interestingly, abnormal shapes of BMC were found for 
the cutC::kan mutant and the complemented mutant (Fig 5.9B&C). Red arrows 
indicate the different structures of BMCs observed from the three strains. For the P. 
mirabilis cutC::kan mutant cultures, microcompartment formation was severely 
disrupted. The cutC::kan mutant microcompartments have angular structures, 
forming sheets and then the sheets rolling up with multiple layers per structure. Next 
to these structures are quite often what seems to be protein aggregates (Fig 5.9B). It 
was not possible to assess the microcompartment structures of the mutant grown on 
choline only because the cells did not grow. Aberrant multi-layered structures and 
protein aggregations were observed when the mutant was grown on glucose and 
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choline (Fig 5.9B). For the complemented mutant, when grown on choline, the 
normal wild-type microcompartment phenotype was recovered after complementing 
with the native cutCD.  Regular shaped microcompartments were observed in the 
complimented mutant but the cutC::kan mutant microcompartments with angular 
stuctures still existed (Fig 5.9C). When grown on glucose plus choline, a 
combination of malformed multi-layered structures, protein aggregates and wild-
type microcompartments were detected by TEM (Fig 5.9A&C).  
Since choline has also been found to enhance anaerobic swarming of P. mirabilis, 
anaerobic swarming plates were prepared and swarmer cells were processed for 
TEM. Interestingly, large numbers of microcompartments were found in elongated, 
hyper-flagellated P. mirabilis swarmer cells in the presence of choline. 
Together, the simultaneous appearance of microcompartments in the cutC::kan 
complemented mutants, accompanied with TMA production and cell growth, 
indicated that the microcompartment structures are associated with choline 
metabolism. The distinct differences in the formation of microcompartments for the 
cutC mutants and the complimented mutant suggest that CutC plays a crucial role in 
the formation of the microcompartments. 
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                            (A)                                           (B)                                                   (C) 
Figure 5.7 Wild type P. mirabilis was grown anaerobically on glucose (A), choline (B) or glucose 
plus choline (C) in the NH4+ defined medium. At 5 different time points (4 hrs, 6 hrs, 8 hrs, 13 hrs, 
25 hrs, 48 hrs, 77 hrs), the cells were fixed respectively for TEM images to investigate the formation 
of microcompartments. Red arrows indicated the microcompartment formed in choline and glucose 
plus choline mediums from 6 hrs onwards (TEM pictures obtained in collaboration with Dr Stefanie 
Frank from University of Kent).  
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                            (A)                                                  (B)                                               (C) 
Figure 5.8 Anaerobic swarming of P. mirabilis wild type on glycerol (A), choline (B), glycerol plus 
choline (C) on NH4+ agar plates. The agar plates were incubated at 30 ºC in an anaerobic cabinet. 
The agar slices were cut from the plates including the outer-ring to the inner ring, and stained with 
0.1 % alcian blue in 0.1 % acetic acid before fixing for TEM. Red arrows indicate the 
microcompartments formed on swarming plates supplemented with choline and glycerol plus choline 
(TEM pictures obtained in collaboration with Dr Stefanie Frank from University of Kent). 
 
 
                           (A)                                               (B)                                                (C) 
Figure 5.9 TEM for wild type (A), the cutC::kan mutant (B) and the cutC::kan complemented mutant 
(C) BMCs. Anaerobic cells were grown on glucose supplemented with choline for 77 hrs and then 
harvested and fixed for TEM. Red arrows show the different structures of BMCs for the three 
phenotypes (TEM pictures obtained in collaboration with Dr Stefanie Frank from University of Kent). 
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5.2.4.4 Microcompartment protein purification 
To better understand the structure of the shell protein, attempts were made to purify 
the microcompartments in liquid culture growth on choline as the sole carbon source. 
All purification work was carried out at the University of Kent in collaboration with 
Dr Stefanie Frank.  
2 litres of liquid culture was harvested and ~ 2 g of cells were gained for purification 
using the protocol from Sinha et al. (2012) (See Chapter 2, Materials and Methods) 
and later TEM imaging. 
Fig 5.10A shows the semi-purified microcompartment protein in liquid culture 
grown on choline. The size of the organelle is estimated to be around 100 nm. 
Interestingly, there are large amounts of phage-like particles present in the culture, 
~ 50 nm in size under TEM with a long phage tail (Fig 5.10B). After several attempts, 
I was not successful in obtaining the pure microcompartments from choline-grown 
cultures. Due to time constraints, this experiment was abandoned and further 
optimization is therefore required in order to obtain purified microcompartments. 
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(A) 
 
 
(B) 
Figure 5.10 TEM image for the purified microcompartment in liquid culture grow on choline (A) 
purified microcompartment protein, 100nm under TEM (B) purified phage alongside the 
microcompartment, ~ 50 nm in size under TEM (TEM pictures obtained in collaboration with Dr 
Stefanie Frank from University of Kent). 
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5.2.4.5 Microcompartment protein in recombinant E. coli 
The role of microcompartments is hypothesized either to help retain the volatile 
intermediates such as aldehyde and carbon dioxide or to protect the cell from the 
potential toxic effects of the intermediates (e.g. acetaldehyde) (Hampel et al., 2014). 
Since one of the products of choline metabolism is acetaldehyde, I presumed that 
the microcompartment proteins are essential in preventing the release of this toxic 
compound into the cell. However, the exact composition of the BMC formed in P. 
mirabilis during choline metabolism is still unknown. The operon of propanediol 
utilisation genes (Pdu) encodes eight shell proteins and it has been proved that each 
single gene is required for the formation of the BMC (Parson et al., 2010). My BlastP 
results showed that the five predicted BMCs of P. mirabilis are composed of PduA/J 
or PduN like proteins (length: PduA 93 aa, PduJ 91 aa, PduN 91 aa) (See Table 5.1 
& Fig 5.11). Therefore, to investigate if the five shell proteins are sufficient for BMC 
formation, they were cloned into an expression vector (pET28a) and overexpressed 
in E. coli (Fig 5.12).  
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Table 5.1 The predicted function for the five shell proteins and the BlastP results 
No. Locus 
tag 
Predicted function Amino acid 
Length 
BlastP 
1 PMI2722 Microcompartment 
protein 
92 aa 
 
 
PduA/J like 
2 PMI2721 Microcompartment 
protein 
94 aa 
 
 
PduA/J like 
3 PMI2720 Microcompartment 
protein 
92 aa 
 
 
PduA/J like 
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4 PMI2718 Microcompartment 
protein 
87 aa 
 
 
PduN like 
5 PMI2714 Microcompartment 
protein 
The first 93 aa 
 
 
PduA/J like 
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Figure 5.11 The cut gene cluster involved in choline degradation in the genome of P. mirabilis and 
the five BMC shell proteins are highlighted in light blue. 
 
 
Figure 5.12 The  map of plasmid pET28a 
 
 
 
                               1 2 3                    4                                                                   5 
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Firstly, the five genes encoding microcompartment proteins were amplified as 
PMI2722-20, PMI2718 and PMI2714 by PCR using specific primers (Chapter 2) 
and high-fidelity Tag DNA polymerase (Fig 5.13A). The primers were engineered 
with NdeI and NheI sites for PMI2722-20, and NcoI and NheI sites for both 
PMI2718 and PMI2714. The three PCR fragments were cloned individually into 
pGEMT. The three fragments were then ligated step by step as described in Fig 
5.13C, resulting in the cloning of all five BMC genes in one expression vector. Note 
that the NheI site is compatible to that of XbaI (see details below for the cloning 
strategy). 
The three PCR products were purified respectively, by running through 1 % (w/v) 
agarose gel and the band of the expected size were purified and further ligated to the 
cloning vector pGEM-T. The ligation DNA was chemically-transformed into E. coli 
JM109 competent cells for blue-white screening and colony PCRs were performed. 
Plasmids with the correct insert were further purified and digested with relevant 
restriction enzymes, which resulted in the three fragments: 877 bp (PMI2722-20), 
264 bp (PMI2718) and 507 bp (PMI2714), suggesting the three BMC genes were all 
successfully cloned into pGEM-T, and the sequences were further confirmed by 
DNA sequencing (Fig 5.13B). 
The three fragments were cut out from pGEM-T vector using relevant restriction 
enzymes, i.e. NdeI and NheI for PMI2722-20, NcoI and NheI for PMI2718 and 
PMI2714, and then cloned into the vector pET28a respectively, to create pET28a 
(PMI2722-20), pET28a (PMI2718) and pET28a (PMI2714). PMI2718 was then cut 
out from pET28a (PMI2718) using XbaI and HindIII, and ligated with pET28a 
(PMI2722-20) cut by NheI and HidIII, because NheI on this plasmid is compatible 
to XbaI, to create pET28a (PMI2722-20-18). Using the same principle, PMI2714 
was cut out from pET28a (PMI2714) using XbaI and HindIII, and ligated with 
pET28a (PMI2722-20-18) which is already digested with NheI and HidIII, to create 
the expression vector pET28a (PMI2722-14) with all the five BMC genes (Fig 
5.13C). 
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(A) 
 
                                              (B)                                                                      (C) 
Figure 5.13 The gel pictures of the three amplified microcompartment proteins (A) the three PCR 
purified proteins (B) and the cloning strategy of the three fragments into pET28a (C). 
 
 
 
 
 
 
                             PMI2722-20                         PMI2718                                  PMI2714 
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The constructed pET28a (PMI2722-14) was then transformed into the expression E. 
coli host BLR (DE3) pLysS. pET28a (PMI2722-20) was also transformed into E. 
coli to generate a comparison control. The transformants were cultivated 
anaerobically in the defined M9 medium and were induced with 400 µM IPTG when 
OD600 reached 0.4-0.6 (See Chapter 2 Materials and Methods). The cells were 
harvested and cellular proteins were prepared by passing through a French press to 
assess the overexpression of the five microcompartment proteins by SDS-PAGE gel 
(Fig 5.14). Further TEM imaging was carried out to visualize the assemble of shell 
proteins (Fig 5.15). 
Fig 5.14 are the SDS-PAGE gel pictures of the overexpression of PMI2722-20 (three 
shell proteins) and PMI2722-14 (five shell proteins). Lane 1 is the induced total cell 
protein for PMI2722-20 (70 µg). Lane 2-5 are induced and un-induced supernatant 
samples for PMI2722-20, with different amount of protein: 120 µg (lane 2-3) and 70 
µg (lane 4-5). Lane 10 is the induced total cell protein for PMI2722-14 (90 µg). Lane 
6-9 are induced and un-induced supernatant samples for PMI2722-14, with different 
amount of protein: 60 µg (lane 6-7) and 90 µg (lane 8-9). The total cell protein 
always contained a higher amount of proteins, thus has brighter band and more 
expression levels than the supernatant (Fig 5.14 lane 1 vs 2-5, lane 10 vs 6-9). 
Samples with higher amount of protein show brighter bands with more expression 
levels than samples with lower amount of protein (Fig 5.14 lane 2 vs 4, lane 8 vs 6). 
Several unspecific bands were found ~ 6 kDa (bottom red arrows) for all the induced 
samples of PMI2722-20 and PMI2722-14, while the un-induced samples do not have 
any of these bands (Fig 5.14 lane 2 vs 3, lane 4 vs 5, lane 6 vs 7 and lane 8 vs 9).  
The size of the five shell proteins is 9.4 kDa (PMI2722), 9.6 kDa (PMI2721), 9.5 
kDa (PMI2720), 9.6 kDa (PMI2718) and 17.7 kDa (PMI2714) respectively, 
therefore, as can been see from Fig 5.14, one or two or all of the three shell proteins, 
PMI2722, PMI2721 and PMI2720, are significantly expressed with the right sizes 
in the IPTG-induced samples. However, there were no expressed bands with the 
correct size for PMI2722-14 induced samples. Induced samples of PMI2722-20 and 
PMI2722-14 all showed an overexpressed band around 130 kDa, as highlighted by 
the red arrows (Fig 5.14 lane 1, 2, 4, 6, 8 and 10). One possibility of the source of 
the protein is from the proteome of the host E. coli overexpression itself. 
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The TEM images of the recombinant shell proteins in E. coli were shown in Fig 5.15, 
with the three constructions: PMI2722-21-20 (three shell proteins) (Fig 5.15A), 
PMI2722-21-20-18 (four shell proteins) (Fig 5.15B) and PMI2722-21-20-18-14 (all 
the five shell proteins) (Fig 5.5C). Large aggregated proteins were found in the 
constructed PMI2722-21-20 (Fig 5.15A) and PMI2722-21-20-18 (Fig 5.15B), but 
hardly any protein aggregates in the constructed PMI2722-21-20-18-14 with all the 
five shell proteins (Fig 5.15C). There are no proper structures in any of the samples.  
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Figure 5.14 SDS-PAGE gel shows the protein overexpression results of the total cell protein and supernatant for pET28a (PMI2722-20) (Lane 1-5) and pET28a 
(PMI2722-14) (Lane 6-10). Lane 1: induced total cell protein for PMI2722-20 (70 µg); lane 2: induced supernatant for PMI2722-20 (120 µg); lane 3: un-induced 
PMI2722-20 (120 µg); lane 4: induced supernatant for PMI2722-20 (70 µg); lane 5: un-induced PMI2722-20 (70 µg); maker; lane 6: induced supernatant for PMI2722-
14 (60 µg); lane 7: un-induced PMI2722-14 (60 µg); lane 8: induced supernatant for PMI2722-14 (90 µg); lane 9: un-induced PMI2722-14 (90 µg); lane 10: induced 
total cell protein for PMI2722-14 (90 µg). 
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Figure 5.15 TEM images of the recombinant microcompartments in E. coli. The recombinant shell 
proteins for PMI2722-21-20 (A), PMI2722-21-20-18 (B) and PMI2722-21-20-18-14 (C) (TEM 
pictures obtained in collaboration with Dr Stefanie Frank from University of Kent) 
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Furthermore, the difference in the formation of microcompartments in the wild type, 
the cutC::kan mutant and the complemented mutant suggests that CutC may be 
required for the microcompartment assembly (Fig 5.16). Therefore, to test this 
hypothesis, the entire cutC operon, 11.325kb from the first shell protein (PMI2722) 
to the last gene on this operon (PMI2710), was amplified using high-fidelity Taq 
DNA polymerase (Fig 5.16A). Although the whole cutC operon was successfully 
amplified (Fig 5.16B), a correct overexpression plasmid vector in E. coli was not 
obtained during the course of the project.   
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(A) 
 
                                                                                  (B) 
Figure 5.16 (A) The whole cutC operon from the first shell protein (PMI2722) to the last gene on 
this operon (PMI2710). (B) The gel pictures of the amplified whole cutC operon PMI2722-10. PCR 
was carried out at a range of annealing temperatures from 72 °C - 55 °C, purified genomic DNA was 
used as template, 2 % DMSO was added into the PCR reagents to enhance the genomic DNA.  
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5.2.5 Investigate the role of the N-terminal domain in CutC of P. 
mirabilis  
The presence of two clusters of CutC in genome sequenced bacteria is supported by 
high bootstrap values in the phylogenetic analysis (See Chapter 4). CutC of P. 
mirabilis has an extra N-terminus of about 300 amino acids compared to that of D. 
desulfuricans (See Chapter 4, Fig 4.4&4.5). The CutC cluster represented by D. 
desulfuricans (848 amino acids in length) is found mainly in obligate anaerobes 
whereas the cluster represented by P. mirabilis (1142 amino acids in length) is found 
in facultative anaerobes. It is therefore likely that these extra amino acids in the N-
terminus of CutC in the P. mirabilis cluster may be essential in facultative anaerobic 
choline degradation. Therefore, to test this hypothesis, a N-terminus truncated CutC 
of P. mirabilis was produced in order to compare the activity with its native form.  
The full-length cutC, together with cutD of P. mirabilis was already cloned (by Dr 
Jameson before I started) into the dual expression vector pCOLADuet (Novagen) to 
obtain the vector pCOLADuet-cutC/D (Fig 5.17). The N-terminus truncated cutC 
(cutC’, 2546 bp) was amplified by PCR using specific primers and high-fidelity Taq 
DNA polymerase (Chapter 2). The primers were engineered with NcoI and PstI 
restriction sites on each end (Fig 5.17). The truncated cutC’ was then cloned into the 
MCS 1 of pCOLADuet-cutD (digested with NcoI and PstI to remove the full length 
cutC) which was transformed into the expression host of E. coli BLR (DE3) pLysS 
(Fig 5.17).  
The PCR product was purified by running through a 1 % (w/v) agarose gel and the 
band of the expected size was purified and further ligated to the cloning vector 
pGEM-T. The ligation DNA was chemically transformed into E. coli JM109 
competent cells for blue-white screening and colony PCR was performed. Plasmids 
with the correct insert were further purified and digested with EcoRI, which resulted 
in a small fragment ~2.5kb (cutC’) and a large fragment of ~3 kb (pGEM-T 
backbone) suggesting cutC’ was successful cloned into pGEM-T. The cutC’ 
sequence was further confirmed by DNA sequencing (Fig 5.18). 
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The cutC’ fragment was then cut out from pGEM-T-cutC’ with NcoI and PstI and 
inserted into the vector pCOLADuet-cutC/D to create pCOLADuet-cutC’/cutD, 
which was then transformed into the expression strain E. coli BLR (DE3) pLysS.   
In addition, using the same procedure, a second version of the truncated cutC’ was 
also produced by Joshua Lee, a final-year undergraduate project student under my 
supervision, which was inserted to the expression host to generate pCOLADuet-
cutC2’/D. The wild-type cutC is 3432 bp, and the N-terminus truncated cutC is 2577 
bp (cutC’) and 2546 bp (cutC2’), respectively. 
The transformants were cultivated anaerobically in the M9 defined medium and 
choline and TMA concentrations were measured. The cells were harvested and 
cellular proteins were prepared by passing through a French press to assess the 
overexpression of CutC’. Data presented in Fig 5.19 shows expression of wild-type 
CutC as highlighted by the red arrows (around 128.4 kDa). No significant induction 
of the CutC’ truncated mutants (96.4 kDa and 93.7 kDa respectively) was observed 
in the IPTG-induced samples. 
Choline consumption and TMA production data obtained by ion exchange 
chromatography shows TMA production occurred for wild type but not for the 
truncated mutants. However, since the protein were not overexpressed for truncated 
cutC, I cannot conclude whether or not they are able to metabolise choline or the 
role of the N-terminus in anaerobic choline degradation. Further experiments are 
required to optimize the overexpression of CutC’ in recombinant E. coli, for example 
by varying the concentrations of IPTG. 
 
 
	 161		
 
Figure 5.17 An N-terminus truncated cutC cloned into the multiple cloning site MCS 1 using the 
NcoI & PstI restriction sites to investigate the role of its N-terminus on enzyme activity. cutD has 
already been cloned into MCS 2 under the sites NdeI &KpnI. 
 
 
Figure 5.18 The PCR products using primers to generate the N-terminus truncated cutC (cutC’). 1kb 
DNA adder (lanes 1 and 11); PCR products (lanes 2-9); positive control using T7 promoter and T7 
terminator primers (lane 10) and negative control (lane 12). The top bright band at ~2.5 kb represents 
the expected size of the truncated cutC’. Other bands < 2 k bp represent non-specific amplification 
by PCR. 
3kb 
 
2kb 
           1                  2                   3                   4                  5                 6                7                8               9              10            11             12 
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Figure 5.19 SDS-PAGE gel shows the protein overexpression results of the total cell protein and 
supernatant for wt (un-inducted and induced respectively), the induced total cell protein and 
supernatant for CutC truncated mutants.  
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5.2.6 Investigation of the role of a putative choline-responsive tetR-
type transcriptional regulator in choline-TMA lyase expression  
Genome analysis of the choline-TMA lyase gene cluster (Chapter 4, Fig 
4.2&Table 4.2) revealed the presence of a tetR type transcriptional regulator in P. 
mirabilis, which is conserved in other cutCD-containing facultative anaerobes 
(Chapter 4, Fig 4.2&Table 4.2). The tetR transcripional regulator and the 
hypothetic promoter region of the cut gene cluster are shown in Fig 5.11, highlighted 
in dark blue and pink resprectively. The TetR group of transcriptional regulators 
usually work as negative regulators, i.e. when a ligand is absent, the regulator will 
bind to the promoter causing an obstruction of RNA polymerase binding to the 
promoter. This results in switching off downstream gene expression. This change of 
the expression of TetR regulons can be quantified by transcriptional fusion reporter 
assay, e.g. lacZ assay. The promoter region of the cut gene cluster (PtetR) is cloned 
into the plamid pBIO1878 (lacZ) (Lidbury et al., 2014) (Fig 5.20) to construct the 
transcriptional fusion plasmid pBIO1878 (PtetR-lacZ), which is then electroporated 
into P. mirabilis. The cells were grown anaerobically in the presence of choline, 
compared with cultures grown in glucose and other structurally related compounds. 
Cells were then collected and the β-galactosidase assays were carried out (Hampel 
et al., 2014). The results presented in Fig 5.21 demonstrated a two-fold induction of 
the promoter activity in the presence of choline, indicating that the cut cluster is 
indeed switched on by choline.  
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Figure 5.20 The map of the plasmid pBIO1878 (lacZ) with unique restriction sites, and the cloning 
scheme to construct the pBIO1878 (PtetR-lacZ). 
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                             (A)                                                                 (B) 
Figure 5.21 The β-galactosidase assay was carried out by using β-Gal levels as a readout for the 
promoter activity for P. mirabilis [pBIO1878 (PtetR-lacZ)] growing in the NH4+ defined medium 
supplemented with glucose and  choline. (A) shows colour change of choline samples compared with 
glucose; (B) shows 2-fold increase of β-galactosidase activity in choline samples compared with 
glucose. 
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5.3 Discussion 
5.3.1 The role of CutC and the role of choline degradation in TMA 
formation in P. mirabilis  
The human gut microbiome is a very complex but important community for human 
health, being involved in many physiological activities such as metabolism of 
xenobiotics, nutrient acquisition, development of mucosal immunity, inflammatory 
responses and the control of pathogens (Lawley and Walker 2013; Petersson et al., 
2011; Reinhardt et al., 2012; Swan et al., 2009). There are more than 1000 bacterial 
species present in human gut, but the most abundant species in a healthy gut belongs 
to the Bacteroidetes and Firmicutes phyla, whilst Proteobacteria only persist at low 
levels (Arumugam et al., 2011; Yatsunenko et al., 2012; El Kaoutari et al., 2013; 
Winter et al., 2013b). 
Recent studies have demonstrated the fundamental role of gut microbiota 
metabolism of quaternary amines (such as choline and carnitine) to TMA (Craciun 
and Balskus 2012; Zhu et al., 2014). Winter et al. (2013a) have found that 
Gammaproteobacteria could benefit from the host immune and inflammatory 
response to enhance anaerobic respiration. When inflammatory responses occur, the 
rich carbon sources in the gut contents are limited for these microbes by the host via 
diarrhoea, however, choline provided by the host enterocytes and gut mucosa is 
highly available. The resultant TMA is then able to react with superoxide species 
provided by the host and converted to TMAO, which enhances anaerobic respiration 
by these Gammaproteobacteria (Balagam and Richardson 2008). This mechanism 
of taking advantage of the host immune response at least partially accounts for the 
success of Gammaproteobacteria in this competitive environment. 
Recent studies have demonstrated that choline degradation to TMA by gut 
microbiota can trigger the accumulation of TMAO in the circulation, which can lead 
to cardiovascular diseases and non-alcohol liver diseases (Wang et al., 2011; Dumas 
et al., 2006). The facultative anaerobe P. mirabilis was used as a model organism to 
study the molecular mechanism of choline degradation to TMA in this PhD project. 
I have combined phylogenetic, metabolic and genetic analyses to confirm the 
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presence and assign the function of a choline utilisation (cut) cluster in a group of 
human Gammaproteobacteria. The cut cluster was found highly expressed when P. 
mirabilis was growing in a defined NH4+ medium supplemented with choline (See 
Chapter 4). P. mirabilis can use choline as a sole carbon source, but is unable to 
utilize the nitrogen and thus excretes TMA. Choline metabolism in P. mirabilis 
enhanced the anaerobic growth rates in liquid culture and anaerobic colony 
expansion rates on swarming agar plates. 
Anaerobic growth experiments showed that P. mirabilis can very rapidly uptake and 
degrade high concentrations of choline to TMA. The cut promoter is up-regulated 
two-fold in the presence of choline in liquid cultures (Fig 5.21) and transcription of 
the cut gene cluster (PMI2710-22) is strongly up-regulated in the presence of choline 
(See Chapter 4). Similar observations have been made in D. desulfuricans 
(Martínez-del Campo et al., 2015).  
P. mirabilis was able to swarm both aerobically and anaerobically on a solid surface. 
The growth phase and source of the P. mirabilis inoculum was crucial to swarming-
associated colony expansion rates. Inoculum from a fresh agar plate with established 
anaerobic swarm cells resulted in the fastest colony expansion rate, whereas 
inoculum from liquid cultures caused slower swarming (data not shown). Sodium 
fumarate was used as electron acceptor in the defined NH4+ medium for anaerobic 
growth in liquid culture or on swarming plates. This is the first time that true 
anaerobic swarming of this bacterium has been studied in detail (Fig 5.3) as 
previously studies used sodium azide as an indicator to mimic anaerobic respiration 
in an aerobic culture (Alteri et al., 2012; Wilkerson and Niederhoffer 1995).  
Anaerobic swarming is important in the largely anaerobic human gut and urinary 
tract environment, offering a competitive advantage for P. mirabilis to cause 
infection (Armbruster and Mobley, 2012). In this study, choline was observed to 
promote anaerobic swarming by increasing the intervals between consolidation 
phases and colony expansion rates (Fig 5.3). However, the mechanism by which 
choline promotes swarming in P. mirabilis is still unclear. It is known that several 
compounds known as environmental cues, for example, glutamine, can increase 
swarming activity although it has no effect on cell growth (Armbruster et al., 2013). 
Increased concentrations of choline enhanced swarming expansion rates, whereas 
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increased glycerol concentrations showed no impact on swarming rates (Fig 
5.6A&B). The data indicate that choline is very likely functioning as an energy 
source instead of a carbon source for this bacterium. Indeed, in the downstream of 
choline metabolism, acetyl-CoA is produced, which is an important energy 
intermediate during the ATC cycle (Fig 5.5). The cutC::kan mutant had no 
enhancement of swarming when grown on choline (Figure 5.4), suggesting that 
choline-derived chemosensing in promoting swarming is unlikely (Armbruster et al., 
2013). 
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5.3.2 The role of microcompartment proteins in choline degradation 
Martínez-del Campo et al. (2015) have identified two different types of cutC genes 
and the phylogenetic analysis has suggested that different cutCs are associated with 
different microcompartment genes. The glycyl radical enzymes-containing 
microcompartment 1 (GRM1) contains both facultative and obligate anaerobes 
(Type I and Type II.b in this study), with around 2.5 kb of cutC, while the glycyl 
radical microcompartment 2 (GRM2) contains only facultative anaerobes (Type II.a 
in this study), mainly Gammaproteobacteria, with an extra 300 amino acids in the 
N-terminus of CutC (Martínez-del Campo et al., 2015). As also can be seen from 
the phylogenetic tree in Chapter 4, Fig 4.10, all identified cut gene clusters contain 
homologues of microcompartment proteins, suggesting a key role of 
microcompartments in choline degradation (Martínez-del Campo et al., 2015). 
Indeed, a mutant of a microcompartment gene in Desulfovibrio alaskensis was 
unable to degrade choline (Kuehl et al., 2014).  
The P. mirabilis cut cluster belongs to the GRM2, which is widely found in 
opportunistic human pathogens (Axen et al., 2014). There were five genes in the P. 
mirabilis cut cluster predicted to encode for microcompartment shell proteins 
(PMI2722, PMI2721, PMI2720, PMI2718 and PMI2714). It has been proved by 
extensive TEM image analyses that microcompartments did form in P. mirabilis 
liquid cultures or swarming agar plates supplemented with choline anaerobically 
(Fig 5.6&5.7).  
During growth in anaerobic liquid culture, a large layer of extracellular 
polysaccharides (EPS) were found around the cells at 13 and 25 hrs (Fig 5.6). EPS 
has been reported to play a role in biofilm formation and protection of pathogenic 
bacteria. Interestingly, at 48 and 77 hrs the EPS layer was breaking up, becoming 
thinner or disappears, which coincided with the increasing cell density (Fig 5.6). It 
is possible that when the cell numbers increase, carbon source becomes a limiting 
factor and EPS was broken down by the bacterium for the production of energy. I 
have reported, for the first time, that swarmer cells can produce microcompartments. 
Because the formation of microcompartments is very energy-consuming, it thus has 
been assumed that swarmer cells need to carefully balance the energy expenditure 
for cell growth, maintaining cellular metabolism and motility (Armitage 1981; 
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Falkinham and Hoffman, 1984) (Fig 5.7). 
One interesting observation in this project is that cutC is very likely to be linked with 
the assemble of microcompartment protein in P.  mirabilis (Fig 5.8). The wild type 
microcompartments appear electron dense, around 100 nm in diameter and are 
irregularly shaped. However angular structured microcompartments were produced 
by the cutC::kan mutant. The complemented mutant produced not only normal 
shaped microcompartments, but also many angular structures (the same as those 
observed in the cutC::kan mutant). The data therefore suggests that choline 
degradation is likely housed inside microcompartments, presumably up until the 
formation of acetyl-CoA. Further catabolism of acetyl-CoA possibly takes place 
outside the microcompartment and similar observations have been made in 1,2-
propanediol utilizing microcompartments (Parsons et al., 2010).  
To better understand the structure of microcompartment protein, attempts were 
made to purify the P. mirabilis BMCs (Fig 5.9A). However, this was not successful 
and future work should focus on modifying the protocol from Sinha et al. (2012) for 
P. mirabilis using cells cultivated on choline as the sole carbon source. Interestingly, 
some unexpected phage like particles were found in the isolated BMCs (Fig 5.9B).  
It was not straightforward for any growth, purification and TEM work on P. 
mirabilis, since it is a human pathogen. Attempts have been made to overexpress 
microcompartment proteins into E. coli to facilitate further investigation and 
manipulation of BMCs. Fig 5.14 shows the assembly of the five microcompartment 
proteins in E. coli, PMI2722-21-20, PMI2722-21-20-18 and the assembly of 
PMI2722-21-20-18-14, however, there are no proper structures in any of the samples. 
It is likely that the presence of a N-terminal His-tag in PMI2722 interfered with 
protein assembly. It is therefore necessary to produce a new construct by removing 
the N-terminus His-tag and assess the impact of His-tag on microcompartment 
assembly. 
In addition, the whole cutC operon, PMI2722-10 (11.325kb) has been successfully 
amplified (Fig 5.15) and further overexpression will be required to assess the 
assembly of microcompartments in E. coli. In addition, the entire cut operon 
(15.238kb in total) including the two regulator genes, tetR regulator (PMI2725) and 
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the protein-tyrosine phosphatase (PMI2709), should be cloned into E. coli to 
investigate their roles in the formation of BMC. (Fig 5.22). Once the shell proteins 
of E. coli recombinants are created, further purification is then required to 
investigate its structure under TEM. 
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5.3.3 The role of the N-terminal domain in CutC of P. mirabilis  
My data presented in Fig 4.10 showed that cut genes are predominately found in 
Gammaproteobacteria (particularly Enterobacteriaceae), Firmicutes and 
Deltaproteobacteria (Chapter 4). Two distinct cutC genes were identified: the first 
kind of cutC gene includes the type I and type II.b cutC gene (as classified in Fig 
4.10, Chapter 4), both are approximately 2.5 kb in length and are mainly found in 
Firmicutes and Deltaproteobacteria. The other kind of cutC gene includes the type 
II.a cutC (as classified in Fig 4.10, Chapter 4), about 3.4 kb in length with a 300 
amino acids N-terminus. Type II.a is mainly found in Gammaproteobacteria 
including P. mirabilis. 
There are a few hypotheses regarding the function of the additional N-terminus in 
CutC. One possibility is that this extra N-terminal domain may be involved in 
stabilising the enzyme during transient oxygen exposure, because the type II.a CutC 
was only found in facultative anaerobes. This additional N-terminal domain may 
therefore help these facultative anaerobes better adapt to living close to intestinal or 
urinary tract epithelia. Another possibility is that this N-terminus domain may play 
a role in the assembly of microcompartments. Abnormal microcompartment 
structures were observed in the cells of both the cutC::kan mutant and the cutC::kan 
complemented mutant (Fig 5.8), which resemble the swiss-roll like structures that 
are formed when only three Pdu shell proteins (PduA, PduB and PduJ) are 
recombinantly produced in E. coli (Parsons et al., 2010). Pang et al. (2014) have 
reported that PduA is a major component of the Pdu shell and may play a crucial 
role in self-assembly the sheets and higher ordered structures in the over-expressed 
E. coli host. Therefore, it is possible that layered swiss-roll like structures may be 
formed by multiple PduA-like Cut proteins, in the absence of CutC. This suggests 
that CutC may be essential for correct assembly of the microcompartments. Clearly 
the role of CutC in microcompartment formation warrants further investigation. 
The two truncated CutC’ of P. mirabilis were used to investigate if the elongated N-
terminus is essential in choline degradation. However, the SDS-PAGE gel showed 
no obvious expression for truncated cutC, thus further experiments are required to 
optimize the overexpression of CutC’ in recombinant E. coli. A number of strategies 
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can be used to improve expression of CutC’, for example by varying the 
concentrations of IPTG or lowing the induction temperature. 
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5.3.4 The role of the tetR transcriptional regulator in choline-TMA 
lyase expression  
The β-galactosidase assay showed a 2-fold increase of the promoter activity in 
choline samples compared with glucose in P. mirabilis [pBIO1878 (PtetR-lacZ)], 
suggesting that choline acts as an inducer for the cutC operon. This can be further 
validated by RT-PCR experiment targeting cutC. RNA will be extracted from cells 
cultivated on choline or glucose and transcription of cutC will be quantified by RT-
PCR. Furthermore, overexpressing tetR in recombinant E. coli and protein 
purification can be carried out. Gel shift assays will be required to determine the 
promoter sequences which interact with the regulator. Furthermore, tetR gene 
knock-out mutant can be made using the TargeTron system as described previously 
in Chapter 3. Once a mutant is obtained, its growth on choline can be further 
investigated. 
In conclusion, the choline utilization mechanism in the model organism P. mirabilis 
represents an efficient example of a human-niche adaptation in Enterobacteriaceae 
and further in vivo studies to confirm this advantageous adaptation is certainly 
warranted. Metagenomics analysis of the gut microbiome has provided an important 
insight into the microbial communities in relation to gut health and disease, but 
understanding microbial metabolism helps to explain the ecology of the microbiota 
in our gut. Here I have shown how choline is utilised as a carbon and energy source 
by P. mirabilis to facilitate growth in liquid broth and swarming on solid surface. I 
have also identified a novel microcompartment involved in choline metabolism in 
this bacterium. These observations represent a mechanism to help better understand 
the interplay between the host and the gut microbiota and may contribute to explain 
the success of these bacteria during gut dysbiosis in future in vivo studies. 
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Chapter 6 
 
The impact of gut 
microbial TMA formation 
on Caenorhabditis elegans 
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6.1 Introduction 
Previous research carried out in the group by Zhu et al. (2014) has identified the 
metabolic pathway and the functional genes involved in carnitine degradation to 
TMA, cntA and cntB, which are responsible for converting carnitine to TMA and 
malate in the human pathogen Acinetobacter baumannii. Zhu et al. identified the 
essential role of cntAB for this bacterium to grow on carnitine by showing the 
disability of the knockout mutants for carnitine utilisation, and the abolished TMA 
production. Carnitine degradation to TMA by CntAB results in the formation of 
malate and it has been shown previously that malate can extend the life span of 
Caenorhabditis elegans (Edwards et al., 2013).  
To gain a better understanding of the role of carnitine degradation in host-microbe 
interaction, C. elegans was used as the model organism. A. baumannii wild-type 
(wt), cntA and cntB mutants were grown on a defined medium (Zhu et al., 2014) on 
carnitine as the sole carbon source to induce the expression of CntAB. C. elegans 
was then cultivated on these A. baumannii strains to determine the impact of 
carnitine transformation to TMA on the life span of the host, by counting live/death 
of every single nematode for every single day during its life span. To further 
determine the impact of bacterial strains on the life span of the worm, a non-
pathogenic Escherichia coli SE11 strain that is known to metabolize carnitine to 
TMA (Zhu et al., 2014), was also used. 
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 6.2 Results 
6.2.1 The impact of TMA formation by A. baumannii on the life span 
of C. elegans  
In order to investigate the impact of carnitine degradation and TMA formation on C. 
elegans, cntA and cntB mutants were compared against the wild type A. baumannii, 
strain (ATCC 19606) to determine the impact of carnitine-to-TMA formation on the 
worm’s life span. Cultivation of A. baumannii strains and C. elegans life span assays 
are detailed in Chapter 2 Materials and Methods.  
Ten age-synchronized adult nematodes per plate were seeded for A. baumannii wild 
type, cntA, and cntB mutant strains, respectively, with ten plates (i.e. 100 worms in 
total for each strain). The E. coli OP50 strain was used for cultivation and general 
maintenance of C. elegans strain N2 before synchronization. A. baumannii wild type, 
cntA and cntB mutants were grown in the defined M9 medium supplemented with 
carnitine or succinate at a final concentration of 20 mM. 100 µl of M9-washed 
bacterial culture was spotted on NH4+ free M9 medium supplemented with carnitine 
or succinate. The plates were maintained at 20 °C every day and the numbers of 
nematodes (alive, dead or missing) and those that were dried on the wall of the petri 
dishes were all recorded. The percentage of surviving nematodes was plotted over 
time and log-rank tests were performed using Kaplan-Meier survival analysis in 
Sigmaplot (version 11.0). 
Preliminary practices were first carried out following the life span protocol for C. 
elegans strain N2 seeded on A. baumannii wild type, or the cntA and cntB mutants. 
Due to the poor practical skill at the beginning of this experiment, a large number of 
censored worms were counted (more than 50% of the total nematodes), most of 
which were caused by accidently killing from picking. Therefore, more practices 
were carried out until sufficient nematodes for the actual experiment were obtained. 
However, the actual life span experiment, shown in Fig 6.1 & Table 6.1, suggests 
that there was no statistical difference between wt, cntA and cntB, and the survival 
rates are almost the same. 
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Figure 6.1 Lifespan analyses showing the survival rates of C. elegans N2 strain over time at 20 °C. 
100 nematodes were used for each strain: A. baumannii wild type (red line), cntA mutant (blue line) 
and cntB mutant (green line).  
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Table 6.1 Survival analysis (log rank test/multiple comparison) of C. elegans N2 strain fed on A. baumannii wild type, cntA or cntB mutant 
Strain Total Event Censored % of censored Median time Unadjusted p value Significance? 
wt 100 89 11 11 22 Log rank p value No 
cntA 100 93 7 7 22 0.313 
cntB 100 93 7 7 22 
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6.2.2 The role of TMA formation in E. coli SE11 on the life span of 
C. elegans 
6.2.2.1 Feeding of E. coli SE11 by C. elegans strain N2  
To investigate the role of carnitine degradation on the life span of C. elegans N2 
strain, an E. coli SE11 strain was investigated which is also capable of producing 
TMA from carnitine (Zhu et al., 2014). Since it has been well documented that A. 
baumannii is pathogenic against C. elegans, it may have a strong pathogenic effect 
itself on C. elegans rather that the effect of TMA formation from carnitine 
degradation on the worm (Jayamani, 2015). In contrast to A. baumannii, the E. coli 
SE11 strain is nonpathogenic and its genome sequence revealed no known virulence 
factors (Oshima et al., 2008).  SE11 was cultivated on different carbon sources, 20 
mM of carnitine, malate, succinate, malate plus TMA, or succinate with TMA, 
respectively. The experiments were carried out at two temperatures, i.e. 25 °C and 
20 °C. 
Data presented in Fig 6.2 and Table 6.2 show that nematodes seeded on E. coli 
SE11 grown on malate and carnitine lived longer than those grown on succinate. 
The survival analysis suggests that, at 25 °C, there is no significant difference 
between carnitine and malate (log rank p=0.910), but there is significant difference 
between succinate and carnitine (log rank p<0.001), and between succinate and 
malate (log rank p<0.001). In addition, TMA with either succinate or malate (Fig 
6.2 D&E) did not affect the longevity of C. elegans (log rank p=0.221/p=0.094).     
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(A)                                                (B)                                                 (C) 
 
 
                                            (D)                                                      (E) 
Figure 6.2 Lifespan analysis of C. elegans strain N2 at 25 °C. The nematode was fed on E. coli SE11 
grown in the presence of different metabolites in the carnitine degradation pathway: 20 mM final 
concentration of carnitine, malate, succinate, malate plus TMA, or succinate with TMA, respectively. 
(A) Carnitine vs malate. (B) Carnitine vs succinate. (C) Malate vs succinate. (D) Succinate alone vs 
succinate plus TMA. (E) Malate alone vs malate plus TMA. 
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Table 6.2 Survival analysis (log rank test) of C. elegans N2 fed on E. coli SE11 grown on various carbon sources at 25 °C 
Substrate Total Event Censored % of 
censored 
Median time Comparisons Log rank p 
value 
Significance? 
Carnitine 100 71 29 29 10 carnitine vs malate p=0.910 No 
Malate 100 60 40 40 9 carnitine vs succinate p=0.001 Yes 
Succinate 100 78 22 22 8 succinate vs malate p<0.001 Yes 
Succinate + TMA 100 67 33 33 8 succinate vs succinate + TMA p=0.221 No 
Malate + TMA 100 70 30 30 9 malate vs malate + TMA p=0.094 No 
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Because the nematode cultivated at 25 °C had a high rate of censored individuals 
(Table 6.2), indicating a stress response at this temperature, the experiment was 
repeated at 20 °C. Furthermore, a higher number of nematodes (120) for each group 
was used in order to improve statistical power. In agreement with the previous 
results, data presented in Fig 6.3 also shows a longer survival time on malate and 
carnitine than those seeded on succinate. There is a significant difference in life span 
between succinate and malate (log rank p=0.001), and a slight difference between 
succinate and carnitine (log rank p=0.015<0.05), but no difference between carnitine 
and malate (log rank p=0.253). No effect of additional TMA on the worm’s 
longevity was found (p=0.232/p=0.177) (Fig 6.3 & Table 6.3). 
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(A)                                                (B)                                                 (C) 
 
 
                                              (D)                                                  (E) 
Figure 6.3 Life span analysis of C. elegans N2 strains cultivated at 20 °C. The nematode was fed on 
E. coli SE11 grown in the presence of different metabolites in the carnitine degradation pathway, 20 
mM concentrations of carnitine, malate, succinate, malate plus TMA, or succinate with TMA. (A) 
Carnitine vs malate degradation on lifespan. (B) Carnitine vs succinate on lifespan. (C) Malate vs 
succinate treatment on lifespan. (D) Succinate vs succinate plus TMA. (E) Malate vs malate plus 
TMA. 
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Table 6.3 Survival analysis (log rank test) of C. elegans N2 fed on E. coli SE11 grown on various carbon sources at 20 °C 
 
 
 
 
 
Substrate Total Event Censored % of censored Median time Comparisons Log rank 
p value 
Significance? 
Carnitine 120 120 0 0 16 carnitine vs malate p=0.253 No 
Malate 120 106 14 12 17 carnitine vs succinate p=0.015 Yes 
Succinate 120 107 13 11 15 succinate vs malate p=0.001 Yes 
Succinate + TMA 120 104 16 13 14 succinate vs succinate + TMA p=0.232 No 
Malate + TMA 120 109 11 9 15 malate vs malate + TMA p=0.177 No 
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6.2.2.2 Feeding of E. coli SE11 by C. elegans strain CF512  
The survival analysis on C. elegans N2 strain shows a large proportion of censored 
cases during the life span (Tables 6.2). Reducing the growth temperature for the 
worm from 25 °C to 20 °C reduced the percentage of censored worms, however, the 
experiments lasted much longer (4 weeks at 20 °C vs 2 weeks at 25 °C). In order to 
shorten the time for each life span experiment, a C. elegans mutant CF512 strain 
was tested. CF512 strain is a temperature-sensitive strain derived from N2 wild type, 
which does not lay eggs and remains sterile at 25 °C. The same procedure of lifespan 
analysis was thus carried out using this strain as model organism (Hsin, 2007). 
Data presented in Fig 6.4 and Table 6.4 suggest that there is a significant difference 
(p<0.05) between succinate and malate (log rank p=0.033). Additional TMA with 
succinate/malate did not affect the longevity of C. elegans CF512 strain (log rank 
p=0.922/p=0.256). There is no significant difference between carnitine and malate 
(log rank p=0.985), however, there is no difference between carnitine and succinate, 
either (log rank p=0.056).          
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(A)                                                (B)                                                 (C) 
 
 
                                           (D)                                                        (E) 
Figure 6.4 Lifespan analysis of C. elegans CF512 strains at 25 °C fed on E. coli SE11 cultivated on 
different carbon sources, 20 mM concentrations of carnitine, malate, succinate, malate plus TMA, or 
succinate with TMA. (A) Carnitine vs malate. (B) Carnitine vs succinate. (C) Malate vs succinate. 
(D) Succinate vs succinate plus additional TMA. (E) Malate vs malate supplemented with TMA. 
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Table 6.4 Survival analysis (log rank test) of C. elegans CF512 at 25 °C fed on E. coli SE11 grown on difference carbon sources 
Substrate Total Event Censored % of censored Median time Comparisons Log rank 
p value 
Significance? 
Carnitine 120 120 0 0 9 carnitine vs malate p=0.985 No 
Malate 120 120 0 0 9 carnitine vs succinate p=0.056 No  
Succinate 120 120 0 0 8 succinate vs malate p=0.033 Yes 
Succinate + TMA 120 120 0 0 8 succinate vs succinate + TMA p=0.922 No 
Malate + TMA 120 120 0 0 9 malate vs malate + TMA p=0.256 No 
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6.3 Discussion 
6.3.1 Compare C. elegans N2 life span during carnitine degradation 
in A. baumannii wild type, cntA and cntB mutants 
At the beginning of the preliminary practices of C. elegans strain N2 life span 
experiments on the three strains of A. baumannii, poor reproductivity was observed 
in each practice and indicated contrasting results of the effect of carnitine 
degradation on C. elegans longevity (data not shown). The reason for the 
inconsistency is probably due to the lack of technical proficient skills of performing 
such experiments at that moment. This can be seen by the high rates of censored 
cases (the percentage of censored cases was almost 50%), in which accidental death 
of worm was caused by improper transfer of worms by picking. Therefore, more 
practices were carried out before the actual experiment was performed. With the 
improved experimental skills, the censored rate became reasonably low for the 
actual experiment. However, in the experiment, the survival rates for wt, cntA and 
cntB were almost the same, i.e. 30 days for wt, cntA and cntB, although the log rank 
p value is improved and no pairwise comparison is required. The above data suggests 
there is no statistically significant difference (p<0.05) in life span of C. elegans fed 
on wt or the mutants of A. baumannii (Fig 6.1 & Table 6.1).  
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6.3.2 Compare C. elegans N2 life span fed on E. coli SE11 grown on 
carnitine and other carbon sources 
For C. elegans N2 strain, the life span experiment was first carried out at 25 °C, 
which promoted a fast growth rate for the worm, however, the nematodes may have 
experienced stresses under this temperature as evidenced by the higher percentage 
of censored cases. Therefore, the experiment was repeated at a lower temperature 
(20 °C) for C. elegans. At both incubation temperatures, the survival analyses 
confirmed that there is a significant difference (p<0.05) between succinate vs 
carnitine, succinate vs malate, but no significant difference is found between 
carnitine and malate. Interestingly, it is confirmed that TMA did not affect the 
longevity of C. elegans (Fig 6.2 & Table 6.2, Fig 6.3 & Table 6.3). 
At 25 °C, multiple group comparison (Fig 6.5 & Table 6.5) showed the same 
significance between carnitine and succinate as in the single group comparison (Fig 
6.2 & Table 6.2). At 20 °C, when single pairs of groups (Fig 6.3 & Table 6.3) were 
compared, the survival analysis confirmed that there is a difference of the life span 
of the worm between succinate vs carnitine. However, there was no difference when 
multiple comparisons were carried out (Fig 6.6 & Table 6.6).  
This is because p values used for single-group comparison vs multiple group 
comparison are different in the Kaplan-Meier survival analysis. When single 
comparison was carried out, p<0.001 was regarded as significant, in which if the 
null hypothesis is true, there is a 1% chance of ending up with a 'statistically 
significant' result simply by chance. However, when multiple-group comparison was 
carried out, this 1% value applies to the entire family of comparisons. The 1% is 
defined as the family-wise error rate, an adjusted p value. This means that if all the 
null hypotheses were true, there is a 1% chance that one or more of the differences 
will be 'statistically significant' simply due to random variation, leaving a 99% 
chance that all the comparisons will be 'not significant' (Krzywinski and Altman, 
2014).  Under this circumstance, multiple comparison will not be reliable, for 
example, comparison between different conditions. The analysis will calculate the 
whole group including conditions, replicates etc. and take the average as adjusted p 
value. Therefore, the single comparison is usually carried out initially to see whether 
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there is a significant level, before the multiple groups of different conditions are 
compared. (Krzywinski and Altman, 2014). 
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Figure 6.5 Survival curves of C. elegans N2 strains at 25 °C growth on different substrates in 
carnitine degradation in E. coli SE11: carnitine, malate, succinate, malate plus TMA, and succinate 
with TMA. 
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Table 6.5 Survival analysis (multiple group comparisons) of C. elegans N2 in different substrates in E. coli SE11 at 25 °C 
Comparisons Statistic Unadjusted P value Significance? 
Succinate vs malate 12.675 0.000371 Yes 
Carnitine vs succinate 10.507 0.00119 Yes 
Malate vs malate +TMA 2.807 0.0938 No 
Succinate vs succinate +TMA 1.497 0.221 No 
Carnitine vs malate 0.0129 0.910 No 
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Figure 6.6 Survival curves of C. elegans N2 strains at 20 °C growth on different substrates in 
carnitine degradation in E. coli SE11: carnitine, malate, succinate, malate plus TMA, and succinate 
with TMA. 
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Table 6.6 Survival analysis (multiple group comparisons) of C. elegans N2 in different substrates in E. coli SE11 at 20 °C 
Comparisons Statistic Unadjusted P value Significance? 
Succinate vs malate 10.560 0.00116 Yes 
Carnitine vs succinate 4.042 0.0444 No 
Succinate vs succinate +TMA 1.823 0.177 No 
Malate vs malate +TMA 1.822 0.177 No 
Carnitine vs malate 1.308 0.253 No 
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6.3.3 Comparison of C. elegans CF512 life span during carnitine 
degradation in E. coli SE11 wild type 
C. elegans CF512 strain was used to reduce the high rate of censored nematodes and 
improve the efficiency of the survival analyses. There is a significant difference 
between succinate and malate, but no difference of carnitine vs succinate and 
carnitine vs malate was found. Additional TMA with succinate/malate did not affect 
the longevity of C. elegans CF512 strain (Fig 6.4 & Table 6.4), but the multiple 
comparison showed no significant differences in the three groups (Fig 6.7 & Table 
6.7). One possible reason is that CF512 is a temperature-sensitive mutant stain of 
N2 (mutations in rrf-3(b26) II and fem-1(hc17) IV genes, which is involved in 
promoting activity of repeated genes and required for masculinization of germline 
and somatic tissues, respectively) and will stay sterile without producing progeny at 
this temperature, however, the mutation may have caused unknown impact on its 
life span during carnitine degradation.  
Overall, the data presented in this Chapter suggest that the bio-degradation of 
carnitine by E. coli SE11 may affect C. elegans life span. This difference cannot be 
attributed to the formation of TMA from carnitine degradation because additional 
TMA did not affect the longevity of the worm. Therefore, in agreement with 
previous reports (Edwards et al., 2013), it is likely that the intermediate, malate 
which is formed from carnitine degradation by the bacterium, may have extended 
the life span of C. elegans. However, due to the time limit of the PhD project, 
biological replicates have not been carried out for any of the three experiments: C. 
elegans N2 life span during carnitine degradation in A. baumannii wild type, cntA 
and cntB mutant, N2 life span during carnitine degradation in SE11, and CF512 life 
span during carnitine degradation in SE11. Therefore, to further ascertain the 
conclusion, 2 or more biological replicates of life span experiments will need to be 
carried out independently. Besides, once the cntA and cntB of mutants of SE11 are 
obtained, further tests will also be required to compare the wt vs cntA or cntB mutant 
of SE11 with at least 3 biological replicates for each life span experiment. 
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Figure 6.7 Survival curves of C. elegans CF512 strains at 25 °C growth on different substrates in 
carnitine degradation in E. coli SE11: carnitine, malate, succinate, malate plus TMA, and succinate 
with TMA. 
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Table 6.7 Survival analysis (multiple group comparisons) of C. elegans CF512 in different substrates in E. coli SE11 at 25 °C 
Comparisons Statistic Unadjusted P value Significance? 
Succinate vs malate 4.565 0.0326 No 
Carnitine vs succinate 3.656 0.0559 No 
Malate vs malate +TMA 1.290 0.256 No 
Succinate vs succinate +TMA 0.00964 0.922 No 
Carnitine vs malate 0.000352 0.985 No 
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Chapter 7 
 
 
 
Summary and future 
perspectives 
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7.1 Chapter 3 - Developing a method for genetic 
manipulation of Proteus mirabilis 
This chapter aimed to establish the genetic mutagenesis method for targeted gene 
knockout in P. mirabilis.  
The initial test of four P. mirabilis strains were first carried out to confirm their ability 
to convert choline to TMA. MIC tests were then carried out for the four stains of P. 
mirabilis, which showed no difference in antibiotic resistance profiles and the strain 
DSMZ4479 was therefore used as the model strain in this study. A few attempts were 
made to establish the plasmid transfer and targeted gene knock-out mutagenesis 
methods. pKNG101 was initially chosen as a suicide vector in order to facilitate 
homologous recombination; however, due to the incompatibility of pR6K-type plasmid 
present in the strain DSMZ4479, it was impossible for conjugating pKNG101 into this 
bacterium. The TargeTron gene knockout kit from Sigma Aldrich was then adopted 
and the cutC gene was successfully deleted from P. mirabilis DSMZ4479. The 
cutC::kan mutant was further complemented by cloning and expression of the native 
cutC/D gene from DSMZ4479, with growth tests subsequently carried out to confirm 
their phenotypes. However, a major limitation of the TargeTron method is the low 
efficiency of electroporation-mediated plasmid transfer, which is estimated to be ~ 
4×105 CFU/µg. Further optimization is required in order to improve the efficiency. 
Furthermore, it remains unknown if similar pR6K-type plasmids are present in other 
clinic P. mirabilis strains, such as P14 and P19, and it remains to be established whether 
pKNG101-based conjugation method will work in those isolates.  
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7.2 Chapter 4 - Comparative transcriptomic analysis 
of Proteus mirabilis by RNA-Seq 
Chapter 4 took the advantage of comparative transcriptomics (RNA-Seq) to investigate 
the key genes involved in choline degradation to TMA in P. mirabilis. From the RNA-
Seq data analysis, 18 highly-expressed genes were identifed in the presence of 
additional choline, including the choline-TMA lyase gene (cutC), activating enzyme 
(cutD) and genes encoding for putative microcompartments. The subsequent 
phylogenetic and genome analyses revealed the functional choline-TMA lyase and the 
cutC gene cluster in P. mirabilis and the cutC gene cluster was compared between P. 
mirabilis and D. desulfuricans (Aim 1). 
The phylogenetic tree presented in Chapter 4, Fig 4.10 has clearly divided species 
according to the different types of cutC genes. There are two distinct groups of CutC. 
Type I and Type II.b contained both facultative and obligate anaerobes with CutC 
around 2.5 kb in length whereas the Type II.a group contained only facultative 
anaerobes (mainly Gammaproteobacteria) with an extra 300 amino acids long N-
terminus domain in CutC. As previously described by Martínez-del Campo et al., the 
cut gene clusters contain homologues of microcompartment proteins, therefore, the role 
of microcompartments in choline degradation was further examined.  
Phylogenetically, CutC belongs to the so-called glycyl radical protein family, which 
also includes B12-independent glycerol dehydrogenase and pyruvate formate lyase. 
Recently, an interesting study from Romano et al. (2015) screened choline utilization 
and TMA formation using 79 bacterial strains isolated from human intestine, many of 
which contained the predicted choline-TMA lyase according to genome analyses. The 
result indicated that two species, Providencia alcalifaciens and Providencia rustiganii, 
did not generate TMA although their genomes do encode a seemingly entire choline-
TMA lyase pathway. On the other hand, one strain, E. tarda strain 23685, does not 
contain cut genes in its genome but produced TMA from choline (Romano et al., 2015). 
These results suggest cautions need to be taken when using cutC as the functional gene 
marker for predicting choline utilization and it is likely that CutC homologs shown in 
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the phylogenetic tree may have other functions rather than choline utilization. It is 
possible that other choline-to-TMA transformation pathways may also exist (e.g. in E. 
tarda), which warrants further investigation. 
Both genome analysis and the constructed phylogenetic tree suggest the presence of an 
extra N-terminus of CutC in some gut microbiota. The type II.a CutC, containing 
mainly sequences of Enterobacteriaceae such as P. mirabilis, has an additional ~300 
amino acids towards the N-terminus (Fig 4.11). Interestingly, the type II.a CutC was 
only identified from facultative anaerobes, therefore the role of this extra N-terminus 
of CutC is postulated to have an association with stabilizing the enzyme during transient 
oxygen exposure (Chapter 4). It may also be involved to facilitate CutC folding during 
translation. It is unfortunate that an attempt to generate a truncated CutC of P. mirabilis 
was not successful due to the lack of expression of the truncated protein (Chapter 5). 
Therefore, further work on mutagenesis and overexpression of the N-terminus of CutC 
will be necessary to confirm these hypotheses.  
The tetR-family transcriptional regulator was also highly expressed. It is hypothesized 
that the tetR gene plays a role as a negative repressor. In the presence of choline, TetR 
will bind to choline instead of the promoter, and thus switch on the transcription of the 
whole gene cluster. Besides, the structure and folding of tRNA may change to assist 
the regulation of the tetR with or without choline. To prove the function of this regulator, 
knock-out mutagenesis and overexpression of this protein followed by gel-shift assays 
are therefore required. 
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7.3 Chapter 5 - Anaerobic choline degradation in 
Proteus mirabilis  
The work presented in this Chapter clearly demonstrated the functional genes involved 
in the choline metabolism to TMA using P. mirabilis as the model system through 
targeted mutagenesis. Using the marker exchange mutagenesis method established in 
Chapter 3, I investigated whether the cutC gene is indeed essential for choline 
degradation and subsequent TMA production in P. mirabilis. In addition, I investigated 
the physiological role of choline degradation to TMA in this bacterium in both liquid 
culture and on solid agar plates. The data presented in this Chapter indicates that choline 
enhanced growth of P. mirabilis in broth culture, and played a greater role in swarming 
where it significantly enhanced swarming speed and reduced the need for consolidation 
(Aim 2). Furthermore, I observed the formation of microcompartments in this 
bacterium during its growth on choline and the role of the shell protein in choline 
degradation (Aim 3). Surprisingly, it was observed that the cutC gene was also required 
for the formation of microcompartments. 
My data showed that choline metabolism enhanced the anaerobic growth rates in liquid 
culture. The addition of choline not only increased swarming rates, but also enhanced 
intervals between colony expansion distance and consolidation phases under anaerobic 
conditions (Fig 5.3). P. mirabilis can use choline as a sole carbon source and is able to 
uptake and degrade high concentrations (~ 20 mM) of choline to TMA rapidly. 
Furthermore, I have confirmed that the cut promoter was up-regulated two-fold with 
the presence of choline in liquid cultures using the beta-galactosidase assay (Fig 5.21). 
This was also confirmed by the RNA-Seq analysis, showing that the transcription of 
the cut gene cluster (PMI2710-22) was strongly up-regulated in the presence of choline 
(Chapter 4). Similarly, induction of cut gene cluster by choline has also been observed 
in D. desulfuricans by Martínez-del Campo et al. (2015).  
However, there are still a few outstanding questions that merit further investigation.  
1. How do microcompartments assemble in P. mirabilis? Overexpression of 
microcompartment proteins into E. coli has been carried out to facilitate further 
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investigation and microcompartment purification. However, no proper structures have 
been gained in any of the samples (Fig 5.14). The likely interference from the N-
terminal His-tag on PMI2722 with protein assembly is a plausible explanation. It is 
therefore wise to re-clone these genes into E. coli without a His-tag and possibly include 
the natural ribosome binding regions for all the 5 genes encoding the 
microcompartment to achieve a desirable ratio of each polypeptide for correct assembly 
of the microcompartment. It is also possible to overexpress the whole cut operon in E. 
coli, together with the putative regulator genes tetR (PMI2725) and/or the protein-
tyrosine phosphatase (PMI2709) (Fig 5.22).  
2. The role of the extra N-terminus in CutC remains elusive. The SDS-PAGE gel of the 
truncated CutC’ of P. mirabilis did not show obvious expression for the two versions 
of the truncated CutC. The concentrations of IPTG and induction temperature may 
affect the expression efficiency in recombinant E. coli. Therefore, further experiments 
are required to optimize the overexpression of CutC’ in recombinant E. coli. Once the 
overexpression is successful, growth experiments of the recombinant E. coli in the 
presence of choline will be required to investigate if the elongated N-terminus is indeed 
essential in choline degradation.  
3. Validation of the role of the tetR regulator in choline metabolism. The β-
galactosidase enzyme assay suggests that choline acted as an inducer for the cut operon 
and a 2-fold increase of the promoter activity was observed in choline samples 
compared with glucose in P. mirabilis [pBIO1878 (PtetR-lacZ)]. A tetR gene knock-out 
mutant is required to firmly establish the role of this regulator in regulating choline 
metabolism (as discussed in Chapter 3). Once a mutant is obtained, its growth on 
choline can be further investigated. Overexpression of tetR in recombinant E. coli and 
protein purification will be further carried out to confirm the interaction of TetR with a 
range of ligands including choline by gel shift assays. 
4. Experiments carried out in this chapter have clearly demonstrated a growth 
advantage from choline metabolism in P. mirabilis, however, further in vivo studies to 
confirm this advantageous adaptation in interaction with the host is certainly warranted. 
A mouse in vivo model can be set up for dietary interventions. Specifically, mice could 
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be treated with choline and non-choline food (e.g. carbohydrate), and various health 
parameters will be assessed including glucose homeostasis, fatty lipids profile and 
TMAO accumulation. The concentrations of glucose and TMAO in the serum could be 
determined by liquid chromatography to assess the link between choline metabolism 
and diabetes and cardiovascular disease. Lipids in the gut metabolites could be 
measured by LC-Mass spectrometry.  
5. Meta-transcriptomics analysis can be used to investigate the microbial community 
under different conditions. Unlike metagenomics, which indicates which microbes are 
present in the microbial community, meta-transcriptomics allows study of the diversity 
of actively transcribed genes, gene expression abundance and gene differential 
expression in a specific microbial environment (Bashiardes et al., 2016). By using 
meta-transcriptomics, sample cultures from human or animals can be prepared and the 
complex microbial community across all species can be identified. Furthermore, 
cultures could be grown under choline and non-choline fed conditions, and the 
differentially expressed genes and the diversity of functional pathways can be explored 
and the abundance of cutC across many taxa can be quantified using this technology. 
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7.4 Chapter 6 - The impact of gut microbial TMA 
formation on Caenorhabditis elegans 
C. elegans was used as the model organism in this chapter to investigate the role of 
carnitine degradation in host-microbe interaction. The worms were fed on 
Acinetobacter baumannii wild-type (wt), cntA and cntB mutants, which were grown on 
carnitine to determine the impact of carnitine transformation to TMA on the life span 
of the host. Escherichia coli SE11 strain was further used to determine the impact of 
bacterial strains on the life span of the worm metabolizing carnitine to TMA (Aim 4). 
Carnitine degradation in A. baumannii wt, cntA and cntB showed no difference on the 
life span of C. elegans N2 strain (Fig 6.1 & Table 6.1). For carnitine degradation in E. 
coli SE11, both multiple group comparison (Fig 6.5 & Table 6.5) and single group 
comparison showed clear difference between carnitine and succinate on C. elegans N2 
strain at 25 °C. At 20 °C, single group comparison (Fig 6.3 & Table 6.3) confirmed 
that there is a difference of the life span of the worm between succinate vs carnitine 
treatments, however, such difference was not obvious when multiple comparisons were 
carried out (Fig 6.6 & Table 6.6). When the C. elegans CF512 strain was used, it was 
found that there is a significant difference between succinate and malate treatments, but 
no difference for carnitine vs succinate or carnitine vs malate (Fig 6.4 & Table 6.4), 
however, multiple comparison showed no significant differences in the three groups 
(Fig 6.7 & Table 6.7). 
The Kaplan-Meier survival analysis uses the log rank test for significance assessment. 
The log rank test calculates chi-squared values for each time event for each group and 
sums the results to give an ultimate chi-squared value.  As can be seen from Table 6.1, 
throughout the analyses, unadjusted p value was used.  Multiple testing corrections have 
been applied here to reduce the number of false positive results (Rich et al., 2010).  
Different results were obtained when using single group comparison and multiple group 
comparison (Fig 6.3 & Table 6.3 vs Fig 6.6 & Table 6.6, Fig 6.4 & Table 6.4 vs Fig 
6.7 & Table 6.7). This is because p values used for single-group comparison vs 
multiple group comparison are different in the Kaplan-Meier survival analysis 
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(Krzywinski and Altman, 2014). When single comparison was carried out, p<0.001 was 
regarded as significant. If the overall p value is below the desired significance level, it 
regards the result as significant. Specifically, if the null hypothesis is true, there is a 1 % 
chance of ending up with a 'statistically significant' result simply by chance. However, 
when multiple-group comparison was carried out, this 1 % value applies to the entire 
family of comparisons. The 1 % is defined as the family-wise error rate, an adjusted p 
value. This means that if all the null hypotheses were true, there is a 1 % chance that 
one or more of the differences will be 'statistically significant' simply due to random 
variation, leaving a 99 % chance that all the comparisons will be 'not significant' 
(Krzywinski and Altman, 2014).  
Single comparison in Fig 6.4 and Table 6.4 suggest that there is a significant difference 
(p<0.05) between succinate and malate (log rank p=0.033). The conventional cut-off is 
p<0.05 (5 %). It did give some confidence for significance, however, the p value (3.3 %) 
was close to the cut-off value (5 %). When small differences appear in comparison, the 
simplest approach is to repeat the experiment, for example succinate-malate 
comparison, to see if similar results will be obtained. If repeatable, the difference is 
likely to be real. If not, the difference obtained in the first comparison is very likely to 
be a false positive. Under this circumstance, the multiple comparison will not be 
reliable since the analysis will calculate the whole group including conditions, 
replicates etc. and take the average as adjusted p value. Therefore, single comparison 
is usually preferred in the first instance to see whether there is a significant level under 
multiple conditions, however, these experiments need to be repeated in order to confirm 
the observations (Krzywinski and Altman, 2014).  
Two C. elegans strains (e.g. CF512 strain and N2 strain) have been used in this study 
and differences in life span have been observed on the same treatment. The mutation in 
the activity of repeated genes and masculinization of germline in CF512 strain may 
have caused unknown impact on its life span during carnitine degradation. Additional 
TMA with either succinate or malate did not affect the longevity of C. elegans CF512 
strain (Fig 6.4 & Table 6.4), suggesting that TMA is not harmful for the worm.  
As discussed above, the bio-degradation of carnitine by E. coli SE11 may have affected 
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the life span of C. elegans. Since the additional TMA did not affect the longevity of the 
worms, it is likely that the intermediate, malate, which is formed from carnitine 
degradation by the bacterium, may have extended the life span of C. elegans. cntA and 
cntB mutants of SE11 are thus required in order to test this hypothesis using the 
experimental procedures established in this thesis. 
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In summary, the data presented in this thesis demonstrates the ability of 
Enterobacteriaceae in human gut to utilize choline and carnitine as a source of nutrients. 
A number of key genes and enzymes essential for the catabolism of choline, such as 
choline-TMA lyase and microcompartment proteins, have been identified by RNA-Seq 
and the functions of these key genes have been confirmed by mutagenesis and culture 
growth in the presence/absence of choline. A number of genes revealed by RNA-Seq 
analysis, which are highly expressed in the presence of choline, still remain 
uninvestigated, providing an avenue for further research. In addition, malate, the 
intermediate of carnitine degradation to TMA, may play a role in host-microbe 
interaction that expends the life span of C. elegans, and this hypothesis warrants further 
investigation. The results presented in this thesis help better understand the interplay 
between the host and the gut microbiota in heath and disease. 
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